<SEC-DOCUMENT>0001552781-24-000464.txt : 20240809
<SEC-HEADER>0001552781-24-000464.hdr.sgml : 20240809
<ACCEPTANCE-DATETIME>20240809161707
ACCESSION NUMBER:		0001552781-24-000464
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20240809
DATE AS OF CHANGE:		20240809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COCA COLA CO
		CENTRAL INDEX KEY:			0000021344
		STANDARD INDUSTRIAL CLASSIFICATION:	BEVERAGES [2080]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				580628465
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268053
		FILM NUMBER:		241193043

	BUSINESS ADDRESS:	
		STREET 1:		ONE COCA COLA PLAZA
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30313
		BUSINESS PHONE:		404-676-2121

	MAIL ADDRESS:	
		STREET 1:		ONE COCA COLA PLAZA
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>e24337_koeuro-424b2.htm
<TEXT>
<HTML STYLE="font: 10pt Times New Roman, Times, Serif">
<HEAD STYLE="font: 10pt Times New Roman, Times, Serif">
     <TITLE STYLE="font: 10pt Times New Roman, Times, Serif"></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: right"><FONT STYLE="font-size: 10pt">Filed pursuant
to Rule 424(b)(2)<BR STYLE="font: 10pt Times New Roman, Times, Serif">
Registration No. 333-268053</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS SUPPLEMENT<BR STYLE="font: 10pt Times New Roman, Times, Serif">
(To Prospectus Dated October 28, 2022)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&euro;1,000,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center; color: Red">&nbsp;<IMG SRC="e24325001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&euro;500,000,000
3.375%</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> Notes due 2037</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&euro;500,000,000
3.750%</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> Notes due 2053</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are offering &euro;500,000,000 principal amount of 3.375% Notes due 2037, which we refer to in this prospectus supplement
as the &ldquo;2037 notes&rdquo; and &euro;500,000,000 principal amount of 3.750% Notes due 2053, which we refer to in this
prospectus supplement as the &ldquo;2053 notes.&rdquo; We collectively refer to all of the series of notes offered hereby as the &ldquo;notes.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
2037 notes will bear interest at a rate per annum of 3.375% and the 2053 notes will bear interest at a rate per annum of 3.750%.
We will pay interest on the 2037 notes on August 15 of each year, beginning on August 15, 2025. We will pay interest
on the 2053 notes on August 15 of each year, beginning on August 15, 2025. The 2037 notes will mature on August 15,
2037 and the 2053 notes will mature on August 15, 2053.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
may redeem any series of the notes at our option and at any time, either in whole or in part, at the applicable redemption price described
in this prospectus supplement. In addition, any series of the notes may be redeemed in whole but not in part, at any time at our option,
in the event of certain developments affecting U.S. taxation. See &ldquo;Description of Notes&mdash;Redemption for Tax Reasons.&rdquo;
The notes will be our unsecured obligations and will rank equally with our unsecured senior indebtedness from time to time outstanding.
The notes will be issued in minimum denominations of &euro;100,000 and in integral multiples of &euro;1,000 in excess thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
intend to apply to list the notes on the New York Stock Exchange (&ldquo;NYSE&rdquo;), and we expect trading on the NYSE to begin within
30 days after the initial issuance of the notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in the notes involves risks. See &ldquo;Risk Factors&rdquo; in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000009/ko-20231231.htm">Annual Report on Form 10-K for the year ended December 31, 2023</A> and
the other information included or incorporated by reference into this prospectus supplement and the accompanying prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>None
of the Securities and Exchange Commission (the &ldquo;SEC&rdquo;), any state securities commission or any other regulatory body has approved
or disapproved of the notes or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any
representation to the contrary is a criminal offense.</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Per
    2037<BR>
    Note</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Total</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Per
    2053<BR>
    Note</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Total</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">Public
    offering price</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right">98.927</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">494,635,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">98.339</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">491,695,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">Underwriting
    discount</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">0.500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.750</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">Proceeds,
    before expenses, to The Coca-Cola Company</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">98.427</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">492,135,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">97.589</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,945,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
public offering prices set forth above do not include accrued interest, if any. Interest on the notes will accrue from and including
August&nbsp;15, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
underwriters expect to deliver the notes to investors through the book-entry delivery system of Clearstream Banking, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>soci&eacute;t&eacute;
anonyme</I></FONT> (&ldquo;Clearstream&rdquo;) and Euroclear Bank S.A./N.V. (&ldquo;Euroclear&rdquo;), on or about August 15,
2024.<BR STYLE="font: 10pt Times New Roman, Times, Serif">
<BR STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><I>Joint
Book-Running Managers</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>Barclays</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>BNP
    PARIBAS</B></FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>J.P.
    Morgan</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>HSBC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>MUFG</B></FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>Standard
    Chartered Bank</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Co-Managers</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Academy
    Securities</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ramirez
    &amp; Co., Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
date of this prospectus supplement is August 8, 2024.</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">TABLE OF CONTENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus
Supplement</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Page</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; text-align: left"><A HREF="#e24325a001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">S-3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a002"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a003"><FONT STYLE="font-size: 10pt">SUMMARY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a004"><FONT STYLE="font-size: 10pt">CURRENCY CONVERSION AND FOREIGN EXCHANGE RISKS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a005"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a006"><FONT STYLE="font-size: 10pt">CAPITALIZATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a007"><FONT STYLE="font-size: 10pt">DESCRIPTION OF NOTES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a008"><FONT STYLE="font-size: 10pt">U.S. FEDERAL INCOME TAX CONSIDERATIONS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="padding-left: 8.65pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -8.65pt"><A HREF="#e24325a009"><FONT STYLE="font-size: 10pt">EUROPEAN UNION DIRECTIVE ON ADMINISTRATIVE COOPERATION AND PROPOSED FINANCIAL TRANSACTIONS TAX</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-25</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a010"><FONT STYLE="font-size: 10pt">UNDERWRITING</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-26</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#e24325a011"><FONT STYLE="font-size: 10pt">LEGAL OPINIONS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">S-31</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%"><A HREF="#e22463a_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OUR COMPANY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_007"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">19</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_008"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_009"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF DEPOSITARY SHARES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_010"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF PURCHASE CONTRACTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">27</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_011"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">28</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_012"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">29</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_013"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">29</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
this prospectus supplement, except as otherwise indicated or the context otherwise requires, the terms &ldquo;The Coca-Cola Company,&rdquo;
&ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; mean The Coca-Cola Company and all entities included
in its consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">References
herein to &ldquo;$&rdquo; and &ldquo;dollars&rdquo; are to the lawful currency of the United States. References to &ldquo;&euro;&rdquo;
and &ldquo;euro&rdquo; are to the lawful currency of the member states of the European Monetary Union (the &ldquo;Member States&rdquo;)
that have adopted the euro as their currency. The financial information presented or incorporated by reference in this prospectus supplement
and the accompanying prospectus has been prepared in accordance with Generally Accepted Accounting Principles in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
CONNECTION WITH THIS OFFERING, J.P. MORGAN SECURITIES PLC, AS STABILIZING MANAGER (OR PERSONS ACTING ON ITS BEHALF) MAY OVER-ALLOT
NOTES OR EFFECT TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICE OF THE NOTES AT LEVELS WHICH MIGHT NOT OTHERWISE PREVAIL. THIS
STABILIZING, IF COMMENCED, MAY BE DISCONTINUED AT ANY TIME AND WILL BE CARRIED OUT IN COMPLIANCE WITH ALL APPLICABLE LAWS AND RULES.
ANY STABILIZATION ACTION MAY BEGIN ON OR AFTER THE DATE ON WHICH ADEQUATE PUBLIC DISCLOSURE OF THE TERMS OF THE OFFER OF THE NOTES IS
MADE AND, IF BEGUN, MAY BE ENDED AT ANY TIME, BUT IT MUST END NO LATER THAN THE EARLIER OF 30 CALENDAR DAYS AFTER THE ISSUE DATE OF THE
NOTES AND NO LATER THAN 60 DAYS AFTER THE DATE OF THE ALLOTMENT OF THE NOTES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes are offered globally for sale only in those jurisdictions where it is lawful to make such offers. The distribution of this prospectus
supplement and the accompanying prospectus and the offering or sale of the notes in some jurisdictions may be restricted by law. Persons
outside the United States who receive this prospectus supplement and the accompanying prospectus should inform themselves about and observe
any applicable restrictions. This prospectus supplement and the accompanying prospectus may not be used for or in connection with an
offer or solicitation by any person in any jurisdiction in which that offer or solicitation is not authorized or to any person to whom
it is unlawful to make that offer or solicitation. See &ldquo;Underwriting&mdash;Selling Restrictions.&rdquo;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">PROHIBITION
OF SALES TO EEA RETAIL INVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available
to any retail investor in the European Economic Area (&ldquo;EEA&rdquo;). For these purposes, a retail investor means a person who is
one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &ldquo;MiFID II&rdquo;);
or (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the &ldquo;Insurance Distribution Directive&rdquo;), where
that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information
document required by Regulation (EU) No 1286/2014 (as amended, the &ldquo;PRIIPs Regulation&rdquo;) for offering or selling the notes
or otherwise making them available to retail investors in the EEA has been prepared, and therefore, offering or selling the notes or
otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. Neither this prospectus
supplement nor the accompanying prospectus is a prospectus for the purposes of Regulation (EU) 2017/1129 (the &ldquo;Prospectus Regulation&rdquo;),
and any offer of the notes in any member state of the EEA is made pursuant to an exemption under the Prospectus Regulation from the requirement
to publish a prospectus for offers of notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">PROHIBITION
OF SALES TO UK RETAIL INVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available
to any retail investor in the United Kingdom. For these purposes, a &ldquo;retail investor&rdquo; means a person who is one (or more)
of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law in the
United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (the &ldquo;EUWA&rdquo;); or (ii) a customer within the meaning
of the provisions of the Financial Services and Markets Act 2000 (as amended, the &ldquo;FSMA&rdquo;) and any rules or regulations made
under the FSMA to implement Directive (EU) 2016/97, as amended, where that customer would not qualify as a professional client, as defined
in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law in the United Kingdom by virtue of the EUWA.
Consequently, no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law in the United Kingdom
by virtue of the EUWA (the &ldquo;UK PRIIPs Regulation&rdquo;) for offering or selling the notes or otherwise making them available to
retail investors in the United Kingdom has been prepared and, therefore, offering or selling the notes or otherwise making them available
to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation. Neither this prospectus supplement nor the
accompanying prospectus is a prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United
Kingdom by virtue of the EUWA (the &ldquo;UK Prospectus Regulation&rdquo;) or FSMA, and any offer of the notes in the United Kingdom
is made pursuant to an exemption under the UK Prospectus Regulation and the FSMA from the requirement to publish a prospectus for offers
of notes.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">MIFID II PRODUCT
GOVERNANCE/PROFESSIONAL INVESTORS AND ECPS ONLY TARGET MARKET</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Solely
for the purposes of each manufacturer&rsquo;s product approval process, the target market assessment in respect of the notes has led
to the conclusion that: (i) the target market for the notes is eligible counterparties and professional clients only, each as defined
in MiFID II; and (ii) all channels for distribution of the notes to eligible counterparties and professional clients are appropriate.
Any person subsequently offering, selling or recommending the notes (a &ldquo;distributor&rdquo;) should take into consideration the
manufacturers&rsquo; target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target
market assessment in respect of the notes (by either adopting or refining the manufacturers&rsquo; target market assessment) and determining
appropriate distribution channels.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">UK MIFIR PRODUCT
GOVERNANCE/PROFESSIONAL INVESTORS AND ECPS ONLY TARGET MARKET</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Solely
for the purposes of each manufacturer&rsquo;s product approval process, the target market assessment in respect of the notes has led
to the conclusion that: (i) the target market for the notes is only eligible counterparties, as defined in the FCA Handbook Conduct of
Business Sourcebook (&ldquo;COBS&rdquo;), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part of domestic
law by virtue of the EUWA (&ldquo;UK MiFIR&rdquo;); and (ii) all channels for distribution of the notes to eligible counterparties and
professional clients are appropriate. Any person subsequently offering, selling or recommending the notes (a &ldquo;distributor&rdquo;)
should take into consideration the manufacturers&rsquo; target market assessment; however, a distributor subject to the FCA Handbook
Product Intervention and Product Governance Sourcebook (the &ldquo;UK MiFIR Product Governance Rules&rdquo;) is responsible for undertaking
its own target market assessment in respect of the notes (by either adopting or refining the manufacturers&rsquo; target market assessment)
and determining appropriate distribution channels.</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
communication of this prospectus supplement, the accompanying prospectus, any related free writing prospectus and any other document
or materials relating to the issue of the notes offered hereby is not being made, and such documents and/or materials have not been approved,
by an authorized person for the purposes of Section 21 of the FSMA. Accordingly, such documents and/or materials are not being distributed
to, and must not be passed on to, the general public in the United Kingdom. In the United Kingdom, such documents and/or materials are
for distribution only to, and are directed only at, persons who (i) are investment professionals falling within Article 19(5) of the
Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &ldquo;Financial Promotion Order&rdquo;), (ii)
are high net worth entities or other persons falling within Article 49(2)(a) to (d) of the Financial Promotion Order, or (iii) are persons
to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) in connection with
the issue or sale of any notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred
to as &ldquo;relevant persons&rdquo;). This prospectus supplement, the accompanying prospectus and any related free writing prospectus
are directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or
investment activity to which this prospectus supplement, the accompanying prospectus or any related free writing prospectus or any of
their contents relates is available only to relevant persons and will be engaged in only with relevant persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a001"></A>ABOUT
THIS PROSPECTUS SUPPLEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
provide information to you about this offering in two separate documents. The accompanying prospectus provides general information about
us and securities we may offer from time to time, some of which may not apply to this offering. This prospectus supplement describes
the specific details regarding this offering. Generally, when we refer to the &ldquo;prospectus,&rdquo; we are referring to both documents
combined. Additional information is incorporated by reference into this prospectus supplement. If information in this prospectus supplement
is inconsistent with the accompanying prospectus, you should rely on this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">You
should rely only on the information contained or incorporated by reference into this prospectus supplement, the accompanying prospectus
or any related free writing prospectus filed by us with the SEC. We have not, and the underwriters have not, authorized anyone else to
provide you with different or additional information. If anyone provides you with different or inconsistent information, you should not
rely on it. We are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where the offer and
sale is not permitted. You should not assume that the information in this prospectus supplement, the accompanying prospectus, any free
writing prospectus or any document incorporated by reference is accurate as of any date other than their respective dates. Our business,
financial condition, results of operations and prospects may have changed since those dates.</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><A NAME="e24325a002"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus supplement and the documents incorporated by reference herein contain statements, estimates or projections that constitute
&ldquo;forward-looking statements&rdquo; as defined under U.S. federal securities laws. Generally, the words &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;intend,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;project,&rdquo; &ldquo;will&rdquo; and similar expressions
identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions
does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that
we expect or anticipate will occur in the future &mdash; including statements relating to volume growth, share of sales and earnings
per share growth, and statements expressing general views about future operating results&nbsp;&mdash; are forward-looking statements.
Forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from
its historical experience and our present expectations or projections. These risks include, but are not limited to, unfavorable economic
and geopolitical conditions, including the direct or indirect negative impacts of the conflict between Russia and Ukraine and conflicts
in the Middle East; increased competition; an inability to be successful in our innovation activities; changes in the retail landscape
or the loss of key retail or foodservice customers; an inability to expand our business in emerging and developing markets; an inability
to successfully manage the potential negative consequences of our productivity initiatives; an inability to attract or retain a highly
skilled and diverse workforce; disruption of our supply chain, including increased commodity, raw material, packaging, energy, transportation
and other input costs; an inability to successfully integrate and manage our acquired businesses, brands or bottling operations or an
inability to realize a significant portion of the anticipated benefits of our joint ventures or strategic relationships; failure by our
third-party service providers and business partners to satisfactorily fulfill their commitments and responsibilities; an inability to
renew collective bargaining agreements on satisfactory terms, or we or our bottling partners experience strikes, work stoppages, labor
shortages, or labor unrest; obesity and other health-related concerns; evolving consumer product and shopping preferences; product safety
and quality concerns; perceived negative health consequences of certain ingredients, such as non-nutritive sweeteners and biotechnology-derived
substances, and of other substances present in our beverage products or packaging materials; failure to digitalize the Coca-Cola system;
damage to our brand image, corporate reputation and social license to operate from negative publicity, whether or not warranted, concerning
product safety or quality, workplace and human rights, obesity or other issues; an inability to successfully manage new product launches;
an inability to maintain good relationships with our bottling partners; deterioration in our bottling partners&rsquo; financial condition;
an inability to successfully manage our refranchising activities; increases in income tax rates, changes in income tax laws or the unfavorable
resolution of tax matters, including the outcome of our ongoing tax dispute or any related disputes with the U.S. Internal Revenue Service
(the &ldquo;IRS&rdquo;); the possibility that the assumptions used to calculate our estimated aggregate incremental tax and interest
liability related to the potential unfavorable outcome of the ongoing tax dispute with the IRS could significantly change; increased
or new indirect taxes; changes in laws and regulations relating to beverage containers and packaging; significant additional labeling
or warning requirements or limitations on the marketing or sale of our products; litigation or legal proceedings; conducting business
in markets with high-risk legal compliance environments; failure to adequately protect, or disputes relating to, trademarks, formulas
and other intellectual property rights; changes in, or failure to comply with, the laws and regulations applicable to our products or
our business operations; fluctuations in foreign currency exchange rates; interest rate increases; an inability to achieve our overall
long-term growth objectives; default by or failure of one or more of our counterparty financial institutions; impairment charges, and
risks regarding potential additional impairments; an inability to protect our information systems against service interruption, misappropriation
of data or cybersecurity incidents; failure to comply with privacy and data protection laws; evolving sustainability regulatory requirements
and expectations; increasing concerns about the environmental impact of plastic bottles and other packaging materials; water scarcity
and poor quality; increased demand for food products, decreased agricultural productivity and increased regulation of ingredient sourcing
due diligence; climate change and legal or regulatory responses thereto; adverse weather conditions; and other risks discussed in our
filings with the SEC, including our&nbsp;<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000009/ko-20231231.htm">Annual Report on Form 10-K for the year ended December 31, 2023</A>, which filings are available
from the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We undertake
no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,
except as required by law.</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<div style="border: solid black 1px; padding: 6pt; width:98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a003"></A>SUMMARY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights selected information contained in, or incorporated by reference into, this prospectus supplement and the accompanying
prospectus and does not contain all of the information that you should consider in making your investment decision. You should read this
summary together with the more detailed information appearing elsewhere in this prospectus supplement, as well as the information in
the accompanying prospectus and in the documents incorporated by reference into this prospectus supplement or the accompanying prospectus.
You should carefully consider, among other things, the matters discussed in the sections titled &ldquo;Risk Factors&rdquo; in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000009/ko-20231231.htm">Annual Report on Form 10-K for the year ended December 31, 2023</A> and the other information included or incorporated by reference into this prospectus
supplement and the accompanying prospectus.</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: center"><FONT STYLE="font-size: 10pt">Our Company</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">General</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Coca-Cola Company is a total beverage company, and beverage products bearing our trademarks, sold in the United States since 1886, are
now sold in more than 200 countries and territories. We own or license and market numerous beverage brands, which we group into the following
categories: Trademark Coca-Cola; sparkling flavors; water, sports, coffee and tea; juice, value-added dairy and plant-based beverages;
and emerging beverages. We own and market several of the world&rsquo;s largest nonalcoholic sparkling soft drink brands, including Coca-Cola,
Sprite, Fanta, Coca-Cola Zero Sugar and Diet Coke/Coca-Cola Light.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
make our branded beverage products available to consumers throughout the world through our network of independent bottling partners,
distributors, wholesalers and retailers as well as our consolidated bottling and distribution operations. Beverages bearing trademarks
owned by or licensed to the Company account for 2.2 billion of the estimated 64 billion servings of all beverages consumed worldwide
every day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
believe our success depends on our ability to connect with consumers by providing them with a wide variety of beverage options to meet
their desires, needs and lifestyles. Our success further depends on the ability of our people to execute effectively, every day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are guided by our purpose, which is to refresh the world and make a difference. Our vision for growth has three connected pillars:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Loved
                                            Brands. We craft meaningful brands and a choice of drinks that people love and enjoy and
                                            that refresh them in body and spirit.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Done
                                            Sustainably. We grow our business in ways that achieve positive change in the world and build
                                            a more sustainable future for our planet.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">For
                                            a Better Shared Future. We invest to improve people&rsquo;s lives, from our employees to
                                            all those who touch our business system, to our investors, to the communities we call home.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
were incorporated in September 1919 under the laws of the State of Delaware and succeeded to the business of a Georgia corporation with
the same name that had been organized in 1892. Our principal office is located at One Coca-Cola Plaza, Atlanta, Georgia 30313, and our
telephone number at that address is (404) 676-2121. We maintain a website at www.coca-colacompany.com, where general information about
us is available. We are not incorporating the contents of the website into this prospectus supplement or the accompanying prospectus.</FONT></P>
</DIV>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<div style="border: solid black 1px; padding: 6pt; width:98%">
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">The Offering</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><FONT STYLE="font-size: 10pt">The
    Coca-Cola Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Securities
    Offered</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&euro;500,000,000</FONT><FONT STYLE="font-size: 10pt">
    principal amount of 3.375% Notes due 2037.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&euro;500,000,000</FONT><FONT STYLE="font-size: 10pt">
    principal amount of 3.750% Notes due 2053.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Maturity
    Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The 2037 notes: August 15,
    2037.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The 2053 notes: August 15,
    2053.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Interest
    Rate</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The 2037 notes: 3.375%
    per annum, payable annually in arrears.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The 2053 notes: 3.750%
    per annum, payable annually in arrears.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Interest
    Payment Dates</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The 2037 notes and the 2053
    notes: August 15 of each year, commencing on August 15, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Optional
    Redemption</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">We may redeem
    any series of the notes at our option and at any time, either as a whole or in part, at the applicable redemption price described
    under &ldquo;Description of Notes&mdash;Optional Redemption.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Redemption
    for Tax Purposes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">We may
    redeem all, but not part, of a series of the notes in the event of certain changes in the tax laws of the United States (or any taxing
    authority in the United States). This redemption would be at 100% of the principal amount, together with accrued and unpaid interest
    on the notes to the date fixed for redemption. See &ldquo;Description of Notes&mdash;Redemption for Tax Reasons.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Ranking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The notes
    will be our unsecured obligations and will rank equally with our unsecured senior indebtedness from time to time outstanding.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Currency
    of Payment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">All payments
    of principal and interest, including payments made upon any redemption of the notes, will be made in euro. If the euro is unavailable
    to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used
    by the then Member States that have adopted the euro as their currency or for the settlement of transactions by public institutions
    of or within the international banking community, then all payments in respect of the notes will be made in United States dollars
    until the euro is again available to us or so used. See &ldquo;Description of Notes&mdash;Issuance in Euro&rdquo; and &ldquo;Currency
    Conversion and Foreign Exchange Risks.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

</DIV>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: black 1px solid; padding: 6pt; width: 98%">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 20%"><FONT STYLE="font-size: 10pt">Additional
    Amounts</font></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 80%">Subject to certain exceptions and limitations set forth herein, we will pay additional amounts as may be necessary to ensure that every net payment on a note to a holder who is not a United States person, after deduction or withholding by us or any of our paying agents for or on account of any present or future tax, assessment or other governmental charge imposed upon or as a result of such payment
    by the United States or any political subdivision or taxing authority of the United States, will not be less than the amount provided
    in such note to be then due and payable. See &ldquo;Description of Notes&mdash;Payment of Additional Amounts.&rdquo;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Further
    Issues</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">We may,
    at any time, without notice to or the consent of the holders of the notes, create and issue further notes ranking equally with any
    series of the notes in all respects (or in all respects other than the payment of interest accruing prior to the issue date of such
    further notes or except for, in some cases, the first payment of interest following the issue date of such further notes).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Book-Entry;
    Form and Denominations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The notes
    of each series will be issued only in registered, book-entry form. For the notes of each series, there will be one or more global
    notes deposited with a common depositary on behalf of Euroclear and Clearstream and registered in the name of the common depositary
    or its nominee. Except in the limited circumstances described under &ldquo;Description of Notes&mdash;Book-Entry; Delivery and Form;
    Global Note,&rdquo; owners of beneficial interests in the notes will not be entitled to have notes registered in their names, will
    not receive or be entitled to receive notes in definitive form and will not be considered to be holders of notes under the senior
    indenture (as defined below). The notes will be issued in minimum denominations of &euro;100,000 and in integral multiples of &euro;1,000
    in excess thereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>

</TABLE>

</DIV>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: black 1px solid; padding: 6pt; width: 98%">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Use
    of Proceeds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">We expect to use the net proceeds
    from this offering for general corporate purposes, which may include working capital, capital expenditures, acquisitions of
    or investments in businesses or assets and redemption and repayment of short-term or long-term borrowings, as well as for making
    any potential payments in connection with our ongoing tax litigation with the IRS and our final contingent consideration payment
    in 2025 in connection with our acquisition of fairlife, LLC (&ldquo;fairlife&rdquo;). See &ldquo;Part II, Item 1. Legal Proceedings&mdash;U.S.
    Federal Income Tax Dispute&rdquo; and &ldquo;Part I, Item 1. Notes to Consolidated Financial Statements&mdash;Note 16: Fair Value
    Measurements&rdquo; in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000044/ko-20240628.htm">Quarterly
    Report on Form 10-Q for the quarter ended June 28, 2024</A> for discussions of such ongoing tax litigation and estimated fairlife
    acquisition payment. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 20%"><FONT STYLE="font-size: 10pt">Listing</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 80%"><FONT STYLE="font-size: 10pt">We intend
    to apply to list the notes on the NYSE. The listing application will be subject to approval by the NYSE. We currently expect trading
    in the notes on the NYSE to begin within 30 days after the original issue date. If such a listing is obtained, we have no obligation
    to maintain such listing, and we may delist the notes at any time.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Marketing
    and Selling Restrictions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The notes
    may be offered for sale in those jurisdictions where it is lawful to make such offers. See &ldquo;Underwriting&mdash;Selling Restrictions.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Tax Considerations</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">You should
    consult your tax advisor with respect to the U.S. federal income tax considerations of purchasing, owning and disposing of the notes
    in light of your own particular situation and with respect to any tax considerations arising under the laws of any state, local,
    foreign or other taxing jurisdiction. See &ldquo;U.S. Federal Income Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Governing
    Law</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The senior
    indenture (as defined herein) is governed and the notes will be governed by the laws of the State of New York.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Trustee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Deutsche
    Bank Trust Company Americas, as successor to Bankers Trust Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Risk
    Factors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">See &ldquo;Risk
    Factors&rdquo; in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000009/ko-20231231.htm">Annual Report on Form 10-K for the year ended December 31, 2023</A> and &ldquo;Currency Conversion and Foreign
    Exchange Risks&rdquo; below for a discussion of certain relevant factors you should carefully consider before deciding to invest
    in the notes.</FONT></TD></TR>
  </TABLE>
</div>
<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a004"></A>CURRENCY
CONVERSION AND FOREIGN EXCHANGE RISKS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Investors
will be required to pay for the notes in euro. If, however, the euro is unavailable to us due to the imposition of exchange controls
or other circumstances beyond our control or if the euro is no longer being used by the then Member States that have adopted the euro
as their currency or for the settlement of transactions by public institutions of or within the international banking community, then
all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. The amount otherwise
payable by us on any date in euro would be converted into U.S. dollars at a rate determined by us in good faith. If applicable laws or
regulations of the Member States (including official pronouncements applying those laws or regulations) mandated, in our good faith determination,
the use of a specific exchange rate for these purposes, we would apply the exchange rate so mandated. Any payment in respect of the notes
so made in U.S. dollars will not constitute an event of default under the notes or the senior indenture governing the notes.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Foreign
Exchange Risk</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">An
investment in notes which are denominated in, and all payments in respect of which are to be made in, a currency other than the currency
of the country in which the investor is resident or the currency in which the investor conducts its business or activities (the home
currency) entails significant risks not associated with a similar investment in a security denominated in the home currency. These include
the possibility of:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">significant
                                            changes in rates of exchange between the home currency and the euro,</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                            imposition or modification of foreign exchange controls with respect to the euro, and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">tax
                                            consequences for the purchaser as a result of any foreign exchange gains or losses resulting
                                            from an investment in the notes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition, if one or more Member States were to withdraw from the European Monetary Union and cease to use the euro as their currency,
the value of the euro could be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have no control over a number of factors affecting this type of note, including economic, financial and political events that are important
in determining the existence, magnitude and longevity of these risks and their results. In recent years, rates of exchange for certain
currencies, including the euro, have been highly volatile, and this volatility may be expected to continue in the future. Fluctuations
in any particular exchange rate that have occurred in the past are not necessarily indicative of fluctuations in the rate that may occur
during the term of the notes. Depreciation of the euro against the home currency could result in a decrease in the effective yield of
the notes below the interest rate and, in certain circumstances, could result in a loss to you on a home currency basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes will be governed by New York law. Under New York law, a New York state court rendering a judgment on the notes would be required
to render the judgment in euro. However, the judgment would be converted into U.S. dollars at the exchange rate prevailing on the date
of entry of the judgment. Consequently, in a lawsuit for payment on the notes, investors would bear currency exchange risk until a New
York state court judgment is entered, which could be a long time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
courts outside of New York, investors may not be able to obtain a judgment in a currency other than U.S. dollars. For example, a judgment
for money in an action based on the notes in many other U.S. federal or state courts ordinarily would be enforced in the United States
only in U.S. dollars. The date used to determine the rate of conversion of euro into U.S. dollars will depend upon various factors, including
which court renders the judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
description of foreign currency risks does not describe all the risks of an investment in securities denominated in a currency other
than the home currency. You should consult your own financial, tax and legal advisors as to the risks involved in an investment in the
notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
of 9:00 a.m. (New York time) on August 7, 2024, the euro/U.S. dollar rate of exchange as reported by Bloomberg was &euro;1/U.S.$1.0921.</FONT></P>
<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a005"></A>USE
OF PROCEEDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
estimate that we will receive net proceeds from this offering of approximately &euro;978.1 million after deducting the
underwriting discounts and estimated expenses of the offering payable by us. We expect to use the net proceeds from this offering
for general corporate purposes, which may include working capital, capital expenditures, acquisitions of or investments in
businesses or assets and redemption and repayment of short-term or long-term borrowings, as well as for making any potential
payments in connection with our ongoing tax litigation with the IRS and our final contingent consideration payment in 2025 in
connection with our acquisition of fairlife. See &ldquo;Part II, Item 1. Legal Proceedings&mdash;U.S. Federal Income Tax
Dispute&rdquo; and &ldquo;Part I, Item 1. Notes to Consolidated Financial Statements&mdash;Note 16: Fair Value Measurements&rdquo;
in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000044/ko-20240628.htm">Quarterly Report on Form
10-Q for the quarter ended June 28, 2024</A> for discussions of such ongoing tax litigation and estimated fairlife acquisition
payment.</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a006"></A>CAPITALIZATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
following table presents our capitalization on a consolidated basis at June 28, 2024 (1) on an actual basis and (2) as adjusted
to give effect to this offering, but not the intended application of the estimated net proceeds from this offering as set forth in &ldquo;Use
of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">You
should read the following information in conjunction with our consolidated financial statements and the notes to those financial statements
and the information under the heading &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;
in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134424000044/ko-20240628.htm">Quarterly Report on Form 10-Q for the quarter ended June 28, 2024</A>, which is incorporated by reference into this prospectus supplement.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">At June 28, 2024</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left">(In millions)</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Actual</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
                                            Adjusted<SUP>(3)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash, cash equivalents and short-term investments:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents<SUP>(1)(2)</SUP>&#9;</FONT></TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">13,708</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">14,776</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Short-term investments&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,691</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,691</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Cash, cash equivalents and short-term investments</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,399</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">18,467</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Debt, including current portion:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Loans and notes payable&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,793</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,793</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Current portion of long-term debt&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,939</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,939</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Notes outstanding<SUP>(2)</SUP>&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,085</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,085</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offered hereby<SUP>(1)</SUP>&#9;</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,068</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total debt&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">43,817</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">44,885</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total debt less cash, cash equivalents and short-term investments&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">26,418</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">26,418</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total equity&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">27,411</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">27,411</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total capitalization&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">71,228</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">72,296</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">As
                                            adjusted cash and cash equivalents gives effect to the receipt by us of estimated cash net
                                            proceeds from this offering. See &ldquo;Use of Proceeds&rdquo; for our expected use
                                            of proceeds from this offering.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Cash
                                            and cash equivalents and Notes outstanding do not give effect to the offering of $750,000,000
                                            aggregate principal amount of our 4.650% Notes due 2034, $1,500,000,000 aggregate principal
                                            amount of our 5.200% Notes due 2055 and $750,000,000 aggregate principal amount of our 5.400%
                                            Notes due 2064 that priced on August 7, 2024. </FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The
                                            amount in the &ldquo;As Adjusted&rdquo; column is the dollar equivalent of the aggregate
                                            principal amount of the notes being offered (giving effect to the discount to the public
                                            of 98.927% with respect to the 2037 notes and 98.339% with respect to the 2053
                                            notes) based upon the euro/U.S. dollar rate of exchange of &euro;1/U.S.$1.0921 as of 9:00
                                            a.m. (New York time) on August <FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT>,
                                            2024, as reported by Bloomberg.</FONT></TD>
</TR></TABLE>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a007"></A>DESCRIPTION
OF NOTES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">THE
FOLLOWING SUMMARY OF THE TERMS OF THE NOTES SUPPLEMENTS THE GENERAL DESCRIPTION OF DEBT SECURITIES CONTAINED IN THE ACCOMPANYING PROSPECTUS.
TO THE EXTENT THE FOLLOWING TERMS ARE INCONSISTENT WITH THE GENERAL DESCRIPTION CONTAINED IN THE ACCOMPANYING PROSPECTUS, THE FOLLOWING
TERMS REPLACE SUCH INCONSISTENT TERMS. YOU SHOULD READ BOTH THE ACCOMPANYING PROSPECTUS AND THIS PROSPECTUS SUPPLEMENT IN THEIR ENTIRETY.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">General</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
2037 notes:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be in an aggregate initial principal amount of &euro;500,000,000, subject to our ability
                                            to issue additional notes which may be of the same series as the 2037 notes as described
                                            under &ldquo;&mdash;Further Issues&rdquo;;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            mature on August 15, 2037;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            bear interest at a rate of 3.375% per annum;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be our senior debt, ranking equally with all our other present and future unsecured and unsubordinated
                                            indebtedness;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be issued in minimum denominations of &euro;100,000 and in integral multiples of &euro;1,000
                                            in excess thereof;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be repaid at par at maturity;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be redeemable by us at any time prior to maturity as described below under &ldquo;&mdash;Optional
                                            Redemption&rdquo;; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            not be subject to any sinking fund.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
2053 notes:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be in an aggregate initial principal amount of &euro;500,000,000, subject to our ability
                                            to issue additional notes which may be of the same series as the 2053 notes as described
                                            under &ldquo;&mdash;Further Issues&rdquo;;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            mature on August 15, 2053;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            bear interest at a rate of 3.750% per annum;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be our senior debt, ranking equally with all our other present and future unsecured and unsubordinated
                                            indebtedness;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be issued in minimum denominations of &euro;100,000 and in integral multiples of &euro;1,000
                                            in excess thereof;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be repaid at par at maturity;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            be redeemable by us at any time prior to maturity as described below under &ldquo;&mdash;Optional
                                            Redemption&rdquo;; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">will
                                            not be subject to any sinking fund.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes offered by this prospectus supplement are senior debt securities issued under our senior indenture, dated April 26, 1988, as amended
(the &ldquo;senior indenture&rdquo;), with Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee. The
senior indenture is subject to the provisions of the Trust Indenture Act of 1939, as amended.</FONT></P>
<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
will issue the notes in fully registered form only. We may issue definitive notes in the limited circumstances set forth in &ldquo;&mdash;Book-Entry;
Delivery and Form; Global Note&mdash;Certificated Notes&rdquo; below. If we issue definitive notes, principal of and interest on such
notes will be payable in the manner described below, the transfer of the notes will be registrable and the notes will be exchangeable
for notes bearing identical terms and provisions, at the office of Deutsche Bank Trust Company Americas, the transfer agent and registrar
for the notes, currently located at 1 Columbus Circle, 17th Floor New York, New York 10019. The paying agent will be Deutsche Bank Trust
Company Americas. However, payment of interest, other than interest at maturity, or upon redemption, on such definitive notes may be
made by check mailed to the address of the person entitled to the interest as it appears on the security register at the close of business
on the regular record date corresponding to the relevant interest payment date. Notwithstanding the foregoing, (1) the depositary, as
holder of the notes, or (2) a holder of more than &euro;5 million in aggregate principal amount of notes in definitive form can require
the paying agent to make payments of interest, other than interest due at maturity, or upon redemption, by wire transfer of immediately
available funds into an account maintained by the holder in the United States by sending appropriate wire transfer instructions as long
as the paying agent receives the instructions in writing not less than ten days prior to the applicable interest payment date. The principal
and interest payable on such note at maturity, or upon redemption, will be paid by wire transfer of immediately available funds against
presentation of a note at the office of the transfer agent and registrar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
senior indenture and the notes do not limit the amount of unsecured indebtedness that may be incurred or the amount of securities that
may be issued by us. We may issue debt securities under the senior indenture in one or more series, each with different terms, up to
the aggregate principal amount which we may authorize from time to time. We also have the right to &ldquo;re-open&rdquo; a previous issue
of a series of debt securities by issuing additional debt securities of such series.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Inapplicability
of Defeasance, Lien, Sale and Leaseback Provisions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
defeasance provisions described in the accompanying prospectus under &ldquo;Description of Debt Securities&mdash;Defeasance of the Indentures
and Securities&rdquo; and in Section 12.01(b) of the senior indenture will not be applicable to the notes. The lien and sale and leaseback
provisions described in the accompanying prospectus under &ldquo;Description of Debt Securities&mdash;Restrictive Covenants&rdquo; and
in Sections 5.03 and 5.04 of the senior indenture will not be applicable to the notes.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Issuance
in Euro</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Initial
holders will be required to pay for the notes in euro, and all payments of interest and principal, including payments made upon any redemption
of the notes, will be payable in euro. If, on or after the date of this prospectus supplement, the euro is unavailable to us due to the
imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then Member States
that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international
banking community, then all payments in respect of the notes will be made in dollars until the euro is again available to us or so used.
The amount otherwise payable by us on any date in euro would be converted into U.S. dollars at a rate determined by us in good faith.
If applicable laws or regulations of the Member States (including official pronouncements applying those laws or regulations) mandated,
in our good faith determination, the use of a specific exchange rate for these purposes, we would apply the exchange rate so mandated.
Any payment in respect of the notes so made in U.S. dollars will not constitute an event of default under the notes or the senior indenture
governing the notes. Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection
with the foregoing.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Interest
on the Notes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Interest
on the notes will accrue from and including August 15, 2024 or from and including the most recent interest payment date to which
interest has been paid or provided for. We will make interest payments on the 2037 notes annually on August 15 of each year, with
the first interest payment being made on August 15, 2025. We will make interest payments on the 2053 notes annually on August
15 of each year, with the first interest payment being made on August 15, 2025. We will make interest payments to the person
in whose name the notes are registered at the close of business on the business day immediately preceding the respective interest payment
date.</FONT></P>
<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
the interest payment date is not a business day at the relevant place of payment, payment of interest will be made on the next day that
is a business day at such place of payment and no interest will accrue as a result of such delayed payment on amounts payable from and
after such interest payment date to the next succeeding business day. For the purposes of the notes, &ldquo;business day&rdquo; means
any day that is not a Saturday or Sunday and that is not a day on which banking institutions are generally authorized or obligated by
law or executive order to close in the City of New York or London and on which the Trans-European Automated Real-time Gross Settlement
Express transfer system, or any successor thereto, operates. Interest on the notes will be computed on the basis of the actual number
of days in the period for which interest is being calculated and the actual number of days from and including the last date on which
interest was paid on the notes (or from August 15, 2024, if no interest has been paid on the notes), to but excluding the next
scheduled interest payment date. This payment convention is referred to as ACTUAL/ACTUAL (ICMA) as defined in the rulebook of the International
Capital Market Association.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Optional
Redemption</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Prior
to May 15, 2037 (three months prior to the maturity date (the &ldquo;2037 Par Call Date&rdquo;)) with respect to the 2037 notes
and prior to February 15, 2053 (six months prior to the maturity date (the &ldquo;2053 Par Call Date&rdquo; and, together with
the 2037 Par Call Date, each a &ldquo;Par Call Date&rdquo;)) with respect to the 2053 notes, we may, at our option, redeem the notes
of the applicable series, in whole or in part, at any time and from time to time, at a redemption price (as determined by us, expressed
as a percentage of principal amount and rounded to three decimal places) equal to the greater of:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">100%
                                            of the principal amount of the applicable series of notes to be redeemed; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">(a)
                                            the sum of the present values of the remaining scheduled payments of principal and interest
                                            on the applicable series of notes to be redeemed discounted to the redemption date (assuming
                                            the notes matured on the applicable Par Call Date) on an annual basis (ACTUAL/ACTUAL (ICMA))
                                            at the applicable comparable government bond rate plus 20 basis points in the case
                                            of the 2037 notes and 20 basis points in the case of the 2053 notes less (b) accrued
                                            and unpaid interest thereon to, but excluding, the applicable redemption date;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">plus,
in either case, accrued and unpaid interest thereon to, but excluding, the applicable redemption date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Neither
the trustee nor the paying agent shall have any responsibility for any calculation of the redemption price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
or after the 2037 Par Call Date with respect to the 2037 notes and the 2053 Par Call Date with respect to the 2053 notes, we may, at
our option, redeem the notes of such series, in whole or in part, at any time and from time to time, at a redemption price equal to 100%
of the principal amount of the applicable series of notes to be redeemed, plus accrued and unpaid interest thereon to, but excluding,
the applicable redemption date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
term &ldquo;comparable government bond rate&rdquo; means the yield to maturity, expressed as a percentage (rounded to three decimal places,
with 0.0005 being rounded upwards), on the third business day prior to the date fixed for redemption, of the comparable government bond
(as defined below) on the basis of the middle market price of the comparable government bond prevailing at 11:00 a.m. (London time) on
such business day as determined by an independent investment bank selected by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
term &ldquo;comparable government bond&rdquo; means, in relation to any comparable government bond rate calculation, at the discretion
of an independent investment bank selected by us, a German federal government bond whose maturity is closest to the maturity of the series
of notes to be redeemed (assuming that such series of notes to be redeemed matured on the applicable Par Call Date), or if such independent
investment bank in its discretion determines that such similar bond is not in issue, such other German federal government bond as such
independent investment bank may, with the advice of three brokers of, and/or market makers in, German federal government bonds selected
by us, determine to be appropriate for determining the comparable government bond rate.</FONT></P>
<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Notice
of any redemption will be mailed or otherwise transmitted in accordance with the applicable procedures of Clearstream and Euroclear to
the holders of the notes not less than 10 days and not more than 60 days before the redemption date of the notes being redeemed. Unless
we default on payment of the redemption price, on and after the redemption date, the notes or any portion of the notes called for redemption
will stop accruing interest. A partial redemption of notes may be effected pursuant to applicable procedures of the depositary or the
paying agent, and may provide for the selection for redemption of portions (equal to the minimum authorized denomination for such notes
or any integral multiple of &euro;1,000 in excess thereof) of the principal amount of such notes of a denomination larger than the minimum
authorized denomination for such notes.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Payment
of Additional Amounts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
will, subject to the exceptions and limitations set forth below, pay as additional interest on the notes such additional amounts as are
necessary in order that the net payment by us of the principal of and interest on the notes to a holder who is not a United States person
(as defined below), after withholding or deduction for any present or future tax, assessment or other governmental charge imposed by
the United States or a taxing authority in the United States, will not be less than the amount provided in the notes to be then due and
payable; <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided</I></FONT>, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>however</I></FONT>,
that the foregoing obligation to pay additional amounts shall not apply:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any tax, assessment or other governmental charge that is imposed by reason of the holder
                                            (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary,
                                            settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust,
                                            partnership or corporation, or a person holding a power over an estate or trust administered
                                            by a fiduciary holder, being considered as:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">being
                                            or having been engaged in a trade or business in the United States or having or having had
                                            a permanent establishment in the United States;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">having
                                            a current or former connection with the United States (other than a connection arising solely
                                            as a result of the ownership of the notes or the receipt of any payment or the enforcement
                                            of any rights thereunder), including being or having been a citizen or resident of the United
                                            States;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">being
                                            or having been a personal holding company, a passive foreign investment company or a controlled
                                            foreign corporation for United States income tax purposes or a corporation that has accumulated
                                            earnings to avoid United States federal income tax;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">being
                                            a controlled foreign corporation within the meaning of Section 957(a) of the United States
                                            Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;) related within the meaning
                                            of Section 864(d)(4) of the Code to the Company;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">being
                                            or having been a &ldquo;10-percent shareholder&rdquo; of the Company as defined in Section
                                            871(h)(3) of the Code, or any successor provision;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">being
                                            subject to income tax withholding or backup withholding as of the date of the purchase by
                                            the holder or beneficial owner of the notes; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">being
                                            a bank receiving payments on an extension of credit made pursuant to a loan agreement entered
                                            into in the ordinary course of its trade or business;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any holder that is not the sole beneficial owner of the notes, or a portion of the notes,
                                            or that is a fiduciary, partnership or limited liability company, but only to the extent
                                            that a beneficial owner with respect to the holder, a beneficiary or settlor with respect
                                            to the fiduciary, or a beneficial owner or member of the partnership or limited liability
                                            company would not have been entitled to the payment of an additional amount had the beneficiary,
                                            settlor, beneficial owner or member received directly its beneficial or distributive share
                                            of the payment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-bottom: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any tax, duty, levy, assessment or other governmental charge which would not have been imposed
                                            but for the presentation of the note or evidence of beneficial ownership thereof (where presentation
                                            is required) for payment on a date more than 30 days after the date on which such payment
                                            becomes due and payable or the date on which payment is duly provided for, whichever occurs
                                            later;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any tax, assessment or other governmental charge that would not have been imposed but for
                                            the failure of the holder or any other person to comply with certification, identification
                                            or information reporting requirements concerning the nationality, residence, identity or
                                            connection with the United States of the holder or beneficial owner of the notes, if compliance
                                            is required by statute, by regulation of the United States or any taxing authority therein
                                            or by an applicable income tax treaty to which the United States is a party as a precondition
                                            to exemption from such tax, assessment or other governmental charge;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any inheritance, gift, estate, personal property, sales, transfer or similar tax, duty levy,
                                            assessment, or similar governmental charge;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any tax, duty, levy, assessment, or other governmental charge that is payable otherwise than
                                            by withholding from payments in respect of the notes;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any tax, duty, levy, assessment or governmental charge that would not have been imposed but
                                            for an election by the holder or beneficial owner of the notes, the effect of which is to
                                            make one or more payments in respect of the notes subject to United States federal income
                                            tax, state or local tax, or any other tax, duty, levy, assessment or other governmental charge;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any tax, duty, levy, assessment or governmental charge imposed under any of Sections 1471
                                            through 1474 of the Code, any applicable United States Treasury Regulations promulgated thereunder,
                                            or any judicial or administrative interpretation of any of the foregoing; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                            any combination of items (1), (2), (3), (4), (5), (6), (7), or (8) above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable
to the notes. Except as specifically provided under this heading &ldquo;&mdash;Payment of Additional Amounts,&rdquo; we will not be required
to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing
authority of or in any government or political subdivision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
we are required to pay additional amounts with respect to the notes, we will notify the trustee and paying agent pursuant to an officers&rsquo;
certificate that specifies the additional amounts payable and when the additional amounts are payable. If the trustee and the paying
agent do not receive such an officers&rsquo; certificate from us, the trustee and paying agent may rely on the absence of such an officers&rsquo;
certificate in assuming that no such additional amounts are payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
used under this heading &ldquo;&mdash;Payment of Additional Amounts&rdquo; and under the heading &ldquo;&mdash;Redemption for Tax Reasons,&rdquo;
the term &ldquo;United States&rdquo; means the United States of America, the states of the United States, and the District of Columbia,
and the term &ldquo;United States person&rdquo; means any individual who is a citizen or resident of the United States for United States
federal income tax purposes, a corporation, partnership or other entity created or organized in or under the laws of the United States,
any state of the United States or the District of Columbia, or any estate or trust the income of which is subject to United States federal
income taxation regardless of its source.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Redemption
for Tax Reasons</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If,
as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated under the laws) of the United States
(or any taxing authority in the United States), or any change in, or amendment to, an official position regarding the application or
interpretation of such laws, regulations or rulings, which change or amendment is announced or becomes effective on or after the date
of this prospectus supplement, we become or, based upon a written opinion of independent counsel selected by us, will become obligated
to pay additional amounts as described under the heading &ldquo;&mdash;Payment of Additional Amounts&rdquo; with respect to the notes,
then we may at any time at our option redeem, in whole, but not in part, any series of the notes on not less than 15 or more than 30
days&rsquo; prior notice, at a redemption price equal to 100% of their principal amount, together with accrued and unpaid interest on
the notes to, but not including, the date fixed for redemption.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>
<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Further
Issues</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
may from time to time, without notice to or the consent of the holders of the notes, create and issue further notes ranking equally with
and having the same terms and conditions as any series of the notes in all respects (other than the issue date, the public offering price,
the payment of interest accruing prior to the issue date of such further notes and, in some cases, the first payment of interest following
the issue date of such further notes). Such further notes may be consolidated and form a single series with the previously issued notes
of that series and have the same terms as to status, redemption or otherwise as the notes of that series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Any
further notes that are not fungible for U.S. federal income tax purposes with the originally issued notes will be issued under separate
ISIN and CUSIP numbers.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Book-Entry;
Delivery and Form; Global Note</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes will initially be represented by one or more fully registered global notes. Each such global note will be deposited with, or on
behalf of, a common depositary and registered in the name of the nominee of the common depositary for the accounts of Clearstream and
Euroclear. Except as set forth below, the global notes may be transferred, in whole and not in part, only to Euroclear or Clearstream
or their respective nominees. You may hold your interests in the global notes in Europe through Clearstream or Euroclear, either as a
participant in such systems or indirectly through organizations that are participants in such systems. Clearstream and Euroclear will
hold interests in the global notes on behalf of their respective participating organizations or customers through customers&rsquo; securities
accounts in Clearstream&rsquo;s or Euroclear&rsquo;s names on the books of their respective depositaries. Book-entry interests in the
notes and all transfers relating to the notes will be reflected in the book-entry records of Clearstream and Euroclear.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
distribution of the notes will be cleared through Clearstream and Euroclear. Any secondary market trading of book-entry interests in
the notes will take place through Clearstream and Euroclear Participants and will settle in same-day funds. Owners of book-entry interests
in the notes will receive payments relating to their notes in euro, except as described under the headings &ldquo;&mdash;Issuance in
Euro&rdquo; and &ldquo;Currency Conversion and Foreign Exchange Risks.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Clearstream
and Euroclear have established electronic securities and payment transfer, processing, depositary and custodial links among themselves
and others, either directly or through custodians and depositaries. These links allow the notes to be issued, held and transferred among
the clearing systems without the physical transfer of certificates. Special procedures to facilitate clearance and settlement have been
established among these clearing systems to trade securities across borders in the secondary market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
policies of Clearstream and Euroclear will govern payments, transfers, exchanges and other matters relating to an investor&rsquo;s interest
in the notes held by them. We have no responsibility for any aspect of the records kept by Clearstream or Euroclear or any of their direct
or indirect participants. We also do not supervise these systems in any way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Clearstream
and Euroclear and their participants perform these clearance and settlement functions under agreements they have made with one another
or with their customers. You should be aware that they are not obligated to perform or continue to perform these procedures and may modify
them or discontinue them at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Except
as provided below, owners of beneficial interests in the notes will not be entitled to have the notes registered in their names, will
not receive or be entitled to receive physical delivery of the notes in definitive form and will not be considered the owners or holders
of the notes under the senior indenture, including for purposes of receiving any reports delivered by us or the trustee pursuant to the
senior indenture. Accordingly, each person owning a beneficial interest in a note must rely on the procedures of the depositary and,
if such person is not a participant, on the procedures of the participant through which such person owns its interest, in order to exercise
any rights of a holder of notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have been advised by Clearstream and Euroclear, respectively, as follows:</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Clearstream</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Clearstream
advises that it is incorporated under the laws of Luxembourg as a professional depositary. Clearstream holds securities for its participating
organizations (&ldquo;Clearstream Participants&rdquo;) and facilitates the clearance and settlement of securities transactions between
Clearstream Participants through electronic book-entry changes in accounts of Clearstream Participants, thereby eliminating the need
for physical movement of certificates. Clearstream provides to Clearstream Participants, among other things, services for safekeeping,
administration, clearance and settlement of internationally traded securities and securities lending and borrowing. Clearstream interfaces
with domestic markets in several countries. As a professional depositary, Clearstream is subject to regulation by the Luxembourg Commission
for the Supervision of the Financial Sector (Commission de Surveillance du Secteur Financier). Clearstream Participants are recognized
financial institutions around the world, including underwriters, securities brokers and dealers, banks, trust companies, clearing corporations
and certain other organizations and may include the underwriters. Indirect access to Clearstream is also available to others, such as
banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a Clearstream Participant, either
directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Distributions
with respect to interests in the notes held beneficially through Clearstream will be credited to cash accounts of Clearstream Participants
in accordance with its rules and procedures.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Euroclear</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Euroclear
advises that it was created in 1968 to hold securities for participants of Euroclear (&ldquo;Euroclear Participants&rdquo;) and to clear
and settle transactions between Euroclear Participants through simultaneous electronic book-entry delivery against payment, thereby eliminating
the need for physical movement of certificates and any risk from lack of simultaneous transfers of securities and cash. Euroclear includes
various other services, including securities lending and borrowing and interfaces with domestic markets in several countries. Euroclear
is operated by Euroclear Bank S.A./N.V. (the &ldquo;Euroclear Operator&rdquo;). All operations are conducted by the Euroclear Operator,
and all Euroclear securities clearance accounts and Euroclear cash accounts are accounts with the Euroclear Operator. Euroclear Participants
include banks (including central banks), securities brokers and dealers and other professional financial intermediaries and may include
the underwriters. Indirect access to Euroclear is also available to other firms that clear through or maintain a custodial relationship
with a Euroclear Participant, either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Terms and Conditions Governing Use of Euroclear and the related Operating Procedures of the Euroclear System, or the Euroclear Terms
and Conditions, and applicable Belgian law govern securities clearance accounts and cash accounts with the Euroclear Operator. Specifically,
these terms and conditions govern:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">transfers
                                            of securities and cash within Euroclear;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">withdrawal
                                            of securities and cash from Euroclear; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">receipt
                                            of payments with respect to securities in Euroclear.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">All
securities in Euroclear are held on a fungible basis without attribution of specific certificates to specific securities clearance accounts.
The Euroclear Operator acts under the Euroclear Terms and Conditions only on behalf of Euroclear Participants and has no record of or
relationship with persons holding securities through Euroclear Participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Distributions
with respect to interests in the notes held beneficially through Euroclear will be credited to the cash accounts of Euroclear Participants
in accordance with the Euroclear Terms and Conditions.</FONT></P>
<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Clearance
and Settlement Procedures</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
understand that investors that hold their notes through Clearstream or Euroclear accounts will follow the settlement procedures that
are applicable to conventional eurobonds in registered form. Notes will be credited to the securities custody accounts of Clearstream
and Euroclear Participants on the business day following the settlement date, for value on the settlement date. They will be credited
either free of payment or against payment for value on the settlement date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
understand that secondary market trading between Clearstream and/or Euroclear Participants will occur in the ordinary way following the
applicable rules and operating procedures of Clearstream and Euroclear. Secondary market trading will be settled using procedures applicable
to conventional eurobonds in registered form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">You
should be aware that investors will only be able to make and receive deliveries, payments and other communications involving the notes
through Clearstream and Euroclear on days when those systems are open for business. Those systems may not be open for business on days
when banks, brokers and other institutions are open for business in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition, because of time-zone differences, there may be problems with completing transactions involving Clearstream and Euroclear on
the same business day as in the United States. United States investors who wish to transfer their interests in the notes, or to make
or receive a payment or delivery of the notes, on a particular day, may find that the transactions will not be performed until the next
business day in Luxembourg or Brussels, depending on whether Clearstream or Euroclear is used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Clearstream
or Euroclear will credit payments to the cash accounts of Clearstream customers or Euroclear Participants, as applicable, in accordance
with the relevant system&rsquo;s rules and procedures, to the extent received by its depositary. Clearstream or the Euroclear Operator,
as the case may be, will take any other action permitted to be taken by a holder under the senior indenture on behalf of a Clearstream
customer or Euroclear Participant only in accordance with its relevant rules and procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Clearstream
and Euroclear have agreed to the foregoing procedures in order to facilitate transfers of the notes among participants of Clearstream
and Euroclear. However, they are under no obligation to perform or continue to perform those procedures, and they may discontinue those
procedures at any time.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Certificated
Notes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
the depositary for any of the notes represented by a registered global note is at any time unwilling or unable to continue as depositary
and a successor depositary is not appointed by us within 90 days, we will issue notes in definitive form in exchange for the registered
global note that had been held by the depositary. Any notes issued in definitive form in exchange for a registered global note will be
registered in the name or names that the depositary gives to the trustee or other relevant agent of the trustee. It is expected that
the depositary&rsquo;s instructions will be based upon directions received by the depositary from participants with respect to ownership
of beneficial interests in the registered global note that had been held by the depositary. In addition, we may at any time determine
that the notes shall no longer be represented by a global note and will issue notes in definitive form in exchange for such global note
pursuant to the procedure described above.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notices</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Notices
to holders of the notes will be sent by mail to the registered holders, or otherwise in accordance with the procedures of the applicable
depositary.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Governing
Law</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">New
York law governs the senior indenture and will govern the notes, without regard to its conflicts of law principles that would result
in the application of any law other than New York law.</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a008"></A>U.S.
FEDERAL INCOME TAX CONSIDERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
following discussion is a summary of U.S. federal income tax considerations generally applicable in connection with the ownership and
disposition of the notes. This discussion is based on the Code, the Treasury regulations promulgated thereunder (the &ldquo;Treasury
Regulations&rdquo;), published positions of the IRS, and judicial decisions, all as in effect on the date hereof and all of which are
subject to change and differing interpretations, possibly with retroactive effect. This discussion addresses tax considerations only
for initial holders of the notes that acquire the notes pursuant to this offering at the initial sale price and hold the notes as &ldquo;capital
assets&rdquo; as defined in the Code (generally, property held for investment). This discussion is general in nature and does not address
all of the tax consequences that may be applicable to holders in light of their particular circumstances or to holders subject to special
treatment under U.S. federal income tax law, such as brokers, financial institutions, insurance companies, regulated investment companies,
real estate investment trusts, controlled foreign corporations, passive foreign investment companies, cooperatives, traders in securities
or currencies who elect to apply a mark-to-market method of accounting, tax-exempt entities or qualified retirement plans, persons that
are (or hold their notes through) partnerships or other pass-through entities, persons required under section 451(b) of the Code to conform
the timing of income accruals with respect to the notes to their financial statements, persons subject to special tax accounting rules,
certain U.S. expatriates, persons who acquire the notes in connection with employment or other performance of services, persons deemed
to sell the notes under the constructive sale provisions of the Code and persons that hold the notes as part of a straddle, hedge, conversion
transaction or other integrated transaction. Furthermore, this discussion does not address the consequences of the alternative minimum
tax, of the Medicare contribution tax on net investment income, or of any state, local, foreign, or non-U.S. income tax laws, or any
other U.S. federal tax considerations (e.g., the U.S. federal gift or estate tax). This discussion also does not address tax considerations
for U.S. holders (as defined below) whose &ldquo;functional currency&rdquo; is not the U.S. dollar. This discussion is not intended to
constitute a complete analysis of all tax considerations of the purchase, ownership and disposition of the notes. No ruling from the
IRS has been or will be sought regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or that
a court would not sustain, a position contrary to any of those set forth below. Prospective purchasers of the notes are urged to consult
their tax advisors regarding the U.S. federal, state, local and foreign income and other tax considerations to them of acquiring, owning
or disposing of the notes in light of their particular circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">For
purposes of this discussion, the term &ldquo;U.S. holder&rdquo; means a beneficial owner of a note that, for U.S. federal income tax
purposes, is (i) a citizen or individual resident of the United States; (ii) a corporation or other entity treated as a corporation for
U.S. federal income tax purposes that is created or organized under the laws of the United States, any state thereof or the District
of Columbia; (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (iv) a trust
if (A) a court within the United States is able to exercise primary supervision over its administration and one or more &ldquo;United
States persons,&rdquo; within the meaning of Section 7701(a)(30) of the Code (a &ldquo;U.S. person&rdquo;), have the authority to control
all substantial decisions of such trust; or (B) the trust has made a valid election under the applicable Treasury Regulations to be treated
as a U.S. person for U.S. federal income tax purposes. For purposes of this discussion, the term &ldquo;non-U.S. holder&rdquo; means
a beneficial owner of a note (other than an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that
is not a U.S. holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
a partnership (including any entity or arrangement treated as a partnership for U.S. federal income tax purposes) beneficially owns the
notes, the U.S. federal income tax treatment of a partner in the partnership will generally depend upon the status of the partner and
the activities of the partnership. Partners in a partnership that beneficially owns the notes should consult their tax advisors as to
the particular U.S. federal income tax considerations applicable to them.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">EACH
PROSPECTIVE INVESTOR SHOULD CONSULT ITS TAX ADVISORS AS TO THE U.S. FEDERAL, STATE, LOCAL, FOREIGN AND ANY OTHER TAX CONSIDERATIONS TO
IT OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF THE NOTES IN LIGHT OF ITS PARTICULAR CIRCUMSTANCES.</FONT></P>
<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Considerations
for U.S. Holders</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Interest</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Interest
on the notes (and any additional amounts) will generally be taxable to a U.S. holder as ordinary interest income at the time it is paid
or accrued in accordance with such U.S. holder&rsquo;s method of accounting for U.S. federal income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
U.S. holder that uses the cash method of tax accounting will be required to include in income the U.S. dollar value of the euro-denominated
interest payment on a note based on the spot rate of exchange on the date of receipt (regardless of whether the payment is in fact converted
to U.S. dollars at that time). No foreign currency exchange gain or loss will be recognized with respect to the receipt of such payment
(other than foreign currency exchange gain or loss realized on the disposition of the euros so received, see &ldquo;&mdash;Transaction
in Euros,&rdquo; below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
U.S. holder that uses the accrual method of tax accounting will accrue interest income on a note in euros and translate the amount accrued
into U.S. dollars based on:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                            average exchange rate in effect during the interest accrual period, or portion thereof, within
                                            such U.S. holder&rsquo;s taxable year; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">at
                                            such U.S. holder&rsquo;s election, at the spot rate of exchange on (1) the last day of the accrual
                                            period, or the last day of the taxable year within such accrual period if the accrual period
                                            spans more than one taxable year, or (2) the date of receipt, if such date is within five
                                            business days of the last day of the accrual period. Such election must be applied consistently
                                            by the U.S. holder to all debt instruments from year to year and can be changed only with
                                            the consent of the IRS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
U.S. holder that uses the accrual method of tax accounting will recognize foreign currency exchange gain or loss on the receipt of an
interest payment equal to the difference between (i) the value of the euros received as interest, as translated into U.S. dollars using
the spot rate of exchange on the date of receipt and (ii) the U.S. dollar amount previously included in income with respect to such payment.
Such foreign currency exchange gain or loss will be treated as ordinary income or loss but will generally not be treated as an adjustment
to interest income received on the notes.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Certain
Additional Payments</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">There
are circumstances in which we might be required to make additional payments on a note, for instance, as described under &ldquo;Description
of Notes&mdash;Payment of Additional Amounts.&rdquo; We intend to take the position that the possibility of such payments does not result
in the notes being treated as nonfunctional currency contingent payment debt instruments under the applicable Treasury Regulations. Our
position is not binding on the IRS. If the IRS takes a position contrary to that described above with respect to a series of notes, a
U.S. holder may be required to accrue interest income based upon a &ldquo;comparable yield&rdquo; (as defined in the Treasury Regulations)
determined at the time of issuance of the notes in such series (which is not expected to differ significantly from the actual yield on
the notes), with adjustments to such accruals when any contingent payments are made that differ from the payments based on the comparable
yield. In addition, any income on the sale, exchange or other taxable disposition of the notes in such series would be treated as ordinary
income rather than as capital gain. U.S. holders should consult their tax advisors regarding their particular tax consequences if the
notes in any series were treated as nonfunctional currency contingent payment debt instruments. The discussion herein assumes that the
notes in each series will not be treated as nonfunctional currency contingent payment debt instruments.</FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->


<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Disposition
of the Notes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Upon
the sale, exchange, retirement at maturity, redemption or other taxable disposition of a note (collectively, a
&ldquo;Disposition&rdquo;), except as noted below with respect to foreign currency exchange gain or loss, a U.S. holder will
generally recognize capital gain or loss equal to the difference between the amount realized by such U.S. holder (except to the
extent such amount is attributable to accrued but unpaid interest, which will be treated as ordinary interest income if such
interest has not been previously included in income) and such U.S. holder&rsquo;s adjusted tax basis in the note. Subject to the
discussion below regarding notes that are traded on an established
securities market, the adjusted tax basis of a note to a U.S. holder will generally be the U.S. dollar value of the euro purchase price
calculated at the spot rate of exchange on the date of purchase (decreased by any payments other than stated interest received on the
note), and the amount realized by a U.S. holder upon the Disposition of a note will generally be the U.S. dollar value of the euros received
calculated at the spot rate of exchange on the date of Disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
the notes are traded on an established securities market, a U.S. holder that uses the cash method of tax accounting, and if it so elects,
a U.S. holder that uses the accrual method of tax accounting, will determine the U.S. dollar values of its adjusted tax bases in the
note and the amount realized on the Disposition of a note by translating euro amounts at the spot rate of exchange on the settlement
date of the purchase or the Disposition, respectively. The election available to accrual basis U.S. holders discussed above must be applied
consistently by the U.S. holder to all debt instruments from year to year and can be changed only with the consent of the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Any
capital gain or loss will be long-term capital gain or loss if the U.S. holder&rsquo;s holding period for the notes exceeds one year
on the date of Disposition. Long-term capital gains recognized by individuals and certain other non-corporate U.S. holders are generally
eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Gain
or loss recognized by a U.S. holder on a Disposition of a note generally will be treated as ordinary income or loss to the extent that
the gain or loss is attributable to changes in the euro to U.S. dollar exchange rate during the period in which the U.S. holder held
such note. Such foreign currency exchange gain or loss will equal the difference between the U.S. dollar value of the euro purchase price
calculated at the spot rate of exchange on the date (1) the note is disposed of (or the spot rate on the settlement date, if applicable)
and (2) of purchase (or the spot rate on the settlement date, if applicable). The recognition of such foreign currency exchange gain
or loss will be limited to the amount of overall gain or loss realized on the Disposition of a note.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Transaction
in Euros</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Euros
received as interest on, or on a Disposition of, a note will have a tax basis equal to their U.S. dollar value determined using the spot
rate of exchange at the time such interest is received or at the time such proceeds from Disposition are received. The amount of gain
or loss recognized on a subsequent sale or other disposition of such euros will be equal to the difference between (1) the amount of
U.S. dollars, or the fair market value in U.S. dollars of the other property received in such sale or other disposition, and (2) the
U.S. holder&rsquo;s adjusted tax basis in such euros. As discussed above, if the notes are traded on an established securities market,
a cash basis U.S. holder (or an electing accrual basis U.S. holder) will determine the U.S. dollar value of the euros by translating
the euros received at the spot rate of exchange on the settlement date of the purchase or the Disposition. A U.S. holder that purchases
a note with previously owned euros will generally recognize gain or loss in an amount equal to the difference, if any, between such U.S.
holder&rsquo;s adjusted tax basis in such euros and the U.S. dollar fair market value of such note on the date of purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Any
such gain or loss generally will be ordinary income or loss and will not be treated as interest income or expense. The conversion of
U.S. dollars to euros and the immediate use of such euros to purchase a note generally will not result in any exchange gain or loss for
a U.S. holder.</FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->


<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Reportable
Transaction Reporting</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Under
applicable Treasury Regulations, a U.S. holder who participates in a &ldquo;reportable transaction&rdquo; (as defined in the Treasury
Regulations) must attach to its United States federal income tax return a disclosure statement on IRS Form 8886. Under the relevant rules,
a loss from a foreign currency transaction is a reportable transaction if the gross amount of the loss is at least $50,000 in a single
tax year for an individuals or trust, whether or not the loss flows through from an S corporation or partnership. U.S. holders should
consult their tax advisors to determine the tax reporting obligations, if any, including any requirement to file IRS Form 8886, with
respect to the ownership or Disposition of the notes or any related transaction such as the disposition of any euros received in respect
of the notes. Prospective purchasers of the notes should consult their tax advisors to determine the reporting obligations, if any, with
respect to an investment in the notes, including any requirement to file IRS Form 8886.</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Considerations
for non-U.S. Holders</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Interest</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
non-U.S. holder will generally not be subject to U.S. federal income or withholding tax, subject to the discussion of the Foreign Account
Tax Compliance Act below, on payments of interest (and, if applicable, additional amounts) on the notes, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided
</I></FONT>that (i) such interest is not effectively connected with the conduct of a trade or business within the United States by the
non-U.S. holder (or, if certain tax treaties apply, such interest is not attributable to a permanent establishment of the non-U.S. holder
within the United States) and (ii) the non-U.S. holder (A) does not actually or constructively own 10% or more of the total combined
voting power of all classes of our voting stock, (B) is not a controlled foreign corporation related to us directly, indirectly or constructively
through stock ownership, (C) is not a bank receiving certain types of interest and (D) satisfies certain certification requirements.
Such certification requirements will be met if (x) the non-U.S. holder provides to us or our paying agent its name and address, and certifies
on an IRS Form W-8BEN or IRS Form W-8BEN-E (or successor form), under penalties of perjury, that it is not a U.S. person or (y) a securities
clearing organization or one of certain other financial institutions holding the note on behalf of the non-U.S. holder certifies on IRS
Form W-8IMY (or appropriate substitute form), under penalties of perjury, that the certification referred to in clause (x) has been received
by it and furnishes us or our paying agent with a copy thereof. In addition, we or our paying agent must not have actual knowledge or
reason to know that the beneficial owner of the notes is a U.S. person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
interest on the notes is not effectively connected with the conduct of a trade or business in the United States by a non-U.S. holder
(and, if certain tax treaties apply, such interest is not attributable to a permanent establishment of the non-U.S. holder within the
United States) but such non-U.S. holder cannot satisfy the other requirements outlined in the preceding paragraph, interest on the notes
will generally be subject to U.S. federal withholding tax (currently imposed at a 30% rate or a lower applicable tax treaty rate).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If
interest on the notes is effectively connected with the conduct of a trade or business within the United States by a non-U.S. holder
(or, if certain tax treaties apply, such non-U.S. holder carries on business through a permanent establishment in the United States and
such interest is attributable to such permanent establishment of the non-U.S. holder within the United States), then the non-U.S. holder
will generally be subject to U.S. federal income tax on such interest on a net income basis and, in the case of a non-U.S. holder that
is a foreign corporation, may also be subject to the branch profits tax (currently imposed at a rate of 30%, or a lower applicable tax
treaty rate). Any such interest will not also be subject to U.S. federal withholding tax, however, if the non-U.S. holder delivers to
us a properly executed IRS Form W-8ECI (or appropriate substitute form) in order to claim an exemption from U.S. federal withholding
tax.</FONT></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Disposition
of the Notes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
non-U.S. holder will generally not be subject to U.S. federal income tax (or any withholding thereof) with respect to gain, if any, recognized
on the Disposition of the notes unless (i) the gain is effectively connected with the conduct of a trade or business within the United
States by the non-U.S. holder (or, if certain tax treaties apply, such non-U.S. holder carries on business through a permanent establishment
in the United States and such gain is attributable to such permanent establishment of the non-U.S. holder within the United States),
or (ii) in the case of a non-U.S. holder that is a nonresident alien individual, such holder is present in the United States for 183
or more days in the taxable year and certain other conditions are satisfied. If the exception under (i) applies, the non-U.S. holder
will generally be subject to U.S. federal income tax on the gain or loss recognized on the Disposition of the notes on a net income basis
at the regular graduated U.S. federal income tax rates generally applicable to U.S. holders unless an applicable tax treaty provides
otherwise, and if such holder is a corporation, it may be subject to the branch profits tax (currently imposed at a rate of 30% or a
lower applicable tax treaty rate). Accrued and unpaid interest realized on a Disposition will be subject to U.S. federal income tax to
the extent interest would have been subject to U.S. federal income tax as described under &ldquo;&mdash;Considerations for non-U.S. Holders&mdash;Interest.&rdquo;
If the exception under (ii) applies, the non-U.S. holder will generally be subject to tax equal to 30% on the capital gain realized on
the Disposition of the notes (after being offset by certain U.S.-source capital losses) except as provided under an applicable tax treaty.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Information
Reporting and Backup Withholding</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
non-U.S. holder will generally be required to comply with certain certification procedures (generally similar to those discussed above)
to establish that such holder is not a U.S. person to avoid backup withholding with respect to payments on, or the proceeds of a Disposition
of, the notes. In addition, we must report annually to the IRS and to each non-U.S. holder the amount of any interest paid to such non-U.S.
holder regardless of whether any tax was actually withheld. Backup withholding is not an additional tax. Copies of the information returns
reporting the amount of interest paid to the non-U.S. holder and the amount of any withholding may also be made available to the tax
authorities in the country in which the non-U.S. holder resides under the provisions of an applicable tax treaty. Any amounts withheld
under the backup withholding rules will be allowed as a refund or credit against a non-U.S. holder&rsquo;s U.S. federal income tax liability,
provided the required information is correctly and timely provided to the IRS.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Foreign
Account Tax Compliance Act</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Sections
1471 through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred to as
the &ldquo;Foreign Account Tax Compliance Act&rdquo; or &ldquo;FATCA&rdquo;) generally impose withholding at a rate of 30% in certain
circumstances on interest payable on the notes held by or through any of certain foreign financial institutions (including investment
funds), unless such institution otherwise qualifies for an exemption or (y) enters into, and complies with, an agreement with the IRS
to report, on an annual basis, information with respect to interests in, and accounts maintained by, the institution that are owned by
certain U.S. persons or by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments,
or (z) if required under an intergovernmental agreement between the United States and an applicable foreign country, reports such information
to its local tax authority, which will exchange such information with the U.S. authorities. An intergovernmental agreement between the
United States and an applicable foreign country, or other guidance, may modify these requirements. Accordingly, the entity through which
the notes are held will affect the determination of whether such withholding is required. Similarly, in certain circumstances, interest
payable on the notes held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will
generally be subject to withholding at a rate of 30%, unless such entity either (y) certifies that such entity does not have any &ldquo;substantial
United States owners&rdquo; or (z) provides certain information regarding the entity&rsquo;s &ldquo;substantial United States owners,&rdquo;
which we will in turn provide to the United States Department of the Treasury. We will not pay any additional amounts in respect of any
amounts withheld under FATCA. Prospective investors should consult their tax advisors regarding the possible implications of these rules
on an investment in the notes.</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a009"></A>EUROPEAN
UNION DIRECTIVE ON ADMINISTRATIVE COOPERATION AND PROPOSED<BR STYLE="font: 10pt Times New Roman, Times, Serif">
FINANCIAL TRANSACTIONS TAX</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">EU
Directive on Administrative Cooperation in the Field of Taxation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
May 25, 2018, the European Union adopted Council Directive (EU) 2018/822 amending European Council Directive 2011/16/EU on administrative
cooperation in the field of taxation that imposes a reporting obligation on parties involved in cross-border transactions that may be
associated with tax planning (&ldquo;DAC 6&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">DAC
6 requires the mandatory and automatic exchange of information regarding cross-border arrangements within its scope. The reporting obligation
applies to cross-border arrangements that satisfy one or more &ldquo;hallmarks&rdquo; provided for in DAC 6 (the &ldquo;Reportable Arrangements&rdquo;).
In the case of a Reportable Arrangement, the information that must be reported generally includes the name of all relevant taxpayers
and intermediaries as well as an outline of the Reportable Arrangement, the value of the Reportable Arrangement and identification of
any EU Member States, which is likely to be concerned by the Reportable Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">DAC
6 imposes requirements on intermediaries (including, but not limited to, tax advisors, accountants, lawyers, banks and financial advisors
and certain persons who provide aid, assistance or advice in relation to such cross-border arrangements) to report information on Reportable
Arrangements to tax authorities. In certain circumstances (including, but not limited to, the relevant intermediary being located outside
of the European Union or bound by legal professional privilege) the obligation to disclose could pass to the taxpayer itself.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
a result of DAC 6, the Company or its advisors or intermediaries may be required to disclose information to European Union tax authorities
regarding Reportable Arrangements in which the Company is involved. The Company or its advisors or intermediaries may also be required
to disclose information to the United Kingdom tax authorities if required by the rules introduced to replace DAC 6 in the United Kingdom.
We may not be aware of all disclosures made pursuant to these rules regarding transactions to which the group is a party.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">The
Proposed Financial Transactions Tax (&ldquo;FTT&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
February 14, 2013, the European Commission published a proposal (the &ldquo;Commission&rsquo;s Proposal&rdquo;) for a Directive for a
common FTT in Belgium, Germany, Estonia, Greece, Spain, France, Italy, Austria, Portugal, Slovenia and Slovakia (the &ldquo;participating
Member States&rdquo;). The Commission&rsquo;s Proposal has very broad scope and could, if introduced, apply to certain dealings in the
notes (including secondary market transactions) in certain circumstances. However, primary market transactions should be exempt and therefore
the issuance and subscription of notes is likely to be exempt from FTT (if adopted).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Under
the Commission&rsquo;s Proposal the FTT could apply in certain circumstances to persons both within and outside of the participating
Member States. Generally, it would apply to certain dealings in the notes where at least one party is a financial institution, and at
least one party is established in a participating Member State. A financial institution may be, or be deemed to be, &ldquo;established&rdquo;
in a participating Member State in a broad range of circumstances, including (a) by transacting with a person established in a participating
Member State or (b) where the financial instrument which is subject to the dealings is issued in a participating Member State.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
FTT proposal (including whether or not it comes into force as proposed or at all) remains subject to negotiation between the participating
Member States and the scope of any such tax and timing of implementation is uncertain. Additional EU Member States may decide to participate
and/or certain of the participating Member States may decide to withdraw.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Prospective
holders of the notes are advised to seek their own professional advice in relation to the FTT.</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a010"></A>UNDERWRITING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Subject
to the terms and conditions of the underwriting agreement, the underwriters named below have severally, and not jointly, agreed to purchase
from us the following respective principal amounts of notes listed opposite their name below at the public offering price less the underwriting
discounts set forth on the cover page of this prospectus supplement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left"><U>Underwriters</U></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Principal<BR>
    Amount <BR>
    of 2037 Notes</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Principal
    <BR>
    Amount <BR>
    of 2053 Notes</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: justify">Barclays Bank PLC</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">133,335,000</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">133,335,000</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">BNP Paribas</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">133,335,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">133,335,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">J.P. Morgan Securities plc</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">133,335,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">133,335,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">HSBC Bank plc</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">26,665,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">26,665,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">MUFG Securities EMEA plc</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">26,665,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">26,665,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Standard Chartered Bank</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">26,665,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">26,665,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Academy Securities, Inc.</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">10,000,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">10,000,000</FONT></TD><TD STYLE="font-size: 12pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: justify">Samuel A. Ramirez &amp; Company, Inc.</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">10,000,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">10,000,000</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: justify">Total&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 10pt">500,000,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 10pt">&euro;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 10pt">500,000,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
underwriting agreement provides that the obligations of the several underwriters to purchase the notes offered hereby are subject to
certain conditions precedent and that the underwriters will purchase all of the notes offered by this prospectus supplement if any of
these notes are purchased. The offering of notes by the underwriters is subject to receipt and acceptance and subject to the underwriters&rsquo;
right to reject any order in whole or in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
estimate that the total expenses of this offering to us, excluding the underwriting discounts, will be approximately &euro;2.0 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have agreed to indemnify the several underwriters against some specified types of liabilities, including liabilities under the Securities
Act of 1933, as amended, and to contribute to payments the underwriters may be required to make in respect of any of these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Each
series of the notes is a new issue of securities with no established trading market. We intend to apply to list the notes on the NYSE.
The listing application will be subject to approval by the NYSE. We currently expect trading in the notes on the NYSE to begin within
30 days after the original issue date. If such a listing is obtained, we have no obligation to maintain such listing, and we may delist
the notes at any time. The underwriters are under no obligation to make a market in any series of notes and may discontinue any market-making
activities at any time without any notice. We cannot assure the liquidity of the trading market for any series of notes or that an active
public market for any series of notes will develop. If an active public trading market for a series of notes does not develop, the market
price and liquidity of that series of notes may be adversely affected. If the notes of any series are traded, they may trade at a discount
from their initial offering price, depending on prevailing interest rates, the market for similar securities, our operating performance
and financial condition, general economic conditions and other factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
connection with the issuance of the notes, J.P. Morgan Securities plc, as stabilizing manager (or persons acting on its behalf),
may over-allot notes or effect transactions with a view to supporting the price of the notes at a level higher than that which might
otherwise prevail. However, there is no assurance that the stabilizing manager (or persons acting on its behalf) will undertake stabilization
action. Any stabilization action may begin on or after the date on which adequate public disclosure of the final terms of the offer of
the notes is made and, if begun, may be ended at any time, but it must end no later than the earlier of 30 calendar days after the issuance
date of the notes and 60 calendar days after the date of the allotment of the notes. Such stabilization shall be conducted in accordance
with all applicable laws and rules. Any loss or profit sustained as a consequence of any such over-allotment or stabilization shall be
for the account of the stabilizing manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
connection with the offering, the underwriters may purchase and sell the notes in the open market. These transactions may include short
sales, purchases to cover positions created by short sales and stabilizing transactions.</FONT></P>
<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Short
sales involve the sale by the underwriters of a greater principal amount of notes than they are required to purchase in the offering.
The underwriters may close out any short position by purchasing notes in the open market. A short position is more likely to be created
if the underwriters are concerned that there may be downward pressure on the price of the notes in the open market prior to the completion
of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Stabilizing
transactions consist of various bids for or purchases of the notes made by the underwriters in the open market prior to the completion
of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the other underwriters a portion of the
underwriting discount received by it because the stabilizing manager has repurchased notes sold by or for the account of that underwriter
in stabilizing or short covering transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Purchases
to cover a short position and stabilizing transactions may have the effect of preventing or slowing a decline in the market prices of
the notes. Additionally, these purchases, along with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the
market prices of the notes. As a result, the prices of the notes may be higher than the prices that might otherwise exist in the open
market. These transactions may be effected in the over-the-counter market or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment,
hedging, financing, corporate trust and brokerage activities. The underwriters and their respective affiliates have performed commercial
banking, investment banking, advisory and other commercial services for us from time to time for which they have received customary fees
and expenses. The underwriters and their respective affiliates may from time to time engage in transactions with and perform services
for us in the ordinary course of their business. In addition, in the ordinary course of their business activities, the underwriters and
their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative
securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments
and securities activities may involve securities and/or instruments of ours or our affiliates. If any of the underwriters or their affiliates
have a lending relationship with us, certain of these underwriters or their affiliates routinely hedge, and certain other of the underwriters
or their affiliates may hedge, their credit exposure to us consistent with their customary risk management policies. Typically, these
underwriters and their affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit
default swaps or the creation of short positions in our securities, including potentially the notes offered hereby. Any such credit default
swaps or short positions could adversely affect the future trading prices of the notes offered hereby. The underwriters and their respective
affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities
or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and
instruments. In addition, an affiliate of Deutsche Bank Securities, Inc. serves as trustee under the indenture and will receive
customary fees in connection with services provided in connection therewith.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Selling
Restrictions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Other
than the United States, to the best of our knowledge, no action has been taken by us or the underwriters that would permit a public offering
of the notes in any jurisdiction where action for that purpose is required. The notes may not be offered or sold, directly or indirectly,
nor may this prospectus supplement or any other offering material or advertisements in connection with the offer and sale of any such
notes be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable
rules and regulations of that jurisdiction. Persons into whose possession this prospectus supplement comes are advised to inform themselves
about and to observe any restrictions relating to the offering of the notes and the distribution of this prospectus supplement. This
prospectus supplement does not constitute an offer to sell or a solicitation of an offer to buy any notes offered by this prospectus
supplement in any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Sales
of notes in the United States by any underwriter that is not a broker-dealer registered with the SEC will be made only through one or
more SEC-registered broker-dealers in compliance with applicable securities laws and the rules of the Financial Industry Regulatory Authority,
Inc.</FONT></P>
<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in Canada</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes may be sold only to purchasers purchasing, or deemed to be purchasing, as principal, that are accredited investors, as defined
in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients,
as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the
notes must be made in accordance with an exemption from, or in a transaction not subject to the prospectus requirements of applicable
securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
supplement (including any amendment thereto) contains a misrepresentation, <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>provided
</I></FONT>that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities
legislation of the purchaser&rsquo;s province or territory. The purchaser should refer to any applicable provisions of the securities
legislation of the purchaser&rsquo;s province or territory for particulars of these rights or consult with a legal advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Pursuant
to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (&ldquo;NI 33-105&rdquo;), the underwriters are not required to
comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in the EEA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available
to any retail investor in the EEA. For the purposes of this provision, the expression &ldquo;retail investor&rdquo; means a person who
is one (or more) of the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                            retail client as defined in point (11) of Article 4(1) of MiFID II; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                            customer within the meaning of the Insurance Distribution Directive, where that customer
                                            would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID
                                            II.</FONT></TD></TR></TABLE>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in the United Kingdom</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available
to any retail investor in the United Kingdom. For the purposes of this provision, the expression &ldquo;retail investor&rdquo; means
a person who is one (or more) of the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                            retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it
                                            forms part of domestic law in the United Kingdom by virtue of the EUWA; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                            customer within the meaning of the provisions of the FSMA and any rules or regulations made
                                            under the FSMA to implement Directive (EU) 2016/97, as amended, where that customer would
                                            not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation
                                            (EU) No 600/2014 as it forms part of domestic law in the United Kingdom by virtue of the
                                            EUWA.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Each
underwriter has represented, warranted and agreed that:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">it
                                            has only communicated and caused to be communicated and will only communicate or cause to
                                            be communicated an invitation or inducement to engage in investment activity (within the
                                            meaning of Section 21 of the FSMA) received by it in connection with the issue or sale of
                                            any notes included in this offering in circumstances in which Section 21(1) of the FSMA does
                                            not apply to us; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">it
                                            has complied and will comply with all applicable provisions of the FSMA with respect to anything
                                            done by it in relation to the notes included in this offering in, from or otherwise involving
                                            the United Kingdom.</FONT></TD></TR></TABLE>
<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in Hong Kong</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">No
notes have been offered or sold, and no notes may be offered or sold, in Hong Kong, by means of any document other than: (i) to persons
whose ordinary business is to buy or sell shares or debentures, whether as principal or agent; (ii) to &ldquo;professional investors&rdquo;
as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong (the &ldquo;SFO&rdquo;) and any rules made thereunder; or
(iii) in other circumstances which do not result in the document being a &ldquo;prospectus&rdquo; as defined in the Companies Ordinance
(Cap. 32) of Hong Kong (the &ldquo;CO&rdquo;) or which do not constitute an offer or invitation to the public for the purpose of the
CO or the SFO. No document, invitation or advertisement relating to the notes has been issued, may be issued or may be in the possession
of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which
are likely to be accessed or read by, the public of Hong Kong (except if permitted under the securities laws of Hong Kong) other than
with respect to notes which are or are intended to be disposed of only to persons outside Hong Kong or only to &ldquo;professional investors&rdquo;
as defined in the SFO and any rules made thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus supplement has not been registered with the Registrar of Companies in Hong Kong. Accordingly, this prospectus supplement may
not be issued, circulated or distributed in Hong Kong, and the notes may not be offered for subscription to members of the public in
Hong Kong. Each person acquiring the notes will be required, and is deemed by the acquisition of the notes, to confirm that he, she or
it is aware of the restriction on offers of the notes described in this prospectus supplement and the relevant offering documents and
that he, she or it is not acquiring, and has not been offered, any notes in circumstances that contravene any such restrictions.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in Japan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
offering has not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948 of Japan,
as amended, the &ldquo;FIEL&rdquo;) and the underwriters will not offer or sell any notes, directly or indirectly, in Japan or to, or
for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or
other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to, or for
the benefit of, any resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance
with, the FIEL and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the relevant time.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in Singapore</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus supplement has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore. Accordingly,
this prospectus supplement and any other document or material in connection with the offer or sale, or invitation for subscription or
purchase, of the notes may not be circulated or distributed, nor may the notes be offered or sold, or be made the subject of an invitation
for subscription or purchase, whether directly or indirectly, to persons in Singapore other than: (i) to an institutional investor under
Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the &ldquo;SFA&rdquo;); (ii) to a relevant person pursuant to
Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275, of the SFA;
or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Where
the notes are subscribed or purchased under Section 275 of the SFA by a relevant person which is: (a) a corporation (which is not an
accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital
of which is owned by one or more individuals, each of whom is an accredited investor; or (b) a trust (where the trustee is not an accredited
investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,
securities (as defined in Section 239(1) of the SFA) of that corporation or the beneficiaries&rsquo; rights and interest (howsoever described)
in that trust shall not be transferred within six months after that corporation or that trust has acquired the notes pursuant to an offer
made under Section 275 of the SFA except: (i) to an institutional investor or to a relevant person defined in Section 275(2) of the SFA,
or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA; (ii) where no consideration
is or will be given for the transfer; (iii) where the transfer is by operation of law; (iv) as specified in Section 276(7) of the SFA;
or (v) as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of
Singapore.</FONT></P>
<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Singapore
Securities and Futures Act Product Classification&thinsp;&mdash;&thinsp;Solely for the purposes of its obligations pursuant to sections
309B(1)(a) and 309B(1)(c) of the SFA, the Company has determined, and hereby notifies all relevant persons (as defined in Section 309A
of the SFA) that the notes are &ldquo;prescribed capital markets products&rdquo; (as defined in the Securities and Futures (Capital Markets
Products) Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products
and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in Switzerland</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus supplement is not intended to constitute an offer or solicitation to purchase or invest in the notes. The notes may not be
publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act (the &ldquo;FinSA&rdquo;)
and no application has or will be made to admit the notes to trading on any trading venue (exchange or multilateral trading facility)
in Switzerland. Neither this prospectus supplement nor any other offering or marketing material relating to the notes constitutes a prospectus
pursuant to the FinSA, and neither this prospectus supplement nor any other offering or marketing material relating to the notes may
be publicly distributed or otherwise made publicly available in Switzerland.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Notice
to Prospective Investors in Taiwan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes have not been and will not be registered or filed with, or approved by, the Financial Supervisory Commission of Taiwan and/or other
regulatory authority of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan
through a public offering or in circumstances which could constitute an offer within the meaning of the Securities and Exchange Act of
Taiwan or relevant laws and regulations that require a registration, filing or approval of the Financial Supervisory Commission of Taiwan
and/or other regulatory authority of Taiwan. No person or entity in Taiwan has been authorized to offer or sell the notes in Taiwan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Notice
to Prospective Investors in the United Arab Emirates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
notes have not been and will not be publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Abu Dhabi
Global Market and the Dubai International Financial Centre) other than in compliance with the laws, regulations and rules of the United
Arab Emirates, the Abu Dhabi Global Market and the Dubai International Financial Centre governing the issue, offering and sale of securities.
Further, this prospectus supplement does not and will not constitute a public offer of securities in the United Arab Emirates (including
the Abu Dhabi Global Market and the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus supplement
has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and Commodities Authority, the Financial
Services Regulatory Authority or the Dubai Financial Services Authority.</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e24325a011"></A>LEGAL
OPINIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
validity of the notes offered hereby will be passed upon for us by Skadden, Arps, Slate, Meagher &amp; Flom LLP, New York, New York,
and for the underwriters by Alston &amp; Bird LLP, Atlanta, Georgia. Alston &amp; Bird LLP from time to time serves as our counsel.</FONT></P>
<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 0; text-align: center; color: Red"><IMG SRC="e24325001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: center"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Debt
Securities<BR>
Common Stock<BR>
Preferred Stock<BR>
Warrants<BR>
Depositary Shares<BR>
Purchase Contracts</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">We may offer,
issue and sell from time to time, together or separately:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">debt
                                         securities, which may be senior or subordinated and may be convertible;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">shares
                                         of our common stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">shares
                                         of our preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">warrants
                                         to purchase debt or equity securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">depositary
                                         shares; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">purchase
                                         contracts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">We may offer
and sell these securities to or through one or more underwriters, dealers and agents, or directly to purchasers, on a continuous
or delayed basis. In addition, selling stockholders may offer and sell, from time to time, these securities on terms described
in a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">This prospectus
describes some of the general terms that may apply to these securities. The specific terms of any securities to be offered will
be described in a prospectus supplement. The prospectus supplement may also add, update or change information contained in this
prospectus. You should read this prospectus and the applicable prospectus supplement carefully before you make your investment
decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">Our common
stock is listed on the New York Stock Exchange under the trading symbol &ldquo;KO.&rdquo; Unless stated otherwise in a prospectus
supplement, none of these securities will be listed on any securities exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">This prospectus
may not be used to sell securities unless accompanied by a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0; text-align: left"><FONT STYLE="font-size: 10pt"><B>You should
carefully read and consider the risk factors incorporated by reference into this prospectus from our Annual Report on Form 10-K
for the year ended December 31, 2021, and any subsequent periodic reports and other information that we file with the Securities
and Exchange Commission before you invest in our securities.</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0; text-align: left"><FONT STYLE="font-size: 10pt"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy
or adequacy of this prospectus or any related prospectus supplement. Any representation to the contrary is a criminal offense.</B></FONT>&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 9pt; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt">The date
of this prospectus is October 28, 2022.</FONT></P>




<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt">TABLE
OF CONTENTS</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%"><A HREF="#e22463a_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OUR COMPANY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_007"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">19</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_008"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_009"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF DEPOSITARY SHARES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">24</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_010"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF PURCHASE CONTRACTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">27</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_011"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">28</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_012"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">29</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#e22463a_013"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><FONT STYLE="font-size: 10pt">29</FONT></TD></TR>
</TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify"><FONT STYLE="font-size: 10pt">In this
prospectus, except as otherwise indicated or the context otherwise requires, the terms &ldquo;The Coca-Cola Company,&rdquo; the
&ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; mean The Coca-Cola Company and all entities included
in our consolidated financial statements.</FONT></P>




<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_001"></A>ABOUT
THIS PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">This prospectus
is part of an &ldquo;automatic shelf&rdquo; registration statement that we filed with the Securities and Exchange Commission (the
&ldquo;SEC&rdquo;) as a &ldquo;well-known seasoned issuer&rdquo; as defined in Rule 405 under the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;). By using a shelf registration statement, we may offer and sell, from time to time:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">debt
                                         securities, which may be senior or subordinated and may be convertible;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">shares
                                         of our common stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">shares
                                         of our preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">warrants
                                         to purchase debt or equity securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">depositary
                                         shares; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">purchase
                                         contracts,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">either separately
or in units, in one or more offerings. This prospectus provides you with a general description of those securities. In addition,
selling stockholders may offer and sell, from time to time, these securities on terms described in a prospectus supplement. Each
time we or selling stockholders sell securities, we will provide a prospectus supplement that will contain specific information
about the terms of that offering and the securities offered. The prospectus supplement may also add, update, change or supersede
information contained in this prospectus. If there is any inconsistency between the information in this prospectus and any prospectus
supplement, you should rely on the information in the prospectus supplement. You should read this prospectus and the applicable
prospectus supplement together with the additional information described herein under the heading &ldquo;Where You Can Find More
Information.&rdquo;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_002"></A>WHERE
YOU CAN FIND MORE INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">You may obtain
from the SEC, through the SEC&rsquo;s website, a copy of the registration statement on Form S-3, including exhibits, that we have
filed with the SEC to register the securities offered under this prospectus. This prospectus is part of the registration statement
and does not contain all the information in the registration statement. Any statement made in this prospectus concerning a contract
or other document of ours is not necessarily complete, and you should read the documents that are filed as exhibits to the registration
statement or otherwise filed with the SEC for a more complete understanding of the document or matter. Each such statement is
qualified in all respects by reference to the document to which it refers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We file annual,
quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public
free of charge at the SEC&rsquo;s website at www.sec.gov and on our corporate website at www.coca-colacompany.com. Information
on our website does not constitute part of, and is not incorporated by reference into, this prospectus or any accompanying prospectus
supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">We &ldquo;incorporate
by reference&rdquo; into this prospectus documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents. The information incorporated by reference is an important part of this prospectus.
Some information contained in this prospectus updates the information incorporated by reference, and information that we file
subsequently with the SEC will automatically update this prospectus. In other words, in the case of a conflict or inconsistency
between information set forth in this prospectus and information that we file later and incorporate by reference into this prospectus,
you should rely on the information contained in the document that was filed later.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">We incorporate
by reference into this prospectus the documents listed below and any filings we make with the SEC under Sections 13(a), 13(c),
14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) after the date of this prospectus
and prior to the time that all the securities offered by this prospectus have been issued as described in this prospectus (other
than, in each case, documents or information deemed to have been &ldquo;furnished&rdquo; and not &ldquo;filed&rdquo; in accordance
with SEC rules):</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">our
                                         Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000002134422000009/ko-20211231.htm" STYLE="-sec-extract: exhibit">Form 10-K</A> for the year ended December 31, 2021, filed with the SEC on
                                         February&nbsp;22, 2022;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">our
                                         Quarterly Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000002134422000016/ko-20220401.htm" STYLE="-sec-extract: exhibit">Form 10-Q</A> for the quarterly period ended April 1, 2022, filed with
                                         the SEC on April&nbsp;28, 2022,</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">our
                                         Quarterly Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000002134422000034/ko-20220701.htm" STYLE="-sec-extract: exhibit">Form 10-Q</A> for the quarterly period ended July 1, 2022, filed with
                                         the SEC on July&nbsp;27, 2022;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">our
                                         Quarterly Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000002134422000042/ko-20220930.htm" STYLE="-sec-extract: exhibit">Form 10-Q</A> for the quarterly period ended September 30, 2022, filed
                                         with the SEC on October 26, 2022;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">our Current Reports on Form 8-K
                                                                                                                                                                                               filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/21344/000155278122000167/e22073_ko-8k.htm" STYLE="-sec-extract: exhibit">February 16, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000155278122000236/e22121_ko-8k.htm" STYLE="-sec-extract: exhibit">March
                                                                                                                                                                                               4, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000155278122000366/e22265_ko-8k.htm" STYLE="-sec-extract: exhibit">April
                                                                                                                                                                                               27, 2022</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000155278122000509/e22375_ko-8k.htm" STYLE="-sec-extract: exhibit">July
                                                                                                                                                                                               21, 2022</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000021344/000155278122000543/e22401_ko-8k.htm" STYLE="-sec-extract: exhibit">August
                                                                                                                                                                                               23, 2022</A>;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">portions
                                         of our Definitive Proxy Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/21344/000120677422000669/ko3966431-def14a.htm" STYLE="-sec-extract: exhibit">Schedule 14A</A>, filed with the SEC on March 11, 2022,
                                         solely to the extent incorporated by reference into Part III of our Annual Report on
                                         Form 10-K for the year ended December 31, 2021; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         descriptions of the common stock set forth in our registration statements filed with
                                         the SEC pursuant to Section 12 of the Exchange Act, and any amendment or report filed
                                         for the purpose of updating those descriptions (including Exhibit 4.1 to our Annual Report
                                         on Form 10-K for the year ended December 31, 2021).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">You may request
a copy of the registration statement, the above filings and any future filings that are incorporated by reference into this prospectus,
other than an exhibit to a filing unless that exhibit is specifically incorporated by reference into that filing, at no cost,
by writing or calling us at the following address: Office of the Secretary, The Coca-Cola Company, One Coca-Cola Plaza, Atlanta,
Georgia 30313; telephone: (404) 676-2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">You should
rely only on the information contained or incorporated by reference in this prospectus, any accompanying prospectus supplement
or any free writing prospectus filed by us with the SEC and any information about the terms of securities offered conveyed to
you by us, our underwriters or agents. We have not authorized anyone else to provide you with additional or different information.
These securities are only being offered in jurisdictions where the offer is permitted. You should not assume that the information
contained in this prospectus, any accompanying prospectus supplement or any free writing prospectus is accurate as of any date
other than their respective dates.</FONT></P>

<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_003"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">This prospectus,
any accompanying prospectus supplement and the documents incorporated by reference herein may contain information that may constitute
&ldquo;forward-looking statements&rdquo; under U.S. federal securities laws. Generally, the words &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;intend,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;project,&rdquo; &ldquo;will&rdquo; and similar
expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words
or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance,
events or developments that we expect or anticipate will occur in the future&nbsp;&mdash; including statements relating to volume
growth, share of sales and earnings per share growth, and statements expressing general views about future operating results&nbsp;&mdash;
are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However,
caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only
as of the date when made. Our Company undertakes no obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements
are subject to certain risks and uncertainties that could cause our Company&rsquo;s actual results to differ materially from historical
experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, the possibility
that the assumptions used to calculate our estimated aggregate incremental tax and interest liability related to the potential
unfavorable outcome of the ongoing tax dispute with the U.S. Internal Revenue Service could significantly change; those described
in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2021 and in our Quarterly Report on Form 10-Q
for the quarter ended April 1, 2022; and those described from time to time in our future reports filed with the Securities and
Exchange Commission.</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_004"></A>OUR
COMPANY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The Coca-Cola
Company is a total beverage company, and beverage products bearing our trademarks, sold in the United States since 1886, are now
sold in more than 200 countries and territories. We own or license and market numerous beverage brands, which we group into the
following categories: Trademark Coca-Cola; sparkling flavors; hydration, sports, coffee and tea; nutrition, juice, dairy and plant-based
beverages; and emerging beverages. We own and market five of the world&rsquo;s top six nonalcoholic sparkling soft drink brands:
Coca-Cola, Sprite, Fanta, Diet Coke and Coca-Cola Zero Sugar.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We make our
branded beverage products available to consumers throughout the world through our network of independent bottling partners, distributors,
wholesalers and retailers as well as our consolidated bottling and distribution operations. Beverages bearing trademarks owned
by or licensed to the Company account for 2.1 billion of the approximately 63 billion servings of all beverages consumed worldwide
every day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We believe
our success depends on our ability to connect with consumers by providing them with a wide variety of beverage options to meet
their desires, needs and lifestyles. Our success further depends on the ability of our people to execute effectively, every day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The Coca-Cola
Company was incorporated in September 1919 under the laws of the State of Delaware and succeeded to the business of a Georgia
corporation with the same name that had been organized in 1892.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Our principal
office is located at One Coca-Cola Plaza, Atlanta, Georgia 30313, and our telephone number at that address is (404) 676-2121.
We maintain a website at www.coca-colacompany.com where general information about us is available. Information on our website
does not constitute part of, and is not incorporated by reference into, this prospectus or the accompanying prospectus supplement.</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_005"></A>USE
OF PROCEEDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Except as
may be otherwise set forth in the applicable prospectus supplement accompanying this prospectus, the net proceeds from the sale
of the securities by us will be used for general corporate purposes, including:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">working
                                         capital;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">capital
                                         expenditures;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">acquisitions
                                         of or investments in businesses or assets;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">redemption
                                         and repayment of short-term or long-term borrowings; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">purchases
                                         of our common stock.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Pending application
of the net proceeds, we may temporarily invest the net proceeds in short-term marketable securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">We will not
receive any proceeds from the sale of securities by selling stockholders.</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_006"></A>DESCRIPTION
OF DEBT SECURITIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">This section
describes the general terms and provisions of the debt securities. The applicable prospectus supplement will describe the specific
terms of the debt securities offered by that prospectus supplement and any general terms outlined in this section that will not
apply to those debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Any debt securities
will be either our senior unsecured obligations issued in one or more series, which we refer to as the &ldquo;senior debt securities,&rdquo;
or our subordinated unsecured obligations issued in one or more series, which we refer to as the &ldquo;subordinated debt securities.&rdquo;
We will issue the senior debt securities under an amended and restated indenture between us and Deutsche Bank Trust Company Americas,
as successor to Bankers Trust Company, as trustee, dated as of April 26, 1988, as amended, which we refer to as the &ldquo;senior
indenture.&rdquo; We will issue the subordinated debt securities under an indenture to be entered into between us and Deutsche
Bank Trust Company Americas, as trustee, which we refer to as the &ldquo;subordinated indenture.&rdquo; We refer to the senior
indenture and the subordinated indenture, collectively, as the &ldquo;indentures.&rdquo; As used in this prospectus, &ldquo;debt
securities&rdquo; means the debentures, notes, bonds and other evidences of indebtedness that we issue and the trustee authenticates
and delivers under the indentures. The indentures and all debt securities issued under the indentures will be governed by and
construed in accordance with the laws of the State of New York. Additionally, the indentures are subject to the provisions of
the Trust Indenture Act of 1939, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We have summarized
selected terms and provisions of the indentures in this section. We have also incorporated by reference the indentures as exhibits
to the registration statement of which this prospectus forms a part. You should read the indentures for additional information
before you buy any debt securities. See &ldquo;Where You Can Find More Information&rdquo; for information on how to obtain copies
of the indentures. The summary that follows includes references to section numbers of the indentures (as supplemented by the first
supplemental indenture to the senior indenture, dated as of February 24, 1992, and the second supplemental indenture to the senior
indenture, dated as of November 1, 2007, in some instances) so that you can more easily locate these provisions. Unless otherwise
indicated, section references are the same for the senior indenture and the subordinated indenture. Capitalized terms used but
not defined in this summary have the meanings specified in the indentures.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">General</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The senior
debt securities will rank equally and ratably with our other unsecured and unsubordinated obligations. The subordinated debt securities
will be subordinated in right of payment to the prior payment in full of our senior debt, including any senior debt securities,
as described below under &ldquo;Subordinated Indenture Provisions&mdash;Subordination.&rdquo; The debt securities will rank junior
to all of our currently existing and future secured debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We are not
limited as to the amount of debt securities that we can issue under the indentures. We may issue debt securities under the indentures
in one or more series, each with different terms, up to the aggregate principal amount which we may authorize from time to time.
We also have the right to &ldquo;reopen&rdquo; a previous issue of a series of debt securities by issuing additional debt securities
of such series. (Section 3.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">A prospectus
supplement relating to a series of debt securities being offered will include specific terms relating to that offering. In addition
to stating whether the securities will be senior or subordinated, these terms will include some or all of the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         title and type of the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         total principal amount of debt securities of that series that are authorized and outstanding
                                         as of the most recent date;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         limit on the total principal amount of the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         price at which the debt securities will be issued;</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         date or dates on which the principal of and premium, if any, on the debt securities will
                                         be payable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         maturity date of the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         minimum denominations in which the debt securities will be issued;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">if
                                         the debt securities will bear interest;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         interest rate on the debt securities or the method of calculating the interest rate;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         date from which interest will accrue;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         record and interest payment dates for the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         first interest payment date;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         place or places at which the principal or premium, if any, and interest, if any, on the
                                         debt securities will be paid;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         optional redemption provisions that would permit us or the holders of the debt securities
                                         to elect redemption of the debt securities prior to their final maturity;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         sinking fund or mandatory redemption or retirement provisions that would obligate us
                                         to redeem the debt securities prior to their final maturity;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         currency or currencies in which the debt securities will be denominated and payable,
                                         if other than U.S. dollars;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         provisions that would permit us or the holders of the debt securities to elect the currency
                                         or currencies in which the debt securities are paid;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         portion of the principal amount of the debt securities that will be payable upon declaration
                                         or acceleration of maturity of the debt securities (if other than the principal amount
                                         of the debt securities);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the provisions described under the heading &ldquo;Defeasance of the Indentures and Securities&rdquo;
                                         below apply to the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the provisions of some or all of the covenants described under the heading &ldquo;Restrictive
                                         Covenants&rdquo; below apply to the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         changes to or additional Events of Default (as defined under the heading &ldquo;Event
                                         of Default&rdquo; below) or covenants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the debt securities will be issued in whole or in part in the form of global securities
                                         and, if so, the depositary for those global securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         special tax implications of the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">for
                                         the subordinated debt securities, whether the specific subordination provisions applicable
                                         to the subordinated debt securities are other than as set forth in the subordinated indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the debt securities are convertible or exchangeable into our common stock or other equity
                                         securities and the terms and conditions upon which such conversion or exchange shall
                                         be effected; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         other terms of the debt securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">If the purchase
price of any debt securities is denominated in a foreign currency or composite currency, or if the principal of or any premium
or interest on any debt securities is payable in a foreign currency or composite currency, we will include the restrictions, elections,
tax consequences, specific terms and other information with respect to the debt securities and the applicable foreign currency
or composite currency in the applicable prospectus supplement.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We may issue
debt securities as Original Issue Discount Securities (as defined below) to be offered and sold at a substantial discount from
their principal amount and typically bearing no interest or interest at a rate which at the time of issuance is below market rates.
An &ldquo;Original Issue Discount Security&rdquo; is any debt security which provides for an amount less than its principal amount
to be due and payable upon a declaration of acceleration of its maturity. (Section 1.01). We will describe the federal income
tax, accounting and other considerations relevant to any such Original Issue Discount Securities in the applicable prospectus
supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The particular
terms of a series of debt securities will be set forth in an officers&rsquo; certificate or supplemental indenture, and described
in the applicable prospectus supplement. We urge you to read the applicable indenture as supplemented by any officers&rsquo; certificate
or supplemental indenture that is applicable to you because that indenture, as supplemented, and not this section, defines your
rights as a holder of the debt securities.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Restrictive
Covenants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The indentures
contain certain restrictive covenants that apply, or may apply, to us and all of our Restricted Subsidiaries (as defined below).
The covenants described below under &ldquo;Restrictions on Liens&rdquo; and &ldquo;Restrictions on Sale and Leaseback Transactions&rdquo;
will not apply to a series of debt securities unless we specifically so provide in the applicable prospectus supplement. These
covenants do not apply to any of our Subsidiaries that are not designated as Restricted Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">You should
carefully read the applicable prospectus supplement for the particular provisions of the series of debt securities being offered,
including any additional restrictive covenants or Events of Default that may be included in the terms of such debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Restrictions
on Liens.</I></B> If the applicable prospectus supplement states that the covenant set forth in Section 5.03 of the indentures
will be applicable to a series of debt securities, then we will be subject to a covenant providing that we will not, nor will
we permit any Restricted Subsidiary (as defined below) to, create, incur, issue, assume or guarantee any debt for money borrowed
(as used in this &ldquo;Restrictive Covenants&rdquo; section, &ldquo;Debt&rdquo;) if such Debt is secured by a mortgage, pledge,
lien, security interest or other encumbrance upon any Principal Property (as defined below) or on any shares of stock or indebtedness
of any Restricted Subsidiary (whether such Principal Property, shares of stock or indebtedness are now owned or acquired in the
future), without, in any such case, effectively providing that the debt securities and, at our option, any of our other indebtedness
or guarantees or any indebtedness or guarantees of a Restricted Subsidiary ranking equally with the debt securities, will be secured
equally and ratably with (or, at our option, prior to) such Debt. The foregoing restrictions do not apply to:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">mortgages
                                         on property, shares of stock or indebtedness of any corporation existing at the time
                                         such corporation becomes a Restricted Subsidiary;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">mortgages
                                         on property existing at the time of acquisition of such property and, in some instances,
                                         certain purchase money mortgages;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">mortgages
                                         securing Debt owing by any Restricted Subsidiary to us or another Restricted Subsidiary;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">mortgages
                                         on property of a corporation existing at the time such corporation is merged into or
                                         consolidated with us or a Restricted Subsidiary or at the time of a sale, lease or other
                                         disposition of the properties of a corporation or firm as an entirety or substantially
                                         as an entirety to us or a Restricted Subsidiary;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">mortgages
                                         in favor of any country or any political subdivision of any country, or any instrumentality
                                         thereof, to secure payments pursuant to any contract or statute or to secure any indebtedness
                                         incurred for the purpose of financing all or any part of the purchase price or the cost
                                         of construction of the property subject to such mortgages; or</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         extension, renewal or replacement (or successive extensions, renewals or replacements),
                                         in whole or in part, of any mortgage referenced in clauses (1) through (5) above, inclusive,
                                         or any mortgage existing at the respective date of the applicable indenture, provided
                                         that the principal amount of Debt secured at the time of such extension may not be increased,
                                         and the collateral which secures the same cannot be expanded.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Notwithstanding
these exceptions, we and one or more Restricted Subsidiaries may, without securing the debt securities, create, incur, issue,
assume or guarantee secured Debt which would otherwise be subject to the foregoing restrictions, provided that if, after giving
effect to such Debt, the aggregate of such secured Debt then outstanding (not including secured Debt permitted under the foregoing
exceptions) at such time does not exceed 10% of our consolidated shareowners&rsquo; equity as of the end of the preceding fiscal
year. (Section 5.03).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Restrictions
on Sale and Leaseback Transactions.</I></B> If the applicable prospectus supplement states that the covenant set forth in Section
5.04 of the indentures will be applicable to a series of debt securities, then we will be subject to the covenant providing that
we will not, and we will not permit any Restricted Subsidiary to, enter into any lease, other than intercompany leases, longer
than three years covering any Principal Property that is sold to any other person in connection with such lease unless:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">we
                                         or such Restricted Subsidiary would be entitled, pursuant to &ldquo;Restrictions on Liens&rdquo;
                                         described above, to incur Debt secured by a mortgage on the Principal Property involved
                                         in an amount at least equal to the Attributable Debt (as defined below) without equally
                                         and ratably securing the debt securities provided that such Attributable Debt shall then
                                         be deemed to be Debt subject to the provisions of such restriction on liens;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">since
                                         the respective date of the applicable indenture and within a period commencing twelve
                                         months prior to the consummation of the sale and leaseback transaction and ending twelve
                                         months after the consummation of such transaction, we or such Restricted Subsidiary has
                                         expended, or will expend, for the Principal Property an amount equal to (a) the net proceeds
                                         of such sale and leaseback transaction, and we elect to designate all of such amount
                                         as a credit against such transaction or (b) a part of the net proceeds of such sale and
                                         leaseback transaction, and we elect to designate such amount as a credit against such
                                         transaction and apply an amount equal to the remainder of the net proceeds as provided
                                         in clause (3) below; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">an
                                         amount equal to such Attributable Debt (less any amount elected under clause (2) above)
                                         is applied within 90 days of such lease to the retirement of Debt, other than intercompany
                                         Debt, which by its terms matures at, or is prepayable or extendible or renewable at the
                                         sole option of the obligor without requiring the consent of the obligee to, a date more
                                         than twelve months after the date of the creation of such Debt. (Section 5.04).</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Consolidation,
Merger and Sale</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">The indentures
generally provide that we may consolidate with or merge into any other corporation, or transfer or lease our properties and assets
as an entirety or substantially as an entirety to any other corporation, if the corporation formed by or resulting from any such
consolidation, into which we are merged or which shall have acquired or leased such properties and assets, shall, pursuant to
a supplemental indenture, assume payment of the principal of (and premium, if any) and interest, if any, on the debt securities
and the performance and observance of the covenants of the indentures. (Section 11.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">If upon (1)
any consolidation or merger of us, or of us and any Subsidiary, with or into any other corporation or corporations, or upon the
merger of another corporation into us, or (2) successive consolidations or mergers to which we or our successors shall be a party
or parties, or (3) upon any sale or conveyance of our property, or the property of us and any Subsidiary, as an entirety or substantially
as an entirety, any Principal Property or any shares of stock or Debt of any Restricted Subsidiary would then become subject to
any mortgage, we will cause the debt securities, and at our option any other indebtedness of or guarantees by us or such Restricted
Subsidiary ranking equally with the debt securities, to be secured equally and ratably with (or, at our option, prior to) any
Debt secured thereby, unless such Debt could have been incurred without us being required to secure the debt securities equally
or ratably with (or prior to) such Debt pursuant to &ldquo;Restrictions on Liens&rdquo; described above. (Section 11.01).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Certain
Definitions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">As used in
the indentures and this prospectus, the following definitions apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;Attributable
Debt&rdquo; means, in respect of a sale and leaseback transaction, as of any particular time, the present value (discounted at
the rate of interest implicit in the terms of the lease involved in such sale and leaseback transaction, as determined in good
faith by us) of the obligation of the lessee thereunder for rental payments (excluding, however, any amounts required to be paid
by such lessee, whether or not designated as rent or additional rent, on account of maintenance and repairs, insurance, taxes,
assessments, water rates or similar charges or any amounts required to be paid by such lessee thereunder contingent upon the amount
of sales, maintenance and repairs, insurance, taxes, assessments, water rates or similar charges) during the remaining term of
such lease (including any period for which such lease has been extended or may, at the option of the lessor, be extended). (Section
1.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;Principal
Property&rdquo; means our manufacturing plants or facilities or those of a Restricted Subsidiary located within the United States
of America (other than its territories and possessions) or Puerto Rico, except any such manufacturing plant or facility which
our board of directors by resolution reasonably determines not to be of material importance to the total business conducted by
us and our Restricted Subsidiaries. (Section 1.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;Restricted
Subsidiary&rdquo; means any Subsidiary (1) substantially all of the property of which is located, or substantially all of the
business of which is carried on, within the United States of America (other than its territories and possessions) or Puerto Rico
and (2) which owns or is the lessee of any Principal Property, but does not include any Subsidiary primarily engaged in financing
activities, primarily engaged in the leasing of real property to persons other than us and our Subsidiaries, or which is characterized
by us as a temporary investment. The terms &ldquo;Restricted Subsidiary&rdquo; does not include Coca-Cola Financial Corporation,
The Coca-Cola Trading Company LLC, 55th &amp; 5th Avenue Corporation, Bottling Investments Corporation or ACCBC Holding Company,
and their respective Subsidiaries. (Section 1.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;Subsidiary&rdquo;
means a corporation more than 50% of the outstanding Voting Stock of which is owned, directly or indirectly, by us or one or more
other Subsidiaries, or by us and one or more other Subsidiaries. (Section 1.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;Voting
Stock&rdquo; means stock of the class or classes having general voting power under ordinary circumstances to elect at least a
majority of the board of directors, managers or trustees of said corporation (irrespective of whether or not at the time stock
of any other class or classes shall have or might have voting power by reason of the happening of any contingency). (Section 1.01).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Event
of Default</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">&ldquo;Event
of Default,&rdquo; when used in the indentures with respect to any series of debt securities, means any of the following events:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">default
                                         for 30 days in payment of any interest on such series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">default
                                         in payment of any principal of or premium, if any, on such series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">default
                                         in payment of any sinking fund installment for such series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">default
                                         for 90 days after written notice in performance of any other covenant in the indentures
                                         (other than a covenant or agreement included in the indentures solely for the benefit
                                         of holders of debt securities of any series other than that series);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">certain
                                         events of bankruptcy, insolvency or reorganization; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         other Event of Default provided with respect to that series. (Section 7.01).</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The indentures
require us to deliver annually to the trustee an officers&rsquo; certificate, in which certain of our officers certify whether
or not they have knowledge of any default in our performance of the covenants described. (Section 5.07).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">If an Event
of Default shall occur and be continuing with respect to the debt securities of any series, the trustee or the holders of not
less than 25% in aggregate principal amount of the debt securities of such series then outstanding may declare the principal (or,
if the debt securities of such series are Original Issue Discount Securities, such portion of the principal amount as may be specified
in the applicable prospectus supplement for such series) of all the debt securities of such series and the interest accrued thereon
to be due and payable. (Section 7.02). The holders of not less than a majority in aggregate principal amount of the outstanding
debt securities of such series (or, in the case of certain Events of Default pertaining to all outstanding debt securities, with
the consent of holders of a majority in aggregate principal amount of all the debt securities then outstanding acting as one class)
may waive any Event of Default with respect to a particular series of debt securities, except an Event of Default in the payment
of principal of or any premium or interest on any debt securities of such series or in respect of a covenant or provision of the
indentures which, under the terms thereof, cannot be modified or amended without the consent of the holders of each outstanding
debt security of such series. (Section 7.11). See &ldquo;Modifications of the Indentures&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Subject to
the provisions of the indentures relating to the duties of the trustee in case an Event of Default shall occur and be continuing,
the trustee is under no obligation to exercise any of the rights or powers under the indentures at the request, order or direction
of any of the holders of debt securities of any series, unless such securityholders shall have offered to the trustee reasonable
security or indemnity against the costs, expenses and liabilities which might be incurred by such exercise. (Section 8.02). Subject
to such provisions for the indemnification of the trustee and certain limitations contained in the indentures, the holders of
a majority in aggregate principal amount of all debt securities of such series at the time outstanding shall have the right to
direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust
or power conferred on the trustee with respect to the debt securities of that series. (Section 7.10).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">If any debt
securities are denominated in a foreign currency or composite currency, then for the purposes of determining whether the holders
of the requisite principal amount of debt securities have taken any action as herein described, the principal amount of such debt
securities shall be deemed to be that amount of United States dollars that could be obtained for such principal amount on the
basis of the spot rate of exchange into United States dollars for the currency or composite currency in which such debt securities
are denominated (as determined by us or an authorized exchange rate agent and evidenced to the trustee) as of the date the taking
of such action by the holders of such requisite principal amount is evidenced to the trustee as provided in the indentures. (Section
14.10).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Modifications
of the Indentures</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We and the
trustee may modify and amend the indentures with the consent of the holders of not less than a majority in aggregate principal
amount then outstanding of any series of the debt securities affected by such modification or amendment. However, we may not,
without the consent of the holders of each debt security so affected:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">extend
                                         the fixed maturity of such series of debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">reduce
                                         the principal amount of such series of debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">reduce
                                         the rate or extend the time of payment of interest on such series of debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">impair
                                         or affect the right of any securityholder to institute suit for payment of principal
                                         or interest or change the coin or currency in which the principal of or interest on such
                                         series of debt securities is payable; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">reduce
                                         the percentage of aggregate principal amount of debt securities of such series from whom
                                         consent is required to modify the indentures. (Section 10.02).</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">In addition,
under our subordinated indenture, without the consent of each holder of each debt security so affected, we may not modify the
provisions of the subordinated indenture with respect to subordination of the debt securities in a manner adverse to the holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We and the
trustee may modify and amend the indentures without the consent of any holders of debt securities to:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">provide
                                         for security for the debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">evidence
                                         the assumption of our obligations under the applicable indenture by a successor;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">add
                                         covenants that would benefit holders of any debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">cure
                                         any ambiguity, omission, defect or inconsistency;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">change
                                         or eliminate any of the provisions of the indentures so long as such change or elimination
                                         becomes effective only when there are no securities created prior to the execution of
                                         the supplemental indenture then outstanding which are entitled to the benefit of such
                                         provision;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">provide
                                         for a successor trustee; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">make
                                         such provisions as may be necessary or advisable in order to comply with the withholding
                                         provisions of the Internal Revenue Code of 1986, as amended, and the rules and regulations
                                         thereunder. (Section 10.01).</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Defeasance
of the Indentures and Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Unless the
applicable prospectus supplement states otherwise, the indentures provide that we will be deemed to have paid and discharged the
entire indebtedness on the debt securities of any series, and our obligations under the indentures with respect to the debt securities
of such series (other than certain specified obligations, such as the obligations to maintain a security register pertaining to
transfer of the debt securities, to maintain a paying agency office, and to replace stolen, lost or destroyed debt securities)
will cease to be in effect, from and after the date that we deposit with the trustee, in trust:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">money
                                         in the currency or composite currency in which the debt securities of such series are
                                         denominated; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">U.S.
                                         Government Obligations, in the case of debt securities denominated in dollars, or obligations
                                         issued or guaranteed by the government which issued the currency in which the debt securities
                                         of such series are denominated, in the case of debt securities denominated in foreign
                                         currencies, which through the payment of interest and principal in accordance with their
                                         terms will provide money in the currency in which the debt securities of such series
                                         are denominated; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                         combination thereof,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">which is sufficient
to pay and discharge the principal and premium, if any, and interest, if any, to the date of maturity on or the redemption date
of, such series of debt securities. (Sections 12.01 and 12.02). In the event of any such defeasance, holders of such debt securities
would be able to look only to such trust fund for payment of principal (and premium, if any) and interest, if any, on their debt
securities until maturity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Such defeasance
may be treated as a taxable exchange of the related debt securities for an issue of obligations of the trust or a direct interest
in the money, U.S. Government Obligations or other obligations held in the trust. In that case, holders of such debt securities
may recognize gain or loss as if the trust obligations or the money, U.S. Government Obligations or other obligations deposited,
as the case may be, had actually been received by them in exchange for their debt securities. Such holders thereafter might be
required to include in income a different amount than would be includable in the absence of defeasance. We encourage prospective
investors to consult with their own tax advisors as to the specific consequences of defeasance.</FONT></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Denominations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Unless the
applicable prospectus supplement states otherwise, the debt securities will be issued only in registered form without coupons,
in U.S. dollars in denominations of $1,000 or any integral multiples of $1,000. We will issue a book-entry security equal to the
aggregate principal amount of outstanding debt securities of the series represented by such book-entry security. We will specify
the denominations of a series of debt securities denominated in a foreign currency or composite currency in the applicable prospectus
supplement. (Sections 3.02 and 3.03).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Registration
and Transfer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">You may exchange
any certificated securities of any series for other certificated securities of the same series and of a like aggregate principal
amount and tenor of different authorized denominations. Upon payment of any taxes and other governmental charges as described
in the indentures, you may present certificated securities for registration of transfer (with the form of transfer duly executed),
without a service charge, at the office of the securities registrar or at the office of any transfer agent that we designate for
such purpose and reference in the applicable prospectus supplement with respect to any series of debt securities. Subject to its
satisfaction with the documents of title and identity of the person making the request, the securities registrar or such transfer
agent, as the case may be, will effect such transfer or exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We have initially
appointed the trustee as securities registrar under the indentures. (Section 3.05). If the prospectus supplement refers to any
transfer agent in addition to the securities registrar initially designated by us with respect to any series of debt securities,
we may at any time rescind the designation of any such transfer agent or approve a change in the location through which any such
transfer agent acts, except that we will be required to maintain a transfer agent in the borough of Manhattan, the city of New
York, for such series. We may at any time designate additional transfer agents with respect to any series of debt securities.
(Section 5.02).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">In the event
of any partial redemption in part of a series of debt securities, we will not be required to (1) issue securities of such series,
register the transfer of securities of such series or exchange debt securities of such series during a period beginning at the
opening of business 15 days before the mailing date of a notice of redemption of such debt securities of that series selected
to be redeemed and ending at the close of business on such mailing date or (2) register the transfer or exchange of any debt security,
or portion of any such debt security, that is called for redemption, except the unredeemed portion of any debt security being
redeemed in part. (Section 3.05).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Payment
and Paying Agents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Unless the
applicable prospectus supplement states otherwise, we will pay the principal of and any premium and interest on debt securities
at the office of the paying agent or paying agents as we may designate from time to time. However, at our option we may pay any
interest by check mailed or delivered to the address of the person entitled to such payment as it appears in the securities register.
(Section 2.02). Unless the applicable prospectus supplement states otherwise, we will pay any installment of interest on debt
securities to the person in whose name the debt security is registered at the close of business on the regular record date for
such interest payment. (Section 3.07). Payments of any interest on the debt securities may be subject to the deduction of applicable
withholding taxes. (Section 5.01).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Unless the
applicable prospectus supplement states otherwise, the principal office of the trustee in the city of New York is designated as
our paying agent for payments with respect to debt securities. Any other paying agents that we may designate at the time of the
offering and issuance of a series of debt securities will be named in the related prospectus supplement. With regard to any series,
we may at any time designate additional paying agents, rescind the designation of any paying agents or approve a change in the
office through which any paying agent acts, except that we will be required to maintain a paying agent in the borough of Manhattan
in the city of New York. (Section 5.02).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The trustee
or any paying agent for the payment of principal of or interest on any debt security will repay to us all moneys paid by us which
remain unclaimed at the end of two years after such principal or interest shall have become due and payable, and, after such repayment
occurs, the holder of the applicable debt security will be entitled to look only to us for payment. (Section 12.04).</FONT></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Concerning
the Trustee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">Deutsche Bank
Trust Company Americas, as successor to Bankers Trust Company, New York, New York, is the trustee under the senior indenture and
has agreed to act as trustee under the subordinated indenture. We maintain banking relationships in the ordinary course of business
with affiliates of Deutsche Bank Trust Company Americas, and affiliates of Deutsche Bank Trust Company Americas have entered into
foreign currency transactions with us, serve as fiscal agents for certain of our outstanding obligations and have provided back-up
lines of credit for our commercial paper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Book-Entry
Delivery and Settlement</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Global
Notes</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We will issue
any debt securities in the form of one or more global notes in definitive, fully registered, book-entry form. The global notes
will be deposited with or on behalf of the Depository Trust Company (&ldquo;DTC&rdquo;) and registered in the name of Cede &amp;
Co., as nominee of DTC.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">DTC,
Clearstream and Euroclear</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Beneficial
interests in the global notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial
owners as direct and indirect participants in DTC. Investors may hold interests in the global notes through either DTC (in the
United States), Clearstream Banking, societe anonyme, Luxembourg, which we refer to as Clearstream, or Euroclear Bank S.A./ N.V.,
as operator of the Euroclear System, which we refer to as Euroclear, in Europe, either directly if they are participants in such
systems or indirectly through organizations that are participants in such systems. Clearstream and Euroclear will hold interests
on behalf of their participants through customers&rsquo; securities accounts in Clearstream&rsquo;s and Euroclear&rsquo;s names
on the books of their U.S. depositaries, which in turn will hold such interests in customers&rsquo; securities accounts in the
U.S. depositaries&rsquo; names on the books of DTC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">DTC has advised
us that:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">DTC
                                         is a limited-purpose trust company organized under the New York Banking Law, a &ldquo;banking
                                         organization&rdquo; within the meaning of the New York Banking Law, a member of the Federal
                                         Reserve System, a &ldquo;clearing corporation&rdquo; within the meaning of the New York
                                         Uniform Commercial Code and a &ldquo;clearing agency&rdquo; registered under Section
                                         17A of the Exchange Act.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">DTC
                                         holds securities that its participants deposit with DTC and facilitates the settlement
                                         among participants of securities transactions, such as transfers and pledges, in deposited
                                         securities through electronic computerized book-entry changes in participants&rsquo;
                                         accounts, thereby eliminating the need for physical movement of securities certificates.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Direct
                                         participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust
                                         companies, clearing corporations and other organizations, some of whom, and/or their
                                         representatives, own DTC.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">DTC
                                         is a wholly-owned subsidiary of The Depository Trust &amp; Clearing Corporation (&ldquo;DTCC&rdquo;).
                                         DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed
                                         Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned
                                         by the users of its regulated subsidiaries.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Access
                                         to the DTC system is also available to others such as both U.S. and non-U.S. securities
                                         brokers and dealers, banks and trust companies that clear through or maintain a custodial
                                         relationship with a direct participant, either directly or indirectly.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The
                                         rules applicable to DTC and its direct and indirect participants are on file with the
                                         SEC.</FONT></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Clearstream
has advised us that it is incorporated under the laws of Luxembourg as a professional depositary. Clearstream holds securities
for its customers and facilitates the clearance and settlement of securities transactions between its customers through electronic
book-entry changes in accounts of its customers, thereby eliminating the need for physical movement of certificates. Clearstream
provides to its customers, among other things, services for safekeeping, administration, clearance and settlement of internationally
traded securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries. As
a professional depositary, Clearstream is subject to regulation by the Luxembourg Commission for the Supervision of the Financial
Sector. Clearstream customers are recognized financial institutions around the world, including underwriters, securities brokers
and dealers, banks, trust companies, clearing corporations and other organizations and may include the underwriters. Indirect
access to Clearstream is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain
a custodial relationship with a Clearstream customer either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Euroclear
has advised us that it was created in 1968 to hold securities for participants of Euroclear and to clear and settle transactions
between Euroclear participants through simultaneous electronic book-entry delivery against payment, thereby eliminating the need
for physical movement of certificates and any risk from lack of simultaneous transfers of securities and cash. Euroclear provides
various other services, including securities lending and borrowing and interfaces with domestic markets in several countries.
Euroclear is operated by Euroclear Bank S.A./ N.V., which we refer to as the Euroclear Operator. All operations are conducted
by the Euroclear Operator, and all Euroclear securities clearance accounts and Euroclear cash accounts are accounts with the Euroclear
Operator. Euroclear participants include banks (including central banks), securities brokers and dealers, and other professional
financial intermediaries and may include the underwriters. Indirect access to Euroclear is also available to other firms that
clear through or maintain a custodial relationship with a Euroclear participant, either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We understand
that the Euroclear Operator is licensed by the Belgian Banking and Finance Commission to carry out banking activities on a global
basis. As a Belgian bank, it is regulated and examined by the Belgian Banking and Finance Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We have provided
the descriptions of the operations and procedures of DTC, Clearstream and Euroclear in this prospectus supplement solely as a
matter of convenience. These operations and procedures are solely within the control of those organizations and are subject to
change by them from time to time. None of us, the underwriters nor the trustee takes any responsibility for these operations or
procedures, and you are urged to contact DTC, Clearstream and Euroclear or their participants directly to discuss these matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We expect
that under procedures established by DTC:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">upon
                                         deposit of the global notes with DTC or its custodian, DTC will credit on its internal
                                         system the accounts of direct participants designated by the underwriters with portions
                                         of the principal amounts of the global notes; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">ownership
                                         of the debt securities will be shown on, and the transfer of ownership thereof will be
                                         effected only through, records maintained by DTC or its nominee, with respect to interests
                                         of direct participants, and the records of direct and indirect participants, with respect
                                         to interests of persons other than participants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">The laws of
some jurisdictions may require that purchasers of securities take physical delivery of those securities in definitive form. Accordingly,
the ability to transfer interests in the debt securities represented by a global note to those persons may be limited. In addition,
because DTC can act only on behalf of its participants, who in turn act on behalf of persons who hold interests through participants,
the ability of a person having an interest in debt securities represented by a global note to pledge or transfer those interests
to persons or entities that do not participate in DTC&rsquo;s system, or otherwise to take actions in respect of such interest,
may be affected by the lack of a physical definitive security in respect of such interest.</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">So long as
DTC or its nominee is the registered owner of a global note, DTC or that nominee will be considered the sole owner or holder of
the debt securities represented by that global note for all purposes under the indenture and under the debt securities. Except
as provided below, owners of beneficial interests in a global note will not be entitled to have debt securities represented by
that global note registered in their names, will not receive or be entitled to receive physical delivery of certificated notes
and will not be considered the owners or holders thereof under the applicable indenture or under the debt securities for any purpose,
including with respect to the giving of any direction, instruction or approval to the trustee. Accordingly, each holder owning
a beneficial interest in a global note must rely on the procedures of DTC and, if that holder is not a direct or indirect participant,
on the procedures of the participant through which that holder owns its interest, to exercise any rights of a holder of debt securities
under the applicable indenture or a global note.</font></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Neither we
nor the trustee will have any responsibility or liability for any aspect of the records relating to or payments made on account
of debt securities by DTC, Clearstream or Euroclear, or for maintaining, supervising or reviewing any records of those organizations
relating to the debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Payments on
the debt securities represented by the global notes will be made to DTC or its nominee, as the case may be, as the registered
owner thereof. We expect that DTC or its nominee, upon receipt of any payment on the debt securities represented by a global note,
will credit participants&rsquo; accounts with payments in amounts proportionate to their respective beneficial interests in the
global note as shown in the records of DTC or its nominee. We also expect that payments by participants to owners of beneficial
interests in the global note held through such participants will be governed by standing instructions and customary practice as
is now the case with securities held for the accounts of customers registered in the names of nominees for such customers. The
participants will be responsible for those payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Distributions
on the debt securities held beneficially through Clearstream will be credited to cash accounts of its customers in accordance
with its rules and procedures, to the extent received by the U.S. depositary for Clearstream.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Securities
clearance accounts and cash accounts with the Euroclear Operator are governed by the Terms and Conditions Governing Use of Euroclear
and the related Operating Procedures of the Euroclear System, and applicable Belgian law (collectively, the &ldquo;Terms and Conditions&rdquo;).
The Terms and Conditions govern transfers of securities and cash within Euroclear, withdrawals of securities and cash from Euroclear,
and receipts of payments with respect to securities in Euroclear. All securities in Euroclear are held on a fungible basis without
attribution of specific certificates to specific securities clearance accounts. The Euroclear Operator acts under the Terms and
Conditions only on behalf of Euroclear participants and has no record of or relationship with persons holding through Euroclear
participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Distributions
on the debt securities held beneficially through Euroclear will be credited to the cash accounts of its participants in accordance
with the Terms and Conditions, to the extent received by the U.S. depositary for Euroclear.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Clearance
and Settlement Procedures</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Initial settlement
for the debt securities will be made in immediately available funds. Secondary market trading between DTC participants will occur
in the ordinary way in accordance with DTC rules and will be settled in immediately available funds. Secondary market trading
between Clearstream customers and/or Euroclear participants will occur in the ordinary way in accordance with the applicable rules
and operating procedures of Clearstream and Euroclear, as applicable, and will be settled using the procedures applicable to conventional
eurobonds in immediately available funds.</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Cross-market
transfers between persons holding directly or indirectly through DTC, on the one hand, and directly or indirectly through Clearstream
customers or Euroclear participants, on the other, will be effected through DTC in accordance with DTC rules on behalf of the
relevant European international clearing system by its U.S. depositary; however, such cross-market transactions will require delivery
of instructions to the relevant European international clearing system by the counterparty in such system in accordance with its
rules and procedures and within its established deadlines (European time). The relevant European international clearing system
will, if the transaction meets its settlement requirements, deliver instructions to the U.S. depositary to take action to effect
final settlement on its behalf by delivering or receiving the debt securities in DTC, and making or receiving payment in accordance
with normal procedures for same-day funds settlement applicable to DTC. Clearstream customers and Euroclear participants may not
deliver instructions directly to their U.S. depositaries.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Because of
time-zone differences, credits of the debt securities received in Clearstream or Euroclear as a result of a transaction with a
DTC participant will be made during subsequent securities settlement processing and dated the business day following the DTC settlement
date. Such credits or any transactions in the debt securities settled during such processing will be reported to the relevant
Clearstream customers or Euroclear participants on such business day. Cash received in Clearstream or Euroclear as a result of
sales of the debt securities by or through a Clearstream customer or a Euroclear participant to a DTC participant will be received
with value on the DTC settlement date but will be available in the relevant Clearstream or Euroclear cash account only as of the
business day following settlement in DTC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Although DTC,
Clearstream and Euroclear have agreed to the foregoing procedures to facilitate transfers of the debt securities among participants
of DTC, Clearstream and Euroclear, they are under no obligation to perform or continue to perform such procedures and such procedures
may be changed or discontinued at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Certificated
Notes</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Individual
certificates in respect of any debt securities will not be issued in exchange for the global notes, except in very limited circumstances.
We will issue or cause to be issued certificated notes to each person that DTC identifies as the beneficial owner of the debt
securities represented by a global note upon surrender by DTC of the global note if:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">DTC
                                         notifies us that it is no longer willing or able to act as a depositary for such global
                                         note or ceases to be a clearing agency registered under the Securities Exchange Act of
                                         1934, and we have not appointed a successor depositary within 90 days of that notice
                                         or becoming aware that DTC is no longer so registered;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">an
                                         event of default has occurred and is continuing, and DTC requests the issuance of certificated
                                         notes; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">we
                                         determine not to have the debt securities of such series represented by a global note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Neither we
nor the trustee will be liable for any delay by DTC, its nominee or any direct or indirect participant in identifying the beneficial
owners of the debt securities. We and the trustee may conclusively rely on, and will be protected in relying on, instructions
from DTC or its nominee for all purposes, including with respect to the registration and delivery, and the respective principal
amounts, of the certificated notes to be issued.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Subordinated
Indenture Provisions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">The subordinated
debt securities will be issued under the subordinated indenture. The subordinated debt securities will rank on an equal basis
with certain of our other subordinated debt that may be outstanding from time to time and will rank junior to all of our senior
debt, as defined below, including any senior debt securities that may be outstanding from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Subordination.
</I></B>If we issue subordinated debt securities, the aggregate principal amount of senior debt outstanding as of a recent date
will be set forth in the applicable prospectus supplement. Neither the senior nor the subordinated indenture restricts the amount
of senior debt that we may incur.</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Holders of
subordinated debt securities should recognize that contractual provisions in the subordinated indenture may prohibit us from making
payments on those securities. Subordinated debt securities are subordinate and junior in right of payment, to the extent and in
the manner stated in the subordinated indenture or any supplement thereto to all of our senior debt, including all debt securities
we have issued and will issue under the senior indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">As used in
the subordinated indenture and this prospectus, the term &ldquo;senior debt&rdquo; means the principal, premium, if any, unpaid
interest and all fees and other amounts payable in connection with any debt for money borrowed other than (1) debt incurred (a)
with respect to certain elections under the federal bankruptcy code, (b) debt to our subsidiaries, (c) debt to our employees,
(d) tax liability, and (e) certain trade payables, (2) all obligations under interest rate, currency and commodity swaps, caps,
floors, collars, hedge arrangements, forward contracts or similar agreements and (3) renewals, modifications and refunds of any
such debt.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Unless otherwise
indicated in the applicable prospectus supplement, we may not pay principal of, premium, if any, or interest on any subordinated
debt securities or defease, purchase, redeem or otherwise retire such securities if:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                         default in the payment of any principal, or premium, if any, or interest on any senior
                                         debt, occurs and is continuing or any other amount owing in respect of any senior debt
                                         is not paid when due; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         other default occurs with respect to any senior debt and the maturity of such senior
                                         debt is accelerated in accordance with its terms, unless and until such default in payment
                                         or event of default has been cured or waived and any such acceleration is rescinded or
                                         such senior debt has been paid in full in cash.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">If there is
any payment or distribution of our assets to creditors upon a total or partial liquidation or a total or partial dissolution or
in a bankruptcy, reorganization, insolvency, receivership or similar proceeding, holders of all present and future senior debt
(which will include interest accruing after, or which would accrue but for, the commencement of any bankruptcy, reorganization,
insolvency, receivership or similar proceeding) are entitled to receive payment in full before any payment or distribution, whether
in cash, securities or other property, in respect of the subordinated indebtedness. In addition, unless otherwise indicated in
the applicable prospectus supplement, in any such event, payments or distributions which would otherwise be made on subordinated
debt securities will generally be paid to the holders of senior debt, or their representatives, in accordance with the priorities
existing among these creditors at that time until the senior debt is paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">After payment
in full of all present and future senior debt, holders of subordinated debt securities will be subrogated to the rights of any
holders of senior debt to receive any further payments or distributions that are applicable to the senior debt until all the subordinated
debt securities are paid in full. The subordinated indenture provides that the foregoing subordination provisions may not be changed
in a manner which would be adverse to the holders of senior debt without the consent of the holders of such senior debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The prospectus
supplement delivered in connection with the offering of a series of subordinated debt securities will set forth a more detailed
description of the subordination provisions applicable to any such debt securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">If the trustee
under the subordinated indenture or any holders of the subordinated debt securities receive any payment or distribution that is
prohibited under the subordination provisions, then the trustee or the holders will have to repay that money to the holders of
the senior debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Even if the
subordination provisions prevent us from making any payment when due on the subordinated debt securities of any series, we will
be in default on our obligations under that series if we do not make the payment when due. This means that the trustee under the
subordinated indenture and the holders of that series can take action against us, but they will not receive any money until the
claims of the holders of senior debt have been fully satisfied.</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_007"></A>DESCRIPTION
OF CAPITAL STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Set forth
below is a summary description of the material terms of our capital stock. For more information, please see our restated certificate
of incorporation, as amended.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Description
of Common Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We may issue
shares of our common stock, either separately or together with other securities offered pursuant to this prospectus. Under our
restated certificate of incorporation, as amended, we are authorized to issue up to 11,200,000,000 shares of our common stock, par
value $0.25 per share, of which 4,324,513,264 shares were issued and outstanding as of October 24, 2022. You should read the
applicable prospectus supplement relating to an offering of shares of our common stock, or of securities convertible, exchangeable
or exercisable for shares of our common stock, for the terms of such offering, including the number of shares of common stock
offered, the initial offering price and market prices and dividend information relating to our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The holders
of our common stock are entitled to one vote for each share on all matters submitted to a vote of shareowners. Each share of our
common stock outstanding is entitled to participate equally in any distribution of net assets made to the shareowners in the liquidation,
dissolution or winding up of our Company and is entitled to participate equally in dividends as and when declared by our board
of directors. There are no redemption, sinking fund, conversion or preemptive rights with respect to the shares of our common
stock. All shares of our common stock have equal rights and preferences. The rights, preferences and privileges of the holders
of our common stock are subject to and may be adversely affected by the rights of holders of shares of any series of our preferred
stock that we may designate and issue in the future.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Description
of Preferred Stock</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Our restated
certificate of incorporation, as amended, authorizes our board of directors to issue, from time to time, up to 100,000,000 shares
of preferred stock, par value $1.00 per share, in one or more series, subject to certain limitations prescribed by law. There
are no preferred shares issued and outstanding as of the date of this prospectus. Our board of directors is authorized to establish
from time to time the number of shares to be included in any series of preferred stock, and to fix the designation, powers, preferences,
and rights of the shares of such series and any qualifications, limitations or restrictions thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The specific
terms of any preferred stock to be sold under this prospectus will be described in the applicable prospectus supplement. If so
indicated in such prospectus supplement, the terms of the preferred stock offered may differ from the general terms set forth
below. Unless otherwise specified in the prospectus supplement relating to the preferred stock offered thereby, each series of
preferred stock offered will rank equal in right of payment to all other series of our preferred stock, and holders thereof will
have no preemptive rights. The preferred stock offered will, when issued, be fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">You should
read the applicable prospectus supplement for the terms of the preferred stock offered. The terms of the preferred stock set forth
in such prospectus supplement may include the following, as applicable to the preferred stock offered thereby:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         title and stated value of the preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         number of shares of the preferred stock offered;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         liquidation preference and the offering price of the preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         dividend rates of the preferred stock and/or methods of calculation of such dividends;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">periods
                                         and/or payment dates for the preferred stock dividends;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         dividends on the preferred stock are cumulative;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         liquidation rights of the preferred stock;</FONT></TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP></SUP></FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         procedures for any auction and remarketing, if any, of the preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         sinking fund provisions, if applicable, for the preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         redemption provisions, if applicable, for the preferred stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the preferred stock will be convertible into or exchangeable for other securities and,
                                         if so, the terms and conditions of conversion or exchange, including the conversion price
                                         or exchange ratio and the conversion or exchange period or the method of determining
                                         the same;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the preferred stock will have voting rights and, if so, the terms of such voting rights;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the preferred stock will be listed on any securities exchange;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">whether
                                         the preferred stock will be issued with any other securities and, if so, the amount and
                                         terms of such other securities; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         other specific terms, preferences or rights of, or limitations or restrictions on, the
                                         preferred stock.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Our authorized
shares of common stock and preferred stock are available for issuance without further action by our shareowners, unless such action
is required by applicable law or the rules of the stock exchange or automated quotation system on which our securities may be
listed or trade. If the approval of our shareowners is not required for the issuance of shares of our common stock or preferred
stock, our board of directors may determine to issue shares without seeking shareowners&rsquo; approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Our board
of directors could issue a series of preferred stock that could, depending on the terms of such series, delay, defer or prevent
a change in control of our Company. Our board of directors would make any determination to issue such shares based on its judgment
as to the best interests of our Company and our shareowners. Our board of directors, in so acting, could issue preferred stock
having terms that could discourage an attempt to acquire our Company, including tender offers or other transactions that some,
or a majority, of our shareowners might believe to be in their best interests, or in which our shareowners might receive a premium
for their stock over the then current market price of such stock.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Certain
Anti-takeover Matters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Our restated
certificate of incorporation, as amended, and by-laws contain provisions that may make it more difficult for a potential acquirer
to acquire us by means of a transaction that is not negotiated with our board of directors. These provisions and General Corporation
Law of the State of Delaware, or the &ldquo;DGCL,&rdquo; could delay or prevent entirely a merger or acquisition that our shareowners
consider favorable. These provisions may also discourage acquisition proposals or have the effect of delaying or preventing entirely
a change in control, which could harm our stock price. Our board of directors is not aware of any current effort to accumulate
shares of our common stock or to otherwise obtain control of our Company and does not currently contemplate adopting or recommending
the approval of any other action that might have the effect of delaying, deterring or preventing a change in control of our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Following
is a description of the anti-takeover effects of certain provisions of our restated certificate of incorporation, as amended,
and of our by-laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>No cumulative
voting.</I></B> The DGCL provides that stockholders of a Delaware corporation are not entitled to the right to cumulate votes
in the election of directors unless its certificate of incorporation, as amended, provides otherwise. Our restated certificate
of incorporation, as amended, does not provide for cumulative voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Calling
of special meetings of shareowners.</I></B> Our by-laws provide that special meetings of our shareowners may be called only by
or at the direction of our board of directors, the chairman of our board of directors, our chief executive officer or by our secretary
if appropriately requested by a person (or group of persons) beneficially owning at least a twenty-five percent (25%) &ldquo;net
long position&rdquo; of the Company&rsquo;s outstanding shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Advance
notice requirements for shareowner proposals and director nominations.</I></B> Our by-laws provide that shareowners seeking to
nominate candidates for election as directors or to bring business before an annual meeting of shareowners or a shareowner requested
special meeting of shareowners must provide timely notice of their proposal in writing to our corporate secretary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Generally,
to be timely, a shareowner&rsquo;s notice regarding an annual meeting of shareowners must be received at our principal executive
offices not less than 120 days prior to the first anniversary of the previous year&rsquo;s annual meeting. Our by-laws also specify
requirements as to the form and content of a shareowner&rsquo;s notice. These provisions may impede shareowners&rsquo; ability
to bring matters before an annual meeting of shareowners, a shareowner requested special meeting of shareowners or make nominations
for directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Limitations
on liability and indemnification of officers and directors.</I></B> The DGCL authorizes corporations to limit or eliminate the
personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&rsquo; fiduciary
duties. Our restated certificate of incorporation, as amended, includes a provision that eliminates the personal liability of
directors for monetary damages for any breach of fiduciary duty in such capacity, except for liability:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">for
                                         any breach of the director&rsquo;s duty of loyalty to us or our shareowners;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">for
                                         acts or omissions not in good faith or which involve intentional misconduct or a knowing
                                         violation of law;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">under
                                         Section 174 of the DGCL (providing for liability of directors for unlawful payment of
                                         dividends or unlawful stock purchases or redemptions); or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">for
                                         any transaction from which the director derived any improper personal benefit.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Our restated
certificate of incorporation, as amended, further provides, that if the DGCL is amended to authorize corporate action further
eliminating or limiting the personal liability of directors, then the liability of the directors will be eliminated or limited
to the fullest extent permitted by the DGCL, as so amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We are also
expressly authorized to carry directors&rsquo; and officers&rsquo; insurance for the benefit of our directors, officers, employees
and agents. We believe that these indemnification provisions and insurance are useful to attract and retain qualified directors
and executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The limitation
of liability and indemnification provisions in the restated certificate of incorporation, as amended, and the by-laws may discourage
our shareowners from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions may also have the
effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful,
might otherwise benefit us and our shareowners. In addition, the shareowner&rsquo;s investment may be adversely affected to the
extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>Board
authority to amend by-laws.</I></B> Under the by-laws, our board of directors has the authority to adopt, amend or repeal the
by-laws without the approval of our shareowners. However, the holders of common stock will also have the right to initiate on
their own, with the affirmative vote of a majority of the shares outstanding and without the approval of our board of directors,
proposals to adopt, amend or repeal the by-laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt"><B><I>General
Corporation Law of the State of Delaware.</I></B> We are a Delaware corporation that is subject to Section 203 of the DGCL. Section
203 provides that, subject to certain exceptions specified in the law, a Delaware corporation shall not engage in certain &ldquo;business
combinations&rdquo; with any &ldquo;interested stockholder&rdquo; for a three-year period following the time that the stockholder
became an interested stockholder unless:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">prior
                                         to such time, the board of directors approved either the business combination or the
                                         transaction that resulted in the stockholder becoming an interested stockholder;</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">upon
                                         consummation of the transaction that resulted in the stockholder becoming an interested
                                         stockholder, the interested stockholder owned at least 85% of the corporation&rsquo;s
                                         voting stock outstanding at the time the transaction commenced, excluding certain shares;
                                         or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">at
                                         or subsequent to that time, the business combination is approved by the board of directors
                                         of the corporation and by the affirmative vote of holders of at least 66 2/3% of the
                                         outstanding voting stock that is not owned by the interested stockholder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Generally,
a &ldquo;business combination&rdquo; includes a merger, asset or stock sale or other transaction resulting in a financial benefit
to the interested stockholder. Subject to certain exceptions, an &ldquo;interested stockholder&rdquo; is a person who, together
with that person&rsquo;s affiliates and associates, owns, or within the previous three years did own, 15% or more of our voting
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Under certain
circumstances, Section 203 makes it more difficult for a person who would be an &ldquo;interested stockholder&rdquo; to effect
various business combinations with a corporation for a three year period. The provisions of Section 203 may encourage any entity
interested in acquiring our company to negotiate in advance with our board of directors because the stockholder approval requirement
would be avoided if our board of directors approves either the business combination or the transaction that results in such entity
becoming an interested stockholder. These provisions also may make it more difficult to accomplish transactions involving our
Company that our shareowners may otherwise deem to be in their best interests.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Listing</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Our common
stock is listed and traded on the New York Stock Exchange under the symbol &ldquo;KO.&rdquo;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Transfer
Agent and Registrar</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">The transfer
agent and registrar for our common stock is Computershare Trust Company, N.A.</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_008"></A>DESCRIPTION
OF WARRANTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">This section
describes the general terms and provisions of the warrants. The applicable prospectus supplement will describe the specific terms
of the warrants offered by that prospectus supplement and any general terms outlined in this section that will not apply to those
warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We may issue
warrants to purchase debt or equity securities. Each warrant will entitle the holder of warrants to purchase for cash the amount
of debt or equity securities at the exercise price stated or determinable in the prospectus supplement for the warrants. We may
issue warrants independently or together with any offered securities. The warrants may be attached to or separate from those offered
securities. We will issue the warrants under warrant agreements to be entered into between us and a bank or trust company, as
warrant agent, all as described in the applicable prospectus supplement. The warrant agent will act solely as our agent in connection
with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial
owners of warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The prospectus
supplement relating to any warrants that we may offer will contain the specific terms of the warrants. These terms may include
the following:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         title of the warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         price or prices at which the warrants will be issued and the currency or composite currency
                                         you may use to purchase the warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         designation, amount and terms of the securities for which the warrants are exercisable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         designation and terms of the other securities, if any, with which the warrants are to
                                         be issued and the number of warrants issued with each other security;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">if
                                         applicable, the principal amount of debt securities you may purchase upon exercise of
                                         each debt warrant and the price and currency or composite currency or other consideration
                                         (which may include debt securities) you may use to purchase such principal amount of
                                         debt securities upon such exercise;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         aggregate number of warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         provisions for adjustment of the number or amount of securities receivable upon exercise
                                         of the warrants or the exercise price of the warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         price or prices at which the securities purchasable upon exercise of the warrants may
                                         be purchased;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         date on and after which the warrants and the securities purchasable upon exercise of
                                         the warrants will be separately transferable, if applicable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">a
                                         discussion of any material U.S. federal income tax considerations applicable to the exercise
                                         of the warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         date on which the right to exercise the warrants will commence, and the date on which
                                         the right will expire;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         maximum or minimum number of warrants that may be exercised at any time;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         terms of any mandatory or option redemption by us;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         identity of the warrant agent;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">information
                                         with respect to book-entry procedures, if any; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         other terms of the warrants, including terms, procedures and limitations relating to
                                         the exchange and exercise of the warrants.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_009"></A>DESCRIPTION
OF DEPOSITARY SHARES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">This section
describes the general terms and provisions of the depositary shares. The applicable prospectus supplement will describe the specific
terms of the depositary shares offered by that prospectus supplement and any general terms outlined in this section that will
not apply to those depositary shares.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">General</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We may, at
our option, elect to offer depositary shares, each representing a fraction (to be set forth in the prospectus supplement relating
to a particular series of preferred stock) of a share of a particular class or series of preferred stock as described below. In
the event we elect to do so, depositary receipts evidencing depositary shares will be issued to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The shares
of any class or series of preferred stock represented by depositary shares will be deposited under a deposit agreement among us,
a depositary selected by us and the holders of the depositary receipts. The depositary will be a bank or trust company having
its principal office in the United States and having a combined capital and surplus of at least $50,000,000. Subject to the terms
of the deposit agreement, each owner of a depositary share will be entitled, in proportion to the applicable fraction of a share
of preferred stock represented by such depositary share, to all the rights and preferences of the shares of preferred stock represented
by the depositary share, including dividend, voting, redemption and liquidation rights. The depositary shares will be evidenced
by depositary receipts issued pursuant to the deposit agreement. Depositary receipts will be distributed to those persons purchasing
the fractional shares of the related class or series of preferred shares in accordance with the terms of the offering described
in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Pending the
preparation of definitive depositary receipts the depositary may, upon our written order, issue temporary depositary receipts
substantially identical to, and entitling the holders thereof to all the rights pertaining to, the definitive depositary receipts
but not in definitive form. Definitive depositary receipts will be prepared without unreasonable delay, and temporary depositary
receipts will be exchangeable for definitive depositary receipts without charge to the holder.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Dividends
and Other Distributions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">The depositary
will distribute all cash dividends or other cash distributions received for the preferred stock to the entitled record holders
of depositary shares in proportion to the number of depositary shares that the holder owns on the relevant record date, <I>provided</I>,
<I>however</I>, that if we or the depositary is required by law to withhold an amount on account of taxes, then the amount distributed
to the holders of depositary shares shall be reduced accordingly. The depositary will distribute only an amount that can be distributed
without attributing to any holder of depositary shares a fraction of one cent. The depositary will add the undistributed balance
to and treat it as part of the next sum received by the depositary for distribution to holders of the depositary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">If there is
a non-cash distribution, the depositary will distribute property received by it to the entitled record holders of depositary shares,
in proportion, insofar as possible, to the number of depositary shares owned by the holders, unless the depositary determines,
after consultation with us, that it is not feasible to make such distribution. If this occurs, the depositary may, with our approval,
sell such property and distribute the net proceeds from such sale to the holders. The deposit agreement also will contain provisions
relating to how any subscription or similar rights that we may offer to holders of the preferred stock will be available to the
holders of the depositary shares.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Withdrawal
of Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">Upon surrender
of the depositary receipts at the corporate trust office of the depositary, unless the related depositary shares have previously
been called for redemption, converted or exchanged into our other securities, the holder of the depositary shares evidenced thereby
is entitled to delivery of the number of whole shares of the related class or series of preferred stock and any money or other
property represented by such depositary shares. Holders of depositary receipts will be entitled to receive whole shares of the
related class or series of preferred stock on the basis set forth in the prospectus supplement for such class or series of preferred
stock, but holders of such whole shares of preferred stock will not thereafter be entitled to exchange them for depositary shares.
If the depositary receipts delivered by the holder evidence a number of depositary shares in excess of the number of depositary
shares representing the number of whole shares of preferred stock to be withdrawn, the depositary will deliver to such holder
at the same time a new depositary receipt evidencing such excess number of depositary shares. In no event will fractional shares
of preferred stock be delivered upon surrender of depositary receipts to the depositary.</font></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Conversion,
Exchange and Redemption</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">If any class
or series of preferred stock underlying the depositary shares may be converted or exchanged, each record holder of depositary
receipts representing the shares of preferred stock being converted or exchanged will have the right or obligation to convert
or exchange the depositary shares represented by the depositary receipts. Whenever we redeem or convert shares of preferred stock
held by the depositary, the depositary will redeem or convert, at the same time, the number of depositary shares representing
the preferred stock to be redeemed or converted. The depositary will redeem the depositary shares from the proceeds it receives
from the corresponding redemption of the applicable series of preferred stock. The depositary will mail notice of redemption or
conversion to the record holders of the depositary shares that are to be redeemed between 30 and 60 days before the date fixed
for redemption or conversion. The redemption price per depositary share will be equal to the applicable fraction of the redemption
price per share on the applicable class or series of preferred stock. If less than all the depositary shares are to be redeemed,
the depositary will select which shares are to be redeemed by lot on a pro rata basis or by any other equitable method as the
depositary may decide. After the redemption or conversion date, the depositary shares called for redemption or conversion will
no longer be outstanding. When the depositary shares are no longer outstanding, all rights of the holders will end, except the
right to receive money, securities or other property payable upon redemption or conversion.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Voting
the Preferred Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">When the depositary
receives notice of a meeting at which the holders of the particular class or series of preferred stock are entitled to vote, the
depositary will mail the particulars of the meeting to the record holders of the depositary shares. Each record holder of depositary
shares on the record date may instruct the depositary on how to vote the shares of preferred stock underlying the holder&rsquo;s
depositary shares. The depositary will try, if practical, to vote the number of shares of preferred stock underlying the depositary
shares according to the instructions. We will agree to take all reasonable action requested by the depositary to enable it to
vote as instructed.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Amendment
and Termination of the Deposit Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We and the
depositary may agree at any time to amend the deposit agreement and the depositary receipt evidencing the depositary shares. Any
amendment that (1) imposes or increases certain fees, taxes or other charges payable by the holders of the depositary shares as
described in the deposit agreement or (2) otherwise materially adversely affects any substantial existing rights of holders of
depositary shares, will not take effect until such amendment is approved by the holders of at least a majority of the depositary
shares then outstanding. Any holder of depositary shares that continues to hold its shares after such amendment has become effective
will be deemed to have agreed to the amendment.</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We may direct
the depositary to terminate the deposit agreement by mailing a notice of termination to holders of depositary shares at least
30 days prior to termination. The depositary may terminate the deposit agreement if 90 days have elapsed after the depositary
delivered written notice of its election to resign and a successor depositary is not appointed. In addition, the deposit agreement
will automatically terminate if:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         depositary has redeemed all related outstanding depositary shares;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">all
                                         outstanding shares of preferred stock have been converted into or exchanged for common
                                         stock; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">we
                                         have liquidated, terminated or wound up our business and the depositary has distributed
                                         the preferred stock of the relevant series to the holders of the related depositary shares.</FONT></TD></TR></TABLE>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Reports
and Obligations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">The depositary
will forward to the holders of depositary shares all reports and communications from us that are delivered to the depositary and
that we are required by law, the rules of an applicable securities exchange or our restated certificate of incorporation, as amended,
to furnish to the holders of the preferred stock. Neither we nor the depositary will be liable if the depositary is prevented
or delayed by law or any circumstances beyond its control in performing its obligations under the deposit agreement. The deposit
agreement limits our obligations to performance in good faith of the duties stated in the deposit agreement. The depositary assumes
no obligation and will not be subject to liability under the deposit agreement except to perform such obligations as are set forth
in the deposit agreement without negligence or bad faith. Neither we nor the depositary will be obligated to prosecute or defend
any legal proceeding connected with any depositary shares or class or series of preferred stock unless the holders of depositary
shares requesting us to do so furnish us with a satisfactory indemnity. In performing our obligations, we and the depositary may
rely and act upon the advice of our counsel on any information provided to us by a person presenting shares for deposit, any holder
of a receipt, or any other document believed by us or the depositary to be genuine and to have been signed or presented by the
proper party or parties.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Payment
of Fees and Expenses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We will pay
all fees, charges and expenses of the depositary, including the initial deposit of the preferred stock and any redemption of the
preferred stock. Holders of depositary shares will pay taxes and governmental charges and any other charges as are stated in the
deposit agreement for their accounts.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Resignation
and Removal of Depositary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">At any time,
the depositary may resign by delivering notice to us, and we may remove the depositary at any time. Resignations or removals will
take effect upon the appointment of a successor depositary and its acceptance of the appointment. The successor depositary must
be appointed within 90 days after the delivery of the notice of resignation or removal and must be a bank or trust company having
its principal office in the United States and having a combined capital and surplus of at least $50,000,000.</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_010"></A>DESCRIPTION
OF PURCHASE CONTRACTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">This section
describes the general terms and provisions of the purchase contracts. The applicable prospectus supplement will describe the specific
terms of the purchase contracts offered by that prospectus supplement and any general terms outlined in this section that will
not apply to those purchase contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We may issue
purchase contracts for the purchase or sale of:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">debt
                                         or equity securities issued by us or securities of third parties, a basket of such securities,
                                         an index or indices of such securities or any combination of the above as specified in
                                         the applicable prospectus supplement;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">currencies;
                                         or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">commodities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Each purchase
contract will entitle the holder thereof to purchase or sell, and obligate us to sell or purchase, on specified dates, such securities,
currencies or commodities at a specified purchase price, which may be based on a formula, all as set forth in the applicable prospectus
supplement. We may, however, satisfy our obligations, if any, with respect to any purchase contract by delivering the cash value
of such purchase contract or the cash value of the property otherwise deliverable or, in the case of purchase contracts on underlying
currencies, by delivering the underlying currencies, as set forth in the applicable prospectus supplement. The applicable prospectus
supplement will also specify the methods by which the holders may purchase or sell such securities, currencies or commodities
and any acceleration, cancellation or termination provisions or other provisions relating to the settlement of a purchase contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The purchase
contracts may require us to make periodic payments to the holders thereof or vice versa, which payments may be deferred to the
extent set forth in the applicable prospectus supplement, and those payments may be unsecured or prefunded on some basis. The
purchase contracts may require the holders thereof to secure their obligations in a specified manner to be described in the applicable
prospectus supplement. Alternatively, purchase contracts may require holders to satisfy their obligations thereunder when the
purchase contracts are issued. Our obligation to settle such pre-paid purchase contracts on the relevant settlement date may constitute
indebtedness.</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_011"></A>PLAN
OF DISTRIBUTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We may sell
the securities being offered hereby in one or more of the following ways from time to time:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">to
                                         underwriters or dealers for resale to the public or to other purchasers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">directly
                                         to one or more purchasers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">through
                                         agents;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">through
                                         dealers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">as
                                         part of a consent solicitation; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">through
                                         a combination of any of these methods of sale.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">We will disclose
in the applicable prospectus supplement any required information with respect to the selling stockholders, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">If we use
underwriters or dealers in the sale, the securities will be acquired by the underwriters or dealers for their own account and
may be resold from time to time in one or more transactions, including:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">at
                                         a fixed price or prices, which may be changed from time to time;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">in
                                         &ldquo;at the market offerings&rdquo; within the meaning of Rule 415(a)(4) under the
                                         Securities Act;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">at
                                         prices related to such prevailing market prices; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">at
                                         negotiated prices.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: left"><FONT STYLE="font-size: 10pt">For each series
of securities, the applicable prospectus supplement will set forth the terms of the offering of the securities, which may include:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         initial public offering price;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         method of distribution, including the names of any underwriters, dealers or agents;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         purchase price of the securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">our
                                         net proceeds from the sale of securities by us;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         underwriting discounts, agency fees, or other compensation payable to underwriters or
                                         agents;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">any
                                         discounts or concessions allowed or reallowed or repaid to dealers; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Symbol">&#183;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">the
                                         securities exchanges on which the securities will be listed, if any.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: left"><FONT STYLE="font-size: 10pt">If we use
underwriters in the sale, they will buy the securities for their own account. The underwriters may then resell the securities
in one or more transactions at a fixed public offering price or at varying prices determined at the time of sale or thereafter.
The obligations of the underwriters to purchase the securities will be subject to certain conditions. The underwriters may be
obligated to purchase all the securities offered if they purchase any securities. Any initial public offering price and any discounts
or concessions allowed or reallowed or paid to dealers may be changed from time to time. In connection with an offering, underwriters
and selling group members and their affiliates may engage in transactions to stabilize, maintain or otherwise affect the market
price of the securities in accordance with applicable law.</FONT></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">If we use
dealers in the sale, we will sell securities to such dealers as principals. The dealers may then resell the securities in one
or more transactions at a fixed offering price or at varying prices to be determined by such dealers at the time of resale. If
we use agents in the sale, they may use their reasonable best efforts to solicit purchases for the period of their appointment.
If we sell directly, no underwriters would be involved. We are not making an offer of securities in any jurisdiction that does
not permit such an offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Underwriters,
dealers and agents that participate in the securities distribution may be deemed to be underwriters as defined in the Securities
Act. Any discounts, commissions or profit they receive when they resell the securities may be treated as underwriting discounts
and commissions under the Securities Act. We may have agreements with underwriters, dealers and agents to indemnify them against
certain civil liabilities, including certain liabilities under the Securities Act, or to contribute with respect to payments that
they may be required to make. Underwriters, dealers and agents may engage in transactions with, or perform services for, us or
our subsidiaries in the ordinary course of their business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">We may authorize
underwriters, dealers or agents to solicit offers from certain institutions whereby the institutions contractually agree to purchase
the securities from us on a future date at a specific price. This type of contract may be made only with institutions that we
specifically approve. Such institutions could include banks, insurance companies, pension funds, investment companies and educational
and charitable institutions. The underwriters, dealers or agents will not be responsible for the validity or performance of these
contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Unless otherwise
specified in the applicable prospectus supplement, we will not list any securities (other than our common stock) on any exchange.
The underwriters, if any, of the securities may make a market in the securities. If the underwriters make a market in the securities,
such market making may be discontinued at any time without notice. No assurance can be given as to the liquidity of the trading
market for any securities.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_012"></A>LEGAL
MATTERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: left"><FONT STYLE="font-size: 10pt">The validity
of the securities offered by this prospectus will be passed upon for us by Skadden, Arps, Slate, Meagher &amp; Flom LLP, New York,
New York, and for any underwriters or agents by counsel named in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-transform: uppercase; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><A NAME="e22463a_013"></A>EXPERTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt">Ernst &amp;
Young LLP, independent registered public accounting firm, has audited our consolidated financial statements included in our Annual
Report on Form 10-K for the year ended December 31, 2021, and the effectiveness of our internal control over financial reporting
as of December 31, 2021, as set forth in their reports, which are incorporated by reference in this prospectus and elsewhere in
the registration statement. Our consolidated financial statements are, and our audited financial statements to be included in
subsequently filed documents will be, incorporated by reference herein in reliance on the reports of Ernst &amp; Young LLP pertaining
to such financial statements and the effectiveness of our internal control over financial reporting as of the respective dates
(to the extent covered by consents filed with the Securities and Exchange Commission), given on the authority of Ernst &amp; Young
LLP as experts in accounting and auditing.</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="border-bottom: Gainsboro 2pt solid; margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="e24325001.jpg" ALT="">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 6pt; border-bottom: Gainsboro 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>e24337_ex107.htm
<DESCRIPTION>FILING FEE IXBRL
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ko="http://thecocacolacompany.com/20240808">
<head>
     <title>EX-FILING FEES</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_028_FFD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_ko_thecocacolacompany.com_20240808 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20240808_20240808 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000021344 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-08-08" id="Fact000003" name="dei:EntityCentralIndexKey">0000021344</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-08-08" id="xdx2ixbrl0009" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-08-08" id="Fact000010" name="ffd:SubmissnTp">424B2</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-08-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-08</xbrli:startDate>
        <xbrli:endDate>2024-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-082024-08-08_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>1</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-08</xbrli:startDate>
        <xbrli:endDate>2024-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-082024-08-08_2">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021344</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>2</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-08</xbrli:startDate>
        <xbrli:endDate>2024-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000016" toRefs="Footnote000035"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000035"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: right"><b><span id="xdx_903_effd--FeeExhibitTp_dxL_c20240808__20240808_zY8OVvmmRR8e" title="::XDX::EX-FILING FEES"><span style="-sec-ix-hidden: xdx2ixbrl0009">Exhibit 107</span></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 12pt"><b>Calculation
of Filing Fee Tables</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 18pt"><b><span id="xdx_90B_effd--SubmissnTp_dxH_c20240808__20240808_zDpE9KnwZUN8" title="::XDX::424B2">424(b)(2)</span></b></span><br/>
<span style="font-size: 10pt">(Form Type)</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 18pt"><b><span id="xdx_90B_edei--EntityRegistrantName_c20240808__20240808_zuyfmDLd1xRb"><ix:nonNumeric contextRef="AsOf2024-08-08" id="Fact000011" name="dei:EntityRegistrantName">The Coca-Cola Company</ix:nonNumeric></span></b></span><br/>
<span style="font-size: 10pt">(Exact Name of Registrant as Specified in its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><b>Table 1: Newly Registered Securities and Carry
Forward Securities</b></p>

<table cellspacing="0" cellpadding="0" id="xdx_306_101_zLFKIA66icwh" summary="xdx: Document - Offerings" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3pt; vertical-align: top; width: 17%; padding-left: 3pt">&#160;</td>
    <td id="xdx_486_effd--OfferingSctyTp_zLjgFkRjrVle" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 8%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Security&#160;Type</b></span></td>
    <td id="xdx_483_effd--OfferingSctyTitl_zMeDfVv00Qa8" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 9%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Security<br/>
Class<br/>
Title</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 7%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Fee<br/>
Calculation<br/>
or Carry<br/>
Forward Rule</b></span></td>
    <td id="xdx_48D_effd--AmtSctiesRegd_pid_z8Evve2rGNyj" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 7%; text-align: center; text-indent: 4.15pt; padding-left: 3pt"><span style="font-size: 8pt"><b>Amount<br/>
Registered</b></span></td>
    <td id="xdx_485_effd--MaxOfferingPricPerScty_pid_dp_zlB7AVYBv404" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 6%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Proposed<br/>
Maximum<br/>
Offering Price<br/>
Per Unit</b></span></td>
    <td id="xdx_483_effd--MaxAggtOfferingPric_pid_z3dHzGiybcUi" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 7%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Maximum<br/>
    Aggregate<br/>
    Offering Price<sup id="xdx_F5D_zHymsjwv91z2">(1)</sup></b></span></td>
    <td id="xdx_481_effd--FeeRate_pid_z74CH9yL8IEg" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 5%; text-align: center; text-indent: 1.9pt; padding-left: 3pt"><span style="font-size: 8pt"><b>Fee Rate</b></span></td>
    <td id="xdx_480_effd--FeeAmt_pid_zJ7Ic4nJ5Rol" style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 8%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Amount of<br/>
Registration Fee</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 5%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Carry<br/>
Forward<br/>
Form Type</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 7%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Carry<br/>
Forward<br/>
File Number</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 6%; text-align: center; padding-left: 3pt"><span style="font-size: 8pt"><b>Carry<br/>
Forward<br/>
Initial<br/>
Effective Date</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3pt; vertical-align: bottom; width: 8%; text-align: center; text-indent: 0.2pt; padding-left: 3pt"><span style="font-size: 8pt"><b>Filing Fee<br/>
<span style="letter-spacing: -0.05pt">Previously P</span>aid<br/>
in Connection<br/>
with Unsold<br/>
Securities<br/>
to be Carried<br/>
Forward</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="13" style="border-bottom: Black 1pt solid; padding-top: 6pt; text-align: center"><span style="font-size: 10pt"><b>Newly Registered Securities</b></span></td></tr>
  <tr id="xdx_41D_20240808__20240808__ffd--OfferingAxis__1_zfg0I7216kDc" style="background-color: rgb(204,238,255)">
    <td id="xdx_98F_effd--PrevslyPdFlg_dbF_c20240808__20240808__ffd--OfferingAxis__1_z73mgr1a7Vp2" style="padding-right: 2pt; text-align: left; vertical-align: top; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_1" format="ixt:booleanfalse" id="Fact000019" name="ffd:PrevslyPdFlg">Fees to Be Paid</ix:nonNumeric></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_1" id="Fact000012" name="ffd:OfferingSctyTp">Debt</ix:nonNumeric></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_1" id="Fact000013" name="ffd:OfferingSctyTitl">3.375% Notes due 2037</ix:nonNumeric></span></td>
    <td id="xdx_987_effd--Rule457rFlg_dbT_c20240808__20240808__ffd--OfferingAxis__1_zWcS3pLk8kgc" style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_1" format="ixt:booleantrue" id="Fact000020" name="ffd:Rule457rFlg">Rule 457(r)</ix:nonNumeric></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt">&#8364;<ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="From2024-08-082024-08-08_1" id="Fact000014" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="From2024-08-082024-08-08_1" id="Fact000015" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="USDPShares">98.927</ix:nonFraction>%</span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2024-08-082024-08-08_1" id="Fact000016" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">540,190,884</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonFraction name="ffd:FeeRate" contextRef="From2024-08-082024-08-08_1" id="Fact000017" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">0.0001476</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:FeeAmt" contextRef="From2024-08-082024-08-08_1" id="Fact000018" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">79,732.17</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td></tr>
  <tr id="xdx_419_20240808__20240808__ffd--OfferingAxis__2_zVRA24Rzdra" style="background-color: White">
    <td id="xdx_985_effd--PrevslyPdFlg_dbF_c20240808__20240808__ffd--OfferingAxis__2_z52OGqfmqZg6" style="padding-right: 2pt; text-align: left; vertical-align: top; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_2" format="ixt:booleanfalse" id="Fact000028" name="ffd:PrevslyPdFlg">Fees to Be Paid</ix:nonNumeric></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_2" id="Fact000021" name="ffd:OfferingSctyTp">Debt</ix:nonNumeric></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_2" id="Fact000022" name="ffd:OfferingSctyTitl">3.750% Notes due 2053</ix:nonNumeric></span></td>
    <td id="xdx_989_effd--Rule457rFlg_dbT_c20240808__20240808__ffd--OfferingAxis__2_zOM5ok08ZT7h" style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonNumeric contextRef="From2024-08-082024-08-08_2" format="ixt:booleantrue" id="Fact000029" name="ffd:Rule457rFlg">Rule 457(r)</ix:nonNumeric></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt">&#8364;<ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="From2024-08-082024-08-08_2" id="Fact000023" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="From2024-08-082024-08-08_2" id="Fact000024" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="USDPShares">98.339</ix:nonFraction>%</span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2024-08-082024-08-08_2" id="Fact000025" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">536,980,110</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt"><ix:nonFraction name="ffd:FeeRate" contextRef="From2024-08-082024-08-08_2" id="Fact000026" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">0.0001476</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:FeeAmt" contextRef="From2024-08-082024-08-08_2" id="Fact000027" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">79,258.26</ix:nonFraction></span></td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td>
    <td style="padding-right: 2pt; vertical-align: top; text-align: center; padding-left: 2pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td><span style="font-size: 8pt">Fees Previously Paid</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="13" style="border-bottom: Black 1pt solid; padding-top: 6pt; text-align: center"><span style="font-size: 10pt"><b>Carry Forward Securities</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 8pt">Carry Forward Securities</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td colspan="4" style="text-align: justify"><span style="font-size: 8pt"><b>Total Offering Amounts</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_98F_effd--TtlOfferingAmt_c20240808__20240808_zQn4CmdUqgy7" style="text-align: center"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="AsOf2024-08-08" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,077,170,994</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_985_effd--TtlFeeAmt_pid_c20240808__20240808_zv3CYo6FyFAk" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="AsOf2024-08-08" id="Fact000031" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">158,990.43</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td colspan="4"><span style="font-size: 8pt"><b>Total Fees Previously Paid</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_980_effd--TtlPrevslyPdAmt_d0_c20240808__20240808_zzmnvlh7wx1g" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="AsOf2024-08-08" id="Fact000032" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td colspan="4"><span style="font-size: 8pt"><b>Total Fee Offsets</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_98A_effd--TtlOffsetAmt_d0_c20240808__20240808_zp7vf3Icy6V4" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="AsOf2024-08-08" id="Fact000033" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td colspan="4" style="text-align: center"><span style="font-size: 8pt"><b>Net Fee Due</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_983_effd--NetFeeAmt_pid_c20240808__20240808_zUvfHAx4K37e" style="border-bottom: Black 1.5pt double; text-align: center"><span style="font-size: 8pt">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="AsOf2024-08-08" id="Fact000034" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">158,990.43</ix:nonFraction></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td id="xdx_F09_zr3doFdPlJq1" style="width: 2%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: justify; line-height: 107%; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; line-height: 107%">(1)</span></td>
    <td id="xdx_F1F_zfEQieaOgP5" style="width: 98%; padding-right: 5.4pt; padding-bottom: 0pt; padding-left: 5.4pt; text-align: justify; font-family: Calibri, Helvetica, Sans-Serif"><ix:footnote id="Footnote000035" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__1_zcgnD6TSXed9"><ix:nonNumeric contextRef="From2024-08-082024-08-08_1" escape="true" id="Fact000036" name="ffd:OfferingNote"> <span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__2_zUxVebWWxsdc"><ix:nonNumeric contextRef="From2024-08-082024-08-08_2" escape="true" id="Fact000037" name="ffd:OfferingNote">Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#8364;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form <span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf"><ix:nonNumeric contextRef="AsOf2024-08-08" id="Fact000038" name="ffd:FormTp">S-3</ix:nonNumeric></span> (No. <span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3"><ix:nonNumeric contextRef="AsOf2024-08-08" id="Fact000039" name="ffd:RegnFileNb">333-268053</ix:nonNumeric></span>) filed by The Coca-Cola
    Company.</ix:nonNumeric></span></ix:nonNumeric></span></span></ix:footnote></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: justify; line-height: 107%; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; line-height: 107%">&#160;&#160;&#160;&#160;</span></td>
    <td style="width: 98%; padding-right: 5.4pt; padding-bottom: 0pt; padding-left: 5.4pt; text-align: justify; font-family: Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">The prospectus supplement to which this Exhibit is attached is a final prospectus for the related offering.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: rgb(226,224,224) 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVsKwkAMRVfQPYT5lj4VtJ+WKmKVUkT8HWwqg+2kZMbXktylY4sYAkm49+QKMRFrWqkWGU7LqoADdn0rLUKFDTLqMzpHttmm4GaFF2UsS22H8wdm5Bh0zMyPE+mEwXpXBusUwnkQLoJ46pY0mUK5E95Xz0g3qkZtlWxB6hpKpp4VWsmv8cNBPklT9xqijshGkU4h8sNRfkMcRjHs6S4fxFcDRZEJbzKUJ9ZMt9658qdF/SUhb7FzcWak/+19AA4wSpk= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>e24325001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 e24325001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 10&$ P$1  (1 0,1 ?_$ (L  0 !!0$! 0
M       ' P0%!@@! @D! 0$!                   ! A   0,# P(#!04%
M!00)!0   0(#!  %!A$2!R$3,4$(46$B,A1Q@4)2%9&A<B,SP6*"0R2QHE,6
MX?&28W.S-$0EA+1U%R<1 0$!                   1 ?_:  P# 0 "$0,1
M #\ ZIH% H% H% H% H% H-2S?E/"L+8+E\N"&WR-6XB#O>5]B!_;4HC6U^J
M9-\G+C8]AERNB4JT2ZVXA(/VZH(3^VE6-_X[Y08R^3<[=)MC]DO5I4CZNVRB
M%+#;@^!P*2 "#51O% H% H% H% H!.E!HF=<UX!A@4W<YZ79H\(,?1QW7W@=
M$_?0:,QZGI$J _=(F$7%RTQP5*GK>;:;V#SU6D?NJ58^G?578I$-$BR8Y<[J
M0!]2EM.U+2M-2DKVK!(I2,,CUF6%,D,R\9F1T@Z.DO(*D_X-B32D2S@W+>$9
MHR#9IZ3)T!7"=T0\G_"?'[JI&Y41@\LS7&L3MBKC?9J(D<?*%'5:S[$)\2:#
M2,2Y^L^29';[2S9IT2+=BZFV7*0D);>4RC>K1.FNFWSH)/>D,L,K>>6EMIL%
M2UJ("0!XDDT%A8;_ !+Y%7-A!2H.\HCR#T#P3T*T#\NO@?.@R= H% H% H%
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MND:A(W #X4]54$+<]\Z3,TN*\?L#BV\<87LW(U"I:]=-QT_!K\H\ZBI4].O
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M1:KTKJN=!6$%9'FM)!!/O&AH/>/> \4PR\_KC4J9<[R$*;1+ENZ[4J&A"4I
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M.JN: F%A5YD2#T"&D;D:_P >T4I&?8S7FB]C_P"*P^-9FE?+(NTHK5I[>TR
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MTV[_ +_.@3/TW1'UG9TU^#N[?'W;J"Y1LVC9IM\M/#2@]H% H% H% H% H%
,H% H% H% H% H/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>5
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140248891824192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000021344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">The Coca-Cola Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-268053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140248891500688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th" colspan="2">
<div>Aug. 08, 2024 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">3.375% Notes due 2037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | $ / shares</a></td>
<td class="nump">0.98927<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 540,190,884<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 79,732.17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"> <span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__2_zUxVebWWxsdc">Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#8364;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form <span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf">S-3</span> (No. <span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3">333-268053</span>) filed by The Coca-Cola
    Company.</span><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">3.750% Notes due 2053<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | $ / shares</a></td>
<td class="nump">0.98339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 536,980,110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 79,258.26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#8364;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form <span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf">S-3</span> (No. <span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3">333-268053</span>) filed by The Coca-Cola
    Company.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__1_zcgnD6TSXed9"> <span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__2_zUxVebWWxsdc">Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#8364;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form <span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf">S-3</span> (No. <span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3">333-268053</span>) filed by The Coca-Cola
    Company.</span></span></span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140248891183936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 08, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 1,077,170,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">158,990.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 158,990.43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?T!V#M7-!IDIG3+=A.F1K6DR$BP#.9HOEG WJ@@!-$;E=I!RNE"25AJV'O7
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M#N,YA+C@_\1(584%K*EH/80XY,C@.L @-39BDF ]9&;7YAY%5.Z&TK\\E,.
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M<',O87!P+GAM;%!+ 0(4 Q0    ( !*""5EUTI]=[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  2@@E9//+!P$$"  #;!0  &
M    @(&M#P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M$H()6;1D'7 B P  _!$   T              ( !)!(  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  2@@E9EXJ[',     3 @  "P              @ %Q
M%0  7W)E;',O+G)E;'-02P$"% ,4    "  2@@E94G%OM5T!  !( P  #P
M            @ %:%@  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ $H()
M6;MLZNRZ    &@,  !H              ( !Y!<  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ $H()6:;\2ELC 0  WP0  !,
M         ( !UA@  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      L "P#*
) @  *AH

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="e24337_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="e24337_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="e24337_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="e24337_ex107.htm">e24337_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "e24337_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "e24337_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/ffd/2024": 2,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 29,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-08",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e24337_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-08",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e24337_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-08-082024-08-08_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e24337_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-08-082024-08-08_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e24337_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-08",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e24337_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-08",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e24337_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001552781-24-000464-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001552781-24-000464-xbrl.zip
M4$L#!!0    ( !*""5F+L;T+MA   ,QH   0    93(T,S,W7V5X,3 W+FAT
M;>U=67?:2A)^SZ_HT4SF)B<L6A (;#,'&Q/O<<!;\L(14@,RVBPUZZ^?:BT@
M@5AC)T[BW.M$2ZNKZNM:6ZWV_O]&AHX&V'$URSSXA\NP_R!L*I:JF9V#?RJ-
MH]/3?_Y7?K??)= ,FIKN =,EQ"YEL\/A,#,4,I;3R7+%8C$[HFT8OU%IE-B.
M9UDN^W!YT5"ZV)#3FND2V53P]"%=,WO+^Z=WITU;CJ[%FM(K(1$AN] UW%5G
M#T0;Y[/^S5A3DMA4])N2L*GF6CF>*ZSBPV\Q?6"TK"U'>08)\<-A_6+6G"2W
MGS7-$D<VW;;E&#*!(:0]B6F63_/Y2"=I%RNQCN \T[$&:_N1T@(7]K,P.'%)
MZ>V6[$X1;[?5.(8A3;@!3_"YL*&*M>2&<"/6L&=-VY$N5BQ%5BP=?@Q;-L<9
M^-=KS4JLQ%"-Q;):?H?HGWVB$1V7CQ_2M=.+TZO/J'9\W-C/^E??[1N8R(AV
MG,9/?6UPP!Q9)L$F2=^,;1!'\<\.&()').LI>1:>ROH$]O^53J.:AG6UA!J8
M[*$KV< E-%)'>^BTZATT65YJUFK5]WR5,HC2Z0T?$XZ:/:N9+&LSE'7S[G+5
MZ4,[/"T>-3&," @!_Q^; -[X"&!Q9/W45/'H'(^;+/W#<T)N"QGSA\W;1K7)
M-0-+\?N'2UMTP3<;7=G!;I-O>G[![\/UKFW1395R<AUT)2PP]$-]B\TZM:MF
M+MJ+W7>PWT?+4L?()6,='S!MT+<2XEB;H!O- "I7>(CJEB&;*?]""N@X6ILJ
MN:H-PL=4S;5U>5Q"IF5B>D\;E:B*8@>LP#O15!6;U"3H&;2ZZAO0C^(K^(C4
M<?N J;A?VE0WJ.F#'2$-C+@F*\0;6H%!)@@'M+!62E0!ICS3@?ULC,P.A $Z
M7J-X09?%D#:XCU(-X^-15VMIY,9F%NSZ1\F&\G)LE&:CWS(TUS4IQ1R?.^23
M"&6C.%.R#FYC!P(J=KW[U$F67"_Z 7GDA;12UZ&<4 ?D+O.5]"!-#S(C5V6"
MYPBXIP/&U0Q;Q]0E!?1C)'T>7*OO!"Q (T\#2P$*GL1S* 1N,VR)O9$.+TXO
M:RJ]T=:P@SR)<&*$.3H]CRO%_,-38MDD:@$M&Q"VU 46(,8[I"H37)YQ'_8S
MNS?_%#;5)<^$=^98BE(/KP7P+86TYEC&C,#LJ,G]&GAGF.&. 3=GUX,[JN8I
ME'J)C1;05,'3F%Y2Z&G_ES8H%>2$E9'F,M%GX6GJ#6@:<665N?ULY"Q*(KM(
M(\):-I&WOT4E^#]9)?@WE8BK1-_4?'V G&)^X TLNY 4E(/<HP1-PJ["6['^
M:5_)G?MIS++^ ^&]-CL2F.5*\T0@*0%E6P"4/NG%2IE8SH*N;2[[/'L)?48H
M5K%I&9JYAN9:/.:))G0;WHZ*OQY&+RU</4PT3=QHD/Q@KWL%G-O5;-0&CP-Y
MAAO):: L)%9PS;*(:1'LI79BD$&L[X(7UW21G<LY_*PH2$7!&VB#\KMW[_;M
MQ80WR[&%]ZNSWCUDR$Y',TN(A?\D&Q)N:F%I6=<Z<-'1.EW"E/=;Y7T72J4P
MC6P66:&):1*5CN:.375TT52F1=&L/)I\D[[<#0RC7I>@ O0*Q0.F5'JH/I1*
M\723"0@%LM!*.ZV-TGX2Z&7_D12V'% &80O[6?I<>?H/<)RURPFX<.L*@3@D
M%,<X)@HX2^S,,4H[3[O:!$H5CK=]R(YD7>G[8__.:D-1 TZ[@P P=".W=&H9
MK1F_B;SR+\ZK9"</[V$PO+,T'0;W)'EPJ_9Q\=P<?K^]DN8'U\OLO03_0^OC
M!_YC;'C\PY9#R_]E_+&4OP\URS$0G3[X^(KQ@K"<3OME7!UW-)?. !%:O2:C
MUA^WC>J%RHWJ+>AQQY**6RPAX[29\DT7HR-+D=-'EB[#D3?E,5]L[3@NQR-@
MQ*O0$2CXC#*27=2PL4+S(Q5I !1QT1&$ P!WS1"NK=,W'L)6V3,SQ)5H5_HX
MX ^*.15Z4OJ.1C0@(YLJ.I(=9_P.M&PH.]&;$3="O+X4K.O O4*G<QFH9^FY
M+:MJ>!XJA,#FFQS+-2<7M?/32CZO*<,N@]R^ ;R/O28E5+64/LW%4!J%N9_+
M;.^LAII*NA0X]OT>:ED.A(6T8NFZ;+LP4.&1%Q+W21!=]XD:$@JX3WN>OH0$
M"N< .T139#V$E%CVC$X!R(0/Z;CM/\.4__MO+L_N[6>).B,1HI&3\H$["05M
M*&0,+F5R\=BI]>J/SAV4W"%'@0PMBQ#+**%#759ZB +A6KJFSHBOXMA_>,JT
M]#Y)1Q+E6*;QH>$'RC'VY:4^*>;&D\47DL0'1]F<7.)J^V[ LE]EZ24!*#X_
M +Z#.-)EU_4/J4#+P7@YV0K/)QO$YD"L6>CV+UB.[R3\L]!3U/LK))X-?S48
M_HI!8.3!KX G4INVIC8GTO%@@'GG\]7X\27'?QE&WC7-I+5L">4RG$C[V@&X
MBF'U3>*#,W.S&T C!M!<RJ/0.*XA(%UCA]J(AY$*?D(_+%3NOAT.<FSN)6'*
M/Y\J73N6;;F @8<)B*<9?<,_"05%5-) X4!@= MUQQ;.!/JL=#HD"INO4X)Z
M,OFLC5O*K?8K=&H'L&+P4(E!, =W9()GE^90<_OV%).:6&U.3L:&^S@<%+D)
M))P?.)IF].WR!GARLTH&JD?L8UC('9T4QQ?2Z7'G)3$4-[%++E/<T2QIK4%E
MV@ %=H8"N"D?A+/"J9(SS\2ZI?\FT=GW0Y",1EV1X_EQ6GC]@NBT;(1W$&XQ
M $U/_.KH]PZ^2\73(/&&0J6%G5\@X#.&A&4"GH+?UV3=/SD&-P<YP@"CZBK#
M_?G6&'-);(;?U25-9T$2*DP=$Z"5#BJL$DJS&5:D#UX[>*!9?1>JN.L #UD+
MX(/R\L@R38I:F*T--=*%< H@!&TB)9UW3BS4PEY&IV$U/B1SB,-?3E [A5PF
M \C,!@>*+MK! <,)6_M-J+5 Z;:>EV #>%=4NJLDF\8!+K*H(7(4JU[H&XIF
M$XK;=H<]+?!<OE=59G*"7!T'O+!*JU#+*2&GT_K L[D4+T@I7A0_,HOAIRC5
M@O!#!QI&^5JMZ9VFVJHESITL8:<@&!V'DPMW-L\L*6_Y>6"IYBXI>./*S:]7
M[N5S."O>7B)_C= !HXU(J659.I;-MJS3A3^QF9[8"_LH2@R-\BZPC XQNJ96
ML6QN)\%_),&3",9Z%_AB ,5@X*,PQ&<3F'(5M\@?+;VP5'JHO9FRD!$*XGMT
M91%0"+6/$<\*A8T F1EB(3!$6MKFQ(+CV^'--G9XKS0$^Z(G]3K*2CM\;5 G
M6")Q^G.&R,=6L4108LKT!,'9!SK'^4JU\+__EH1\;B] J.;(7M2,2!2;HV!V
M4]-<'$NS;Z@64;&B&3(4$L&!>\"<7M481-^V>=V';S]%EDVQ_D\(8\CGZ\%Q
M.8#),QD[(BEN@Z0+@M)W9GP$U.AKY:*4*?*%!4S?OQI0_[,2U?G)CATAS>^D
MG-[B C''IK@BFY*DW.^HF<$$QXZX%7;"+7@?#WD\]0N%_.O%;87R^7,B.^(F
M[:YOA6*J(/ 9;M%F?R9J26]VWDCM1BJYYBIN6G/QS<E=O<+GZA/5D5>47/==
MC>#$.DO\T3H+6!#Y+Y^?VL;3]T[^=ZFS^$WK+%[Z.^LL?@X&[J^JL^:E7UYE
M!G56063C=98H;%EG%7^PS@([_'(I6CU6^GY3Z/X^=5:R)2;46<6W.FN=F@IO
M==:.==8\DEM5K!O468)0_-OJK'E(MRI=Y^HL(9\J2E!K<;^E9FY79\WCMEM]
M^O?56?.X[5:?AG46+TH9_M>B]L<7/S^]SHJ\L]OFM=1J_?6J@.C[2*\46*XF
M&TJT/I_@.7[OC= ;H><EM,(^_TQF7V$?&Z\QV$/KYWI^X>(#;X$+6K:,?N6:
MBJV6#6PDU1JU7,[K[JMM?IK!O#'RYS.RPL>\"?M::;P:0-\8^5%&-@C*'JVU
M$3E1\:91>O8]0Y3IQ[Y+M/9X_7+*&XO(^FQMO+_^>2'@SH.ZJ7DLKL^[(?IT
M'MH@R5\V?C5S1X9Z^]09%Q*%VVA$5DP3Q'E@-OY:4F WG")@YR<(N!1;**2X
M ILJ%K=[];\]TN(,Z<A:_$2@!\+1-RM?&]<JO8U3O6<>B*0IFY5CP.T^3<.)
M$N#/9G+"BPS!:VB^N]-9,9VQQO]LZ&.2YSV>Q\^\;/.9;;$SVYJ^VJ46IK+)
M!C8QS('>+0Q'W.9? 6UM8"OM*\KF%E8V]Y9M@AU+E=WN2B<WC8%OMO5C 7US
M@Z*!V\7/%Z]_EAU58MD 2+#*B.S"H"V<*N/\W>;?;CZO$4UYW,*"A#<+>A71
M:><$TOL8AGA65NVO_9#J=0S#S,+"CWQ!A'59X.V@?5(9Y<Z%PKH]%#(B6)AJ
M]5LZ?MY$<,KE%@:VVR+QORX1S'H;CY1_;*.46==;[&6R-;GM=B)9X4$25B[6
MV&)SX@BJ55.O];,G;LI>0)1_O_"QHYC)1;]1#&U!6OQP,6B94(#O(;K17KJ+
M_2[I?EI[R#.,MFQH^KB$CN"!EJ.ET G6!YA* GC(IIL.-I5=-*GPR35HQLTO
M@9'P*_?EJ\QJ7*TY:1]_U;#\I7,MSF-6E#8&C=T.M.T0 A-N!QN?^2XBO@L:
MW:ZZI,M4*[&9OIW?(FQW3,..%C<U"Z<7Z J_;;Y\4CIF-7_3>,!J<>>OD+"K
MR'0CVL4E<4(^:5DBY9$IHV<5A8>H,KK#K?O[D:LJ.R_T6R%*8;DHX=XK6/44
M6C.1K"C@3>C^\\C[LC>R ! B [@91+HXNJ=31:%[ ""N* @INA<54()F:@K1
M'=55U+<A>LD(]QTKJU*WY" \4KJ@8A@Y0)@^&RS@X[+_X3)LD>=2'C/0EX-M
MRP'F4&L,<=6RZ'?I'00=5OH=T']42"&*0LK;6,K;^\]?-4Q9C.U'T"!PR]L
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MAE[^/U!+ 0(4 Q0    ( !*""5F+L;T+MA   ,QH   0              "
K 0    !E,C0S,S=?97@Q,#<N:'1M4$L%!@     !  $ /@   .00      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>e24337_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="AsOf2024-08-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
        </entity>
        <period>
            <startDate>2024-08-08</startDate>
            <endDate>2024-08-08</endDate>
        </period>
    </context>
    <context id="From2024-08-082024-08-08_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-08</startDate>
            <endDate>2024-08-08</endDate>
        </period>
    </context>
    <context id="From2024-08-082024-08-08_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000021344</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-08</startDate>
            <endDate>2024-08-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-08-08" id="Fact000003">0000021344</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="AsOf2024-08-08" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:SubmissnTp contextRef="AsOf2024-08-08" id="Fact000010">424B2</ffd:SubmissnTp>
    <dei:EntityRegistrantName contextRef="AsOf2024-08-08" id="Fact000011">The Coca-Cola Company</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="From2024-08-082024-08-08_1" id="Fact000019">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="From2024-08-082024-08-08_1" id="Fact000012">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2024-08-082024-08-08_1" id="Fact000013">3.375% Notes due 2037</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="From2024-08-082024-08-08_1" id="Fact000020">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="From2024-08-082024-08-08_1"
      decimals="INF"
      id="Fact000014"
      unitRef="Shares">500000000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2024-08-082024-08-08_1"
      decimals="INF"
      id="Fact000015"
      unitRef="USDPShares">0.98927</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="From2024-08-082024-08-08_1"
      decimals="INF"
      id="Fact000016"
      unitRef="USD">540190884</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="From2024-08-082024-08-08_1"
      decimals="INF"
      id="Fact000017"
      unitRef="Ratio">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="From2024-08-082024-08-08_1"
      decimals="INF"
      id="Fact000018"
      unitRef="USD">79732.17</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="From2024-08-082024-08-08_2" id="Fact000028">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="From2024-08-082024-08-08_2" id="Fact000021">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2024-08-082024-08-08_2" id="Fact000022">3.750% Notes due 2053</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="From2024-08-082024-08-08_2" id="Fact000029">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="From2024-08-082024-08-08_2"
      decimals="INF"
      id="Fact000023"
      unitRef="Shares">500000000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2024-08-082024-08-08_2"
      decimals="INF"
      id="Fact000024"
      unitRef="USDPShares">0.98339</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="From2024-08-082024-08-08_2"
      decimals="INF"
      id="Fact000025"
      unitRef="USD">536980110</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="From2024-08-082024-08-08_2"
      decimals="INF"
      id="Fact000026"
      unitRef="Ratio">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="From2024-08-082024-08-08_2"
      decimals="INF"
      id="Fact000027"
      unitRef="USD">79258.26</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2024-08-08"
      decimals="0"
      id="Fact000030"
      unitRef="USD">1077170994</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2024-08-08"
      decimals="INF"
      id="Fact000031"
      unitRef="USD">158990.43</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2024-08-08"
      decimals="0"
      id="Fact000032"
      unitRef="USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2024-08-08"
      decimals="0"
      id="Fact000033"
      unitRef="USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2024-08-08"
      decimals="INF"
      id="Fact000034"
      unitRef="USD">158990.43</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2024-08-082024-08-08_1" id="Fact000036"> &lt;span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__2_zUxVebWWxsdc"&gt;Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#x20ac;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form &lt;span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf"&gt;S-3&lt;/span&gt; (No. &lt;span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3"&gt;333-268053&lt;/span&gt;) filed by The Coca-Cola
    Company.&lt;/span&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="From2024-08-082024-08-08_2" id="Fact000037">Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#x20ac;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form &lt;span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf"&gt;S-3&lt;/span&gt; (No. &lt;span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3"&gt;333-268053&lt;/span&gt;) filed by The Coca-Cola
    Company.</ffd:OfferingNote>
    <ffd:FormTp contextRef="AsOf2024-08-08" id="Fact000038">S-3</ffd:FormTp>
    <ffd:RegnFileNb contextRef="AsOf2024-08-08" id="Fact000039">333-268053</ffd:RegnFileNb>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000016"
          xlink:label="Fact000016"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><xhtml:span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__1_zcgnD6TSXed9"><xhtml:span id="xdx_903_effd--OfferingNote_c20240808__20240808__ffd--OfferingAxis__2_zUxVebWWxsdc">Calculated
    in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a euro/dollar exchange rate of &#x20ac;1/$1.0921,
    as reported by Bloomberg on August 7, 2024, and relates to the Registration Statement on Form <xhtml:span id="xdx_903_effd--FormTp_c20240808__20240808_zGFJjSq5V3rf">S-3</xhtml:span> (No. <xhtml:span id="xdx_907_effd--RegnFileNb_c20240808__20240808_zxL269m0eoY3">333-268053</xhtml:span>) filed by The Coca-Cola
    Company.</xhtml:span></xhtml:span></xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
